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Cytochrome	  c	  oxidase	  (COX)	  is	  the	  terminal	  enzyme	  of	  the	  respiratory	  chain.	  Due	  to	  its	  
multimeric	  nature,	   assembly	  and	  maturation	   requires	   the	   concerted	  action	  of	  over	  20	  
assembly	  factors	  in	  yeast.	  COX	  is	  composed	  of	  both	  nuclear-­‐	  and	  mitochondria-­‐encoded	  
protein	   subunits.	   Its	   catalytic	   core	   is	   formed	  by	   three	  mitochondria-­‐encoded	   subunits	  
(Cox1,	   Cox2	   and	   Cox3)	   harboring	   essential	   prosthetic	   groups.	   This	   study	   analysed	  
different	   stages	   during	   early	   cytochrome	   c	   oxidase	   assembly	   steps	   and	   extends	   the	  
understanding	  of	  this	  process.	  
Upon	   separation	   of	   the	   ribosome-­‐binding	   and	  membrane-­‐insertion	   domains	   of	   Oxa1,	  
defects	   in	  COX	  assembly	  were	  observed	  while	  membrane	   integration	  of	  mitochondrial	  
translation	   products	   remained	   unaltered.	   These	   findings	   indicate	   that	   the	   Oxa1-­‐
ribosome	   complex	   serves	   as	   a	   platform	   for	   binding	   of	   COX	   assembly	   factors	   and	   is	  
therefore	  required	  for	  effective	  assembly	  of	  cytochrome	  c	  oxidase.	  	  
By	  using	  SILAC	  analysis,	  Mss51	  interaction	  partners	  from	  a	  complex,	  accumulating	  in	  a	  
COX	  assembly	  mutant	  (coa1Δ),	  were	  identified.	  This	  analysis	  demonstrated	  that	  the	  first	  
nuclear-­‐encoded	   subunits	   (Cox5a/Cox6)	   are	   added	   to	   assembly	   intermediates	   before	  
the	  release	  of	  Mss51,	  suggesting	  a	  new	  sequence	  of	  COX	  assembly	  events.	  Additionally,	  
the	   Mss51	   interactome	   identified	   Oms1,	   a	   potential	   novel	   factor	   involved	   in	   COX	  
assembly.	  	  
Interestingly,	   COX1	   translational	   regulation	   is	   uncoupled	   from	   COX	   assembly	   in	   cells,	  
expressing	   Shy1YD,	   a	   Leigh	   syndrome	   patient	   SURF1	  mutation,	   transferred	   to	   yeast.	   I	  
showed	   here	   that	   COX	   assembly	   intermediates	   accumulate	   in	   this	  mutant,	   explaining	  
the	  mechanism	  behind	  the	  uncoupling	  phenomenon.	  In	  an	  unbiased	  characterization	  of	  
Shy1-­‐containing	  complexes,	   the	  heme	  a	   synthase	  Cox15	  was	   found	  to	   form	  complexes	  
with	  Shy1.	  Furthermore,	  Cox15	  associates	  with	  COX	  assembly	   intermediates,	   allowing	  
insights	   into	   its	   role	   in	   the	   heme	   transfer	   mechanism	   during	   Cox1	   maturation.	  
Additional	   experiments	   suggested	   that	   Cox15	   displays	   a	   role	   in	   COX	   assembly	   that	   is	  







1.1.1	  Origin,	  evolution	  and	  morphology	  of	  mitochondria	  
The	   term	   “mitochondria”	  was	   first	   used	   in	   1897,	   describing	   an	   intracellular	   structure	  
that	   was	   first	   observed	   in	   the	   1840s.	   According	   to	   the	   endosymbiont	   theory,	  
mitochondria	  originate	  from	  the	  symbiosis	  of	  an	  aerobe	  bacterium	  (α-­‐proteobacterium)	  
(Sicheritz-­‐Pontén	  et	  al.	  1998;	  Gray	  et	  al.	  2001)	  with	  an	  eukaryotic	  ancestor	  cell.	  The	  vast	  
majority	   of	   the	   genetic	   information	   was	   transferred	   from	   the	   symbiont	   to	   the	   host	  
nucleus	   during	   evolution	   (Adams	   &	   Palmer	   2003;	   Bowles	   et	   al.	   2007),	   however	   the	  
exact	   mechanism	   for	   this	   phenomenon	   remains	   unclear.	   As	   a	   consequence,	  
mitochondria	  have	  to	  take	  up	  proteins,	  lipids	  and	  RNAs	  in	  order	  to	  fulfill	  their	  different	  
biochemical	   functions	   in	   the	   cell.	   Thus,	   mitochondria	   were	   transformed	   from	   a	  
symbiont	  to	  an	  organelle	  that	  got	  fully	  integrated	  into	  the	  cellular	  physiology	  (Dyall	  et	  
al.	   2004).	   Within	   cells,	   mitochondria	   form	   highly	   dynamic	   tubular	   networks	   that	  
undergo	  permanent	  fusion	  and	  fission	  processes	  (Hoppins	  et	  al.	  2007).	  	  
Mitochondria	  are	  enclosed	  by	  two	  phospholipid	  membranes	  with	  specific	  composition,	  
resulting	   in	   four	   mitochondrial	   sub-­‐compartments.	   The	   matrix	   is	   enclosed	   by	   the	  
mitochondrial	   inner	  membrane	  and	  the	   intermembrane	  space	  separates	  the	   inner	  and	  
outer	   membrane.	   Each	   compartment	   has	   features	   that	   allow	   them	   to	   carry	   out	  
specialized	  functions.	  The	  outer	  mitochondrial	  membrane	  encloses	  the	  entire	  organelle	  
and	   contains	   large	   numbers	   of	   integral	   proteins	   called	   porins	   that	   form	   channels	  
allowing	  small	  molecules	  to	  freely	  diffuse	  from	  one	  side	  of	  the	  membrane	  to	  the	  other.	  
Larger	  proteins	  are	  actively	   transported	  across	   the	  outer	  mitochondrial	  membrane	  by	  
the	  translocase	  of	  the	  outer	  membrane	  (Endo	  &	  Yamano	  2010).	  For	  the	  exchange	  of	  e.g.	  
lipids	  and	  calcium,	  the	  outer	  mitochondrial	  membrane	  can	  form	  contact	  sites	  with	  other	  
organelles,	  such	  as	  the	  endoplasmic	  reticulum	  membrane	  (de	  Brito	  &	  Scorrano	  2010).	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Unlike	   the	   outer	   membrane,	   the	   inner	   membrane	   is	   highly	   impermeable	   to	   most	  
molecules.	   In	   order	   to	   fulfill	   its	   functions,	   the	   mitochondrial	   inner	   membrane	   is	  
extremely	  rich	  in	  proteins,	  harboring	  for	  example	  the	  oxidative	  phosphorylation	  system	  
and	  the	  translocase	  of	  the	  inner	  membrane.	  Furthermore,	  this	  membrane	  is	  rich	  in	  the	  
unusual	   phospholipid	   cardiolipin	   that	   is	   also	   found	   in	   bacterial	   plasma	   membranes	  
(Hoch	   1992).	   In	   order	   to	   increase	   the	  membrane	   surface	   and	   therefore	   the	   ability	   to	  
produce	  energy,	   the	   inner	  membrane	   forms	  characteristic	   invaginations,	  called	  cristae	  
(Frey	   et	   al.	   2002).	   The	   matrix,	   enclosed	   by	   the	   inner	   membrane,	   contains	   metabolic	  
enzymes	  but	  also	  the	  mitochondrial	  DNA	  and	  mitochondrial	  ribosomes.	  
Even	   though	   most	   genetic	   information	   of	   the	   endosymbiont	   was	   transferred	   to	   the	  
nucleus,	  mitochondria	  maintained	  their	  own	  genome	  and	  translational	  machinery.	  The	  
reason	  is	  speculated	  to	  be	  the	  high	  hydrophobicity	  of	  the	  encoded	  proteins	  which	  would	  
complicate	   the	   transport	   across	   two	   membranes	   (Wallace	   2007).	   The	   mitochondrial	  
DNA	   is	   an	   extra-­‐chromosomal	   element	   that	   is	   inherited	   in	   a	  non-­‐mendelian,	  maternal	  
fashion.	  
Due	   to	   the	   dual	   genetic	   origin	   of	   mitochondrial	   proteins,	   coordination	   of	   the	  
mitochondrial	  protein	  expression	  and	  import	  during	  biogenesis	  is	  essential	  to	  maintain	  
a	  functional	  organelle.	  
1.1.2	  Mitochondrial	  functions	  
Mitochondria	   are	   best	   known	   for	   the	   production	   of	   ATP	   and	   therefore	   are	   often	  
described	  by	   the	  popular	   term	   “powerplant	   of	   the	   cell”.	   Thus,	  mitochondria	   carry	  out	  
oxidative	  phosphorylation,	  the	  controlled	  burning	  of	  nutrients,	  coupled	  to	  the	  synthesis	  
of	  ATP	  with	   its	  high-­‐energy	  phosphate	  bonds	  (Mitchell	  &	  Moyle	  1968)	   that	   is	  used	  by	  
the	   majority	   of	   cellular	   processes.	   In	   addition	   to	   their	   central	   role	   in	   ATP	   synthesis,	  
mitochondria	   fulfill	   a	   number	   of	   other	   vital	   cellular	   functions.	   Central	   metabolic	  
pathways,	  like	  the	  citric	  acid	  cycle	  and	  the	  β-­‐oxidation	  of	  fatty	  acids	  are	  accommodated	  
in	   mitochondria	   .	   Besides	   these	   functions,	   mitochondria	   also	   provide	   the	   cell	   with	   a	  
number	  of	  metabolites	  such	  as	  amino	  acids	  and	  steroids.	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In	  contrast	   to	  the	  general	  believe,	   the	  ATP	  production	  by	  oxidative	  phosphorylation	   is	  
not	   essential	   in	   many	   organisms;	   however,	   iron-­‐sulfur	   cluster	   biogenesis	   in	  
mitochondria	  is	  an	  essential	  process	  for	  all	  life	  even	  in	  non-­‐respiring	  organisms	  (Kispal	  
et	  al.	  2005).	  In	  many	  organisms	  the	  respiratory	  function	  of	  mitochondria	  is	  dispensable	  
or	  has	  been	  lost,	  e.g.	  the	  yeast	  S.	  cerevisiae	  is	  able	  to	  ferment	  sugar	  to	  produce	  ATP.	  Iron-­‐
sulfur	   clusters	   are	   essential	   co-­‐factors	   for	   a	   variety	   of	   cytosolic	   enzymes	   but	   also	   for	  
mitochondrial	  proteins,	  involved	  in	  electron-­‐transfer	  processes	  (Lill	  2009).	  
Mitochondria	   also	   execute	   functions	   related	   to	   cell	   death	   in	   higher	   eukaryotes	  
(Martinou	  &	  Youle	  2011),	   calcium	  signaling	  and	  storage	   (Rimessi	  et	  al.	  2008)	  and	  are	  
also	   the	   main	   source	   of	   reactive	   oxygen	   species	   (ROS) as	   inevitable	   by-­‐products	   of	  
cellular	  respiration	  (Pan	  2011).	  
Due	   to	   central	   roles	   of	   mitochondria	   in	   energy	   production,	   reactive	   oxygen	   species	  
biology,	   apoptosis	   and	  other	   cellular	  processes,	   their	   dysfunction	   is	   implicated	  with	   a	  
diverse	  set	  of	  human	  mitochondrial	  disorders	  and	  diseases	  (see	  section	  1.1.6).	  
1.1.3	  Oxidative	  Phosphorylation	  system	  
Mitochondria	   oxidize	   nutrients	   via	   oxidative	   phosphorylation	   (OXPHOS)	   in	   order	   to	  
generate	   energy.	   The	  mitochondrial	  OXPHOS	   system	   consists	   of	   two	   sub-­‐systems,	   the	  
electron	  transport	  chain	  (ETC),	  composed	  of	  complexes	  I–IV,	  and	  the	  ATP	  synthase	  (or	  
complex	   V).	   The	   respiratory	   chain	   transfers	   electrons	   from	   reducing	   equivalents	  
(NADH,	  FADH2),	  produced	  by	  e.g.	  the	  citric	  acid	  cycle	  within	  mitochondria,	  to	  molecular	  
oxygen.	   The	   electron	   flux	   is	   coupled	   to	   proton	   pumping	   and	   therefore	   generates	   a	  
proton	   gradient	   across	   the	   inner	   mitochondrial	   membrane	   (Δψ) (Hosler	   et	   al.	   2006).	  
This	   gradient	   drives	   the	   ATP	   synthesis	   via	   the	   F1FO-­‐ATP-­‐synthase	   (Mitchell	   &	   Moyle	  
1968;	  Yoshida	  et	  al.	  2001)	  (FIG	  1.1).	  
	  





FIG	  1.1	  Oxidative	  Phosphorylation	  system	  in	  mitochondria	  
(A)	  Shown	  are	  the	  respiratory	  chain	  complexes	  II-­‐IV	  and	  the	  F1FO-­‐ATP	  synthase	  (V)	  in	  the	  inner	  mitochondrial	  
membrane	  of	  S.	  cerevisiae	  mitochondria	  (B)	  Respiratory	  chain	  complexes	  I-­‐IV	  and	  the	  F1FO-­‐ATP	  synthase	  (V)	  in	  
the	  inner	  mitochondrial	  membrane	  of	  mammalian	  mitochondria.	  Electron	  flux	  (e-­‐)	  along	  the	  respiratory	  chain	  is	  
illustrated.	  Brown	  arrows	  indicate	  proton	  (H+)	  flux	  across	  the	  inner	  membrane.	  Coenzyme	  Q	  (CoQ),	  cytochrome	  
c	  (Cyt	  c),	  intermembrane	  space	  (IMS).	  Mitochondria-­‐encoded	  subunits	  are	  depicted	  in	  red	  
	  
In	   detail,	   electrons	   are	   passed	   from	   the	   NADH	   dehydrogenase	   (complex	   I)	   and	   the	  
succinate	  dehydrogenase	   (complex	   II)	   to	   coenzyme	  Q	   (CoQ).	  Coenzyme	  Q	  shuttles	   the	  
electrons	   further	  to	  the	  cytochrome	  bc1	  complex	  (or	  cytochrome	  c	   reductase;	  complex	  
III).	  Subsequently,	  electrons	  are	  transferred	  to	  the	  mobile	  carrier	  cytochrome	  c	  and	  to	  
the	   cytochrome	   c	   oxidase	   (complex	   IV).	   This	   terminal	   oxidase	   uses	   the	   electrons	   to	  
reduce	  molecular	  oxygen	  to	  water.	  All	  OXPHOS	  complexes	  are	  multi-­‐subunit	  complexes	  
that	   are,	   with	   the	   exception	   of	   complex	   II,	   composed	   of	   mitochondrial-­‐	   and	   nuclear-­‐
encoded	  subunits.	  	  
Despite	   the	   functional	   conservation	   of	   the	   mitochondrial	   oxidative	   phosphorylation	  
system,	  the	  composition	  of	  the	  complexes	  varies	  between	  species.	  FIG	  1.1	  illustrates	  the	  
S.	  cerevisiae	   (A)	   and	   the	   mammalian	   (B)	   OXPHOS	   systems	   and	   their	   differences.	   In	  
S.	  cerevisiae,	   no	   complex	   I	   but	   small	   proteins,	   fulfilling	   a	   similar	   function	   in	   electron	  
transfer	   to	  CoQ,	  are	   found	   (Grandier-­‐Vazeille	  et	  al.	  2001).	  However,	   in	   contrast	   to	   the	  
mammalian	  system,	  these	  proteins	  do	  not	  contribute	  to	  the	  proton	  gradient	  across	  the	  
inner	  mitochondrial	  membrane.	  The	  yeast	  and	  the	  mammalian	  OXPHOS	  complexes	  also	  
show	   differences	   in	   the	   total	   number	   of	   subunits	   and	   the	   number	   of	   mitochondria-­‐
encoded	  subunits	  (compare	  FIG	  1.2).	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Although	  respiratory	  chain	  complexes	  II,	  III	  and	  IV	  have	  been	  crystallized	  as	  individual	  
complexes,	  they	  can	  be	  visualized	  by	  BN-­‐PAGE	  after	  mild	  solubilization	  of	  mitochondrial	  
membranes	   as	   higher	   homo-­‐	   and	   heterooligomers,	   called	   supercomplexes	   or	  
respirasomes	  (Schägger	  &	  Pfeiffer	  2000;	  M.	  Zhang	  et	  al.	  2002).	  It	  is	  however	  still	  under	  
debate	   whether	   respiratory	   chain	   complexes	   are	   free	   moving	   entities,	   linked	   by	   the	  
mobile	  electron	  carriers	   (fluid	  model)	   (Hackenbrock	  et	  al.	  1986)	  or	   if	   they	  are	   indeed	  
organized	  in	  supercomplexes	  (solid	  model)	  (Schägger	  &	  Pfeiffer	  2000).	  The	  solid	  model	  
is	   challenged	   by	   the	   lack	   of	   evidence	   for	   the	   existence	   of	   supercomplexes	   in	   vivo.	  
Furthermore	  the	  functional	  role	  of	  supercomplexes	  is	  not	  clear.	  The	  rational	  behind	  the	  
formation	   of	   these	   supercomplexes	   is	   believed	   to	   be	   the	   optimization	   of	   electron	  
transport	   and	   the	   reduction	  of	  distances	   for	   the	  mobile	   electron	  carriers	  between	   the	  
complexes	   (Acín-­‐Pérez	   et	   al.	   2008).	   Using	   BN-­‐PAGE	   analysis	   of	   solubilized	   yeast	  
mitochondria,	   complex	   III	   is	   found	  as	  a	  dimer	  (III2)	  as	  well	  as	   in	  complex	  with	  one	  or	  
two	  copies	  of	  complex	  IV	  (III2IV,	  III2IV2).	  In	  mammals,	  complex	  III	  dimers	  associate	  with	  
complex	   I	  and	  complex	   IV	   in	  various	  supercomplexes.	  The	  F1FO-­‐ATP-­‐sythase	  (complex	  
V)	  does	  not	  form	  hetero-­‐oligomers	  and	  is	   found	  in	  its	  monomeric	  and	  (homo-­‐)dimeric	  
form	   (V,	  V2)	   (Arnold	   et	   al.	   1998).	  The	  dimeric	   form	  of	   complex	  V	   is	   formed	  at	   a	   fixed	  
angle	  and	  leads	  to	  membrane	  curvature	  (Paumard	  et	  al.	  2002;	  Zick	  et	  al.	  2009).	  	  
A	   recent	   study	   in	   mouse	   fibroblasts	   suggests	   that	   the	   organization	   into	   higher	  
supercomplexes	  defines	  dedicated	  CoQ	  and	  cytochrome	  c	  pools	  and	  that	  supercomplex	  
assembly	   is	   dynamic	   and	   organizes	   electron	   flux	   to	   optimize	   the	   use	   of	   available	  
substrates	  (Lapuente-­‐Brun	  et	  al.	  2013).	  The	  same	  study	  suggests	  that	  the	  solid	  and	  fluid	  
state	  are	  just	  the	  very	  extremes	  of	  an	  equilibrium	  that	  the	  cell	  uses	  to	  adapt	  to	  varying	  
carbon	  sources.	  
Supercomplex	  assembly	  factors	  are	  a	  matter	  of	  recent	  research.	  The	  yeast	  proteins	  Rcf1	  
and	  Rcf2	  are	  proposed	  to	  be	  supercomplex	  III:IV	  assembly	  factors	  (Vukotic	  et	  al.	  2012;	  
Y.-­‐C.	   Chen	   et	   al.	   2012;	   Strogolova	   et	   al.	   2012)	   In	  mammals,	   a	   factor	   required	   for	   the	  
correct	  assembly	  of	  supercomplexes	  (SCAF1,	  originally	  termed	  Cox7A21),	  was	  recently	  
identified	  (Lapuente-­‐Brun	  et	  al.	  2013).	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1.1.4	  Mitochondrial	  genome/	  dual	  genetic	  origin	  of	  mitochondrial	  proteome	  
Prior	  to	  the	  symbiosis	  of	  the	  proto-­‐mitochondrion	  and	  the	  host	  cell,	  both	  had	  genomes	  
sufficient	   for	   their	   independent	   lifestyles	   (Wallace	   2007).	   However,	   upon	   transfer	   of	  
genes	   to	   the	   nucleus,	   mitochondria	   were	   no	   longer	   independent	   but	   kept	   the	   core	  
machineries	   for	   their	   biogenesis:	   Mitochondria	   retained	   their	   own	   genome,	   encoding	  
for	  tRNAs,	  rRNA	  and	  8	  proteins	  in	  yeast	  (13	  proteins	  in	  human).	  The	  proteins	  encoded	  
by	  the	  mtDNA	  are	  mainly	  the	  hydrophobic	  subunits	  of	  the	  respiratory	  chain	  complexes.	  
In	  most	  species	  the	  mitochondrial	  genome	  is	  a	  circular	  DNA	  molecule,	  containing	  very	  
compact	  genetic	   information.	  The	  mitochondrial	  DNA	   is	   inherited	   in	  a	  non-­‐mendelian,	  
maternal	  fashion.	  In	  humans	  and	  animals	  this	  is	  achieved,	  in	  part,	  by	  the	  dilution	  of	  the	  
sperm	  mtDNAs	   by	   ovarian	  mtDNAs	   at	   fertilization,	   the	   oocyte	   having	   over	   100,000	  
mtDNA	   copies	   whereas	   the	   sperm	   only	   has	   hundreds	   (X.	   Chen	   et	   al.	   1995)	   (residual	  
paternal	  mtDNAs	  are	  selectively	  removed	  in	  animals).	  
Although	  the	  genes	  encoded	  by	  the	  mitochondrial	  genome	  vary	  between	  species	  for	  not	  
yet	   fully	   understood	   reasons,	   there	   is	   a	  minimal	   set	   of	   proteins	   that	   is	  mitochondria-­‐
encoded	   in	   all	   eukaryotes:	  All	  mtDNAs	  analysed	   to	  date	   contain	  COB	   and	  COX1	   genes,	  
which	  are	  central	  to	  coupling	  electron	  transport	  to	  proton	  pumping	  in	  complexes	  III	  and	  
IV,	  respectively	  (Wallace	  2007).	  
	  In	   the	   yeast	   Saccharomyces	   cerevisiae,	   eight	   proteins	   are	   synthesized	   in	   the	  
mitochondrial	  matrix:	  cytochrome	  b	  (Cob)	  of	  the	  bc1	  complex;	  subunits	  1–3	  (Cox1,	  Cox2,	  
and	  Cox3)	  of	  cytochrome	  c	  oxidase;	  Atp6,	  Atp8,	  and	  Atp9	  of	  the	  F1FO-­‐ATP-­‐synthase;	  and	  
the	  ribosomal	  protein	  Var1	  .	  In	  order	  to	  express	  these	  proteins,	  mitochondria	  retained	  a	  
complete	  expression	  machinery.	  
Mitochondria	   contain	   around	   1000	   mitochondrial	   proteins	   in	   yeast	   (Sickmann	   et	   al.	  
2003;	  Reinders	  et	  al.	  2006;	  Premsler	  et	  al.	  2009).	  99%	  of	  these	  proteins	  are	  of	  cytosolic	  
origin,	  translated	  at	  cytosolic	  ribosomes	  as	  precursor	  forms	  and	  subsequently	  imported	  
into	   mitochondria.	   In	   contrast,	   the	   mitochondria-­‐encoded	   subunits	   are	   translated	   on	  
membrane-­‐bound	  mitochondrial	   ribosomes	   and	   inserted	   into	   the	   inner	  mitochondrial	  
membrane	  in	  a	  co-­‐translational	  manner	  by	  the	  Oxa1	  machinery	  (FIG	  1.2).	  The	  number	  
of	  nuclear	  and	  mitochondria-­‐encoded	  subunits	  of	  the	  OXPHOS	  complexes	  (of	  mammals	  
and	   yeast)	   are	   depicted	   in	   FIG	   1.2.	   The	   dual	   genetic	   origin	   of	  mitochondrial	   proteins	  
requires	   a	   coordination	   of	   the	   mitochondrial	   protein	   expression	   and	   import	   during	  
organellar	  biogenesis.	  
	  





FIG	  1.2	  Biogenesis	  of	  respiratory	  chain	  complexes	  
Respiratory	  chain	  complexes	  are	  composed	  of	  subunits	  of	  dual	  genetic	  origin.	  Number	  of	  subunits	  per	  complex,	  
encoded	  by	  the	  mitochondrial	  genome	  (mtDNA)	  are	  depicted	  in	  red,	  number	  of	  subunits,	  encoded	  by	  the	  nuclear	  
genome	   (nDNA)	   in	   blue.	   Numbers	   are	   indicated	   for	   mammalian	   OXPHOS	   complexes	   (for	   S.	   cerevisiae	   in	  
brackets).	   Cytosolic	   precursor	   proteins	   (blue)	   contain	   information	   that	   targets	   them	   to	   mitochondria	   (+++).	  
Precursors	  are	  directed	  to	  the	  inner	  mitochondrial	  membrane	  by	  the	  translocase	  of	  the	  outer	  membrane	  (TOM)	  
and	   the	   presequence	   translocase	   of	   the	   inner	  membrane	   (TIM23)	   complexes.	  Mitochondria-­‐encoded	   proteins	  
(red)	   are	   inserted	   into	   the	   inner	   mitochondrial	   membrane	   in	   a	   co-­‐translational	   manner	   by	   the	   translocase	  
oxidase	   assembly	   (Oxa1)	   machinery	   and	   assemble	   together	   with	   imported	   proteins	   into	   mature	   respiratory	  
chain	  complexes.	  Outer	  membrane	  (OM),	  intermembrane	  space	  (IMS),	  inner	  membrane	  (IM)	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1.1.5	  Mitochondrial	  protein	  biogenesis	  
1.1.5.1	  Import	  pathways	  for	  nuclear-­‐encoded	  proteins	  
Following	  translation	  on	  cytosolic	  ribosomes,	  precursor	  proteins	  are	  bound	  by	  cytosolic	  
chaperones	   (Young	   et	   al.	   2003)	   and	   imported	   into	   mitochondria	   along	   various	  
pathways	  (Becker	  et	  al.	  2012).	   It	   is	  widely	  accepted	   that	   import	  of	  precursor	  proteins	  
into	  mitochondria	  occurs	  in	  a	  post-­‐translational	  manner. 
In	   general,	   precursor	   proteins	   are	   transported	   across	   or	   into	   the	   outer	  membrane	   by	  
the	   TOM	   complex	   (Hill	   et	   al.	   1998;	   Künkele	   et	   al.	   1998;	   Model	   et	   al.	   2008).	   After	  
traversing	   the	   outer	   membrane,	   transport	   mechanisms	   diverge,	   depending	   on	   the	  
targeting	  information	  present	  in	  the	  precursor	  proteins.	  A	  precursor	  protein	  is	  further	  
transported	   to	   its	   destination	   (outer	  membrane,	   IMS,	   inner	  membrane	   or	  matrix)	   by	  
specialized	   import	   machineries	   (Neupert	   &	   Herrmann	   2007;	   Chacinska	   et	   al.	   2009;	  
Dudek	  et	  al.	  2013).	  
The	   most	   prevalent	   mitochondrial	   import	   signal	   is	   an	   N-­‐terminal	   extension	   termed	  
presequence	   that	   is	   present	   in	   about	   70%	   of	   mitochondrial	   precursors	   (Vögtle	   et	   al.	  
2009)	   and	   forms	   an	   amphipathic	   α-­‐helix	   with	   a	   net	   positive	   charge	   (Heijne	   1986).	  
Presequence-­‐containing	   proteins	   are	   inserted	   into	   the	   inner	   membrane	   or	   imported	  
into	   the	  matrix	   by	   the	   translocase	   of	   the	   inner	  membrane	   23	   (TIM23)	   (Becker	   et	   al.	  
2012;	  Dudek	  et	  al.	  2013).	  	  
Complete	  matrix	   translocation	   of	   pre-­‐proteins	   depends	   both	   on	  Δψ	   as	  well	   as	   on	   the	  
additional	   activity	   of	   the	   presequence	   translocase-­‐associated	   import	   motor,	   PAM	  
(reviewed	   by	   Van	   Der	   Laan	   et	   al.	   2010).	   Most	   N-­‐terminal	   presequences	   are	  
proteolytically	   removed	   after	   import	   by	   the	   mitochondrial	   processing	   peptidase	   and	  
other	  proteases,	  resulting	  in	  an	  N-­‐terminal	  truncation	  of	  the	  mature	  protein.	  (Taylor	  et	  
al.	  2001;	  Mossmann	  et	  al.	  2012).	  However,	  some	  proteins	  contain	  presequences	  that	  are	  
followed	   by	   a	   hydrophobic	   sorting	   signal.	   This	   sorting	   signal	   induces	   translocation	  
arrest	   and	   the	   lateral	   release	   of	   preproteins	   (lateral	   sorting)	   into	   the	   inner	  
mitochondrial	   membrane	   by	   a	   stop-­‐	   transfer	   mechanism	   (Van	   Der	   Laan	   et	   al.	   2006;	  
Bohnert	   et	   al.	   2010).	  Lateral	  membrane	   integration	  of	  proteins	  depends	  on	  Δψ	   as	   the	  
sole	   energy	   source.	   The	   inner	  membrane	   protease	   (IMP)	   cleaves	   off	   the	   hydrophobic	  
sorting	   signal	   of	   some	   of	   these	   proteins,	   which	   subsequently	   remain	   soluble	   in	   the	  
intermembrane	  space	  (Koppen	  &	  Langer	  2007;	  Mossmann	  et	  al.	  2012;	  Teixeira	  &	  Glaser	  
2013).	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Another	  type	  of	  inner	  membrane	  proteins	  is	  initially	  imported	  to	  the	  matrix	  in	  a	  PAM-­‐
dependent	   manner	   and	   subsequently	   membrane-­‐inserted	   with	   the	   help	   of	   the	  
evolutionary	   conserved	   export	   translocase	   Oxa1	   (Hell	   et	   al.	   1998;	   Jia	   et	   al.	   2007;	  
Bohnert	   et	   al.	   2010).	   This	  mechanism	   is	   known	   as	   “conservative	   sorting”	   (Neupert	  &	  
Herrmann	   2007).	   Oxa1	   closely	   cooperates	   with	   the	   TIM23–PAM	   machinery	   for	   the	  
biogenesis	   of	   nuclear-­‐encoded	   multi-­‐spanning	   inner	   membrane	   proteins	   (Reif	   et	   al.	  
2005;	  Bohnert	   et	   al.	   2010).	  The	   term	   “conservative	   sorting”	  was	   initially	  used	   for	   the	  
sorting	  pathway	  of	  the	  Rieske	  iron-­‐sulfur	  protein	  (Rip1).	  This	  protein	  consists	  of	  a	  large	  
C-­‐terminal	  IMS	  domain	  that	  contains	  the	  iron	  sulfur	  cluster.	  In	  vitro	  import	  experiments	  
indicate	   that	   the	   entire	   precursor	   is	   initially	   imported	   into	   the	   matrix	   (Nett	   &	  
Trumpower	  1996)	  where	   the	   iron-­‐sulfur	   cluster	   is	   incorporated	   into	   the	  protein.	   The	  
catalytic	   domain	   is	   subsequently	   exported	   into	   the	   IMS	   and	  only	   then	   assembled	   into	  
the	  bc1	  complex	  (Golik	  et	  al.	  2003).	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1.1.5.2	  Mitochondrial	  protein	  export	  
Mitochondria-­‐encoded	   membrane	   proteins	   that	   are	   translated	   on	   membrane	   bound	  
mitochondrial	   ribosomes	   have	   to	   be	   integrated	   into	   the	   inner	   membrane	   in	   a	  
co-­‐translational	  manner.	  This	  process	  has	  been	  termed	  export	  and	  is	   facilitated	  by	  the	  
mitochondrial	   export	   machinery	   (OXA	   -­‐	   for	   oxidase	   assembly).	   The	   OXA	   complex	  
consists	  of	  Oxa1	  as	  core	  subunit	  (Nargang	  et	  al.	  2002;	  Kohler	  et	  al.	  2009).	  Oxa1	  belongs	  
to	   a	   conserved	   protein	   family	   known	   as	   YidC/Alb3/Oxa1	   family,	   the	   bacterial,	  
mitochondrial	  and	  plastid	  members	  of	  which	  assist	  the	  membrane	  insertion	  of	  proteins	  
(Bonnefoy	   et	   al.	   2009;	   Wang	   &	   Dalbey	   2011).	   Oxa1	   is	   an	   integral	   inner	   membrane	  
protein	  that	  contains	  five	  trans-­‐membrane	  domains	  and	  presents	  N	  out–C	  in	  orientation	  
(Luirink	   et	   al.	   2001;	   Stoldt	   et	   al.	   2012).	   By	   cooperation	   with	   the	   membrane	   protein	  
Mba1,	  which	  acts	  as	  a	  ribosome	  receptor,	  Oxa1	  orients	  the	  ribosome	  exit	  site	   towards	  
the	  inner	  membrane	  insertion	  machinery	  (Ott	  et	  al.	  2006;	  Hell	  et	  al.	  2001).	  However,	  so	  
far	  uncharacterized	  additional	  membrane	  anchors	  apparently	  exist,	   as	  both	  ribosomal	  
subunits	  remain	  membrane-­‐bound	  even	  in	  the	  absence	  of	  Oxa1	  and	  Mba1.	  
Oxa1	   is	   particularly	   involved	   in	   Cox2	   biogenesis:	   Cox2	   is	   synthesized	   as	   a	   precursor	  
protein	  (pCox2)	  with	  a	  cleavable	  amino	  terminal	  extension.	  Prior	  to	  the	  cleavage,	  pCox2	  
interacts	   with	   the	   Oxa1	   machinery	   which	   facilitates	   membrane	   insertion	   of	   the	   first	  
pCox2	  transmembrane	  domain	  and	  concomitant	  export	  of	  its	  N-­‐terminal	  domain	  across	  
the	  inner	  membrane	  (reviewed	  in	  Soto	  et	  al.	  2012).	  
However,	   Oxa1	   is	   required	   not	   only	   for	   the	   membrane	   insertion	   of	   mitochondria-­‐
encoded	  proteins	  but	  is	  also	  a	  crucial	  factor	  for	  the	  export	  of	  nuclear-­‐encoded	  subunits	  
of	   respiratory	   chain	   complexes:	   Oxa1	   mediates	   the	   conservative	   sorting	   pathway	   of	  
presequence-­‐containing	  inner	  membrane	  proteins	  that	  are	  initially	  transported	  into	  the	  
matrix	  before	  they	  are	  inserted	  into	  the	  inner	  membrane	  (described	  in	  section	  1.1.5.1).	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1.1.6	  Mitochondria	  associated	  diseases	  
Mitochondrial	   diseases	   are	   a	   diverse	   group	   of	   disorders	   caused	   by	   dysfunctional	  
mitochondria.	  These	  diseases	  may	  be	  the	  result	  of	  spontaneous	  or	  inherited	  mutations	  
in	   the	   mitochondrial	   genome	   or	   in	   nuclear	   genes	   that	   code	   for	   mitochondrial	  
components.	  In	  about	  15%	  of	  the	  cases,	  mitochondrial	  function	  is	  affected	  by	  defects	  in	  
the	   mitochondrial	   DNA	   (Dimauro	   &	   Davidzon	   2005).	   Diseases	   related	   to	   mtDNA	  
mutations	   are	   transmitted	   by	   non-­‐mendelian,	   maternal	   inheritance.	   In	   addition,	  
mitochondrial	  dysfunction	  may	  also	  be	  caused	  by	  secondary	  effects	  of	  drugs,	  infections,	  
or	  other	  environmental	  causes.	  Mitochondrial	  disorders	  in	  humans	  are	  not	  rare:	  when	  
studies	   in	  children	  and	  adults	  are	  combined	  and	  both	  nuclear	  DNA	  and	  mitochondrial	  
DNA	  mutations	  are	  considered,	  the	  minimum	  prevalence	  is	  at	  least	  1	  in	  5000	  (Schaefer	  
et	  al.	  2004).	  Deficiencies	  in	  mitochondrial	  function	  often	  affect	  multiple	  tissues,	  leading	  
to	  multi-­‐systemic	  diseases	  that	  present	  with	  pleiotropic	  phenotypic	  features	  (Scharfe	  et	  
al.	  2009).	  The	  effects	  of	  mitochondrial	  disease	  can	  be	  quite	  varied	  since	  the	  distribution	  
of	  the	  defective	  mitochondrial	  DNA	  varies	  from	  organ	  to	  organ	  within	  the	  body	  and	  each	  
mutation	   is	   modulated	   by	   other	   genome	   variants.	   Defects	   in	   nuclear-­‐encoded	  
mitochondrial	   genes	   are	   associated	   with	   hundreds	   of	   clinical	   disease	   phenotypes	  
including	   anemia,	   dementia,	   hypertension,	   lymphoma,	   retinopathy,	   seizures,	   and	  
neurodevelopmental	   disorders.	   However,	   since	   heart,	   skeletal	   muscle,	   and	   brain	   are	  
among	   the	  most	  energy-­‐dependent	   tissues	  of	   the	  body,	  many	  mitochondrial	  disorders	  
present	   themselves	   as	   encephalo-­‐cardiomyopathies.	   Encephalomyopathies	   have	  
traditionally	   been	   described	   as	   defects	   of	   the	   respiratory	   chain,	   however	   other	  
important	  mitochondrial	   functions	   including	   protein	   import,	   organellar	   dynamics	   and	  
programmed	  cell	  death	  can	  also	  be	  affected	  (Dimauro	  &	  Schon	  2008).	  
Mitochondrial	  encephalomyopathy,	  lactic	  acidosis,	  and	  stroke-­‐like	  episodes	  (MELAS)	  is	  
a	   family	   of	   mitochondrial	   disorders	   that	   are	   caused	   exclusively	   by	   defects	   in	   the	  
mitochondrial	   genome.	   The	   MELAS	   family	   includes	   also	   the	   MERRF	   syndrome	  
(Myoclonic	  Epilepsy	  with	  Ragged	  Red	  Fibers)	  and	  Leber´s	  hereditary	  optic	  neuropathy	  
(LHON).	  All	   pathogenic	  LHON	  point	  mutations	   affect	   genes	   in	   the	  mitochondrial	  DNA,	  
encoding	   for	   subunits	   of	   complex	   I	   of	   the	   respiratory	   chain	   (Wallace	   et	   al.	   1988;	  
Dimauro	  &	  Schon	  2008).	  The	  MERRF	  syndrome	  is	  mainly	  caused	  by	  a	  point	  mutation	  in	  
the	   mitochondrial	   gene	   for	   tRNA-­‐Lys	   thereby	   disrupting	   the	   synthesis	   of	   proteins	  
essential	  for	  oxidative	  phosphorylation	  (Dimauro	  et	  al.	  2002).	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Leigh	   syndrome,	   an	   infantile	   subacute	   necrotizing	   encephalomyelopathy,	   caused	   by	  
disorders	   of	   the	   oxidative	   phosphorylation	   system	   is	   implicated	   with	   mutations	   in	  
either	   the	   mitochondrial	   or	   nuclear	   DNA.	   Over	   30	   genes	   have	   been	   linked	   to	   Leigh	  
syndrome,	  including	  SURF1	  and	  other	  assembly	  factors	  of	  cytochrome	  c	  oxidase	  (Tiranti	  
et	  al.	  1998;	  Zhu	  et	  al.	  1998;	  Y.	  Zhang	  et	  al.	  2007;	  Finsterer	  2008).	  
	  
Leigh	   syndrome	   (LS)	   is	   a	   fatal	   neurodegenerative	   condition,	   pathologically	  
characterized	  by	  subacute	  symmetrical	  necrotic	  lesions	  in	  the	  subcortical	  regions	  of	  the	  
central	  nervous	   system,	   first	  described	   in	  1951	   (Leigh	  1951).	   LS	   is	   the	  most	   common	  
mitochondrial	  disorder	  of	   infancy	  with	  a	  prevalence	  of	  1:40000	  (Rahman	  et	  al.	  1996).	  
The	   syndrome	   results	   from	   impaired	   mitochondrial	   energy	   metabolism,	   in	   detail	   by	  
respiratory	   chain	   defects	   or	   in	   rare	   cases	   defects	   of	   the	   pyruvate	   dehydrogenase	  
complex.	   LS	   can	   be	   caused	   by	   maternally	   inherited	   mutations	   in	   the	   mtDNA,	   but	  
inheritance	   can	   also	   be	   autosomal-­‐recessive	   or	   X-­‐linked.	   A	   number	   of	   different	  
mutations	   in	   nuclear	   or	   mitochondrial	   genes	   are	   found	   in	   patients	   (Finsterer	   2008):	  
mutations	  affecting	  subunits	  of	  complex	  I,	  mutations	  affecting	  complex	  II,	  complex	  IV	  or	  
the	  F1FO-­‐ATP-­‐synthase.	  Over	  30	  genes	  have	  been	   linked	   to	  Leigh	   syndrome,	   including	  
SURF1	  and	  other	  assembly	  factors	  of	  cytochrome	  c	  oxidase	  (Tiranti	  et	  al.	  1998;	  Zhu	  et	  al.	  
1998;	  Y.	  Zhang	  et	  al.	  2007;	  Finsterer	  2008).	  Cytochrome	  c	  oxidase	  deficiency	   is	  one	  of	  
the	   most	   common	   causes	   of	   LS	   (Péquignot	   et	   al.	   2001),	   but	   interestingly	   all	   the	  
mutations	   described	   to	   date	   have	   been	   in	   genes	   coding	   for	   proteins	   required	   for	  
cytochrome	  c	  oxidase	   assembly	   and	  not	   for	   structural	   subunits.	   Leigh	   Syndrome	  with	  
isolated	  cytochrome	  c	  oxidase	  deficiency	  is	  most	  commonly	  caused	  by	  SURF1	  mutations	  
(Péquignot	   et	   al.	   2001;	   Shoubridge	   2001).	   These	   patients	   typically	   retain	   10-­‐20	  %	   of	  
cytochrome	  c	  oxidase	  activity	  (Shoubridge	  2001).	  In	  this	  study,	  we	  analysed	  a	  mutation	  
affecting	  a	  conserved	  amino	  acid	  in	  SURF1	  in	  its	  yeast	  homolog	  Shy1.	  The	  investigated	  
SURF1Y274D/Shy1Y344D	  missense	  mutation	  has	  been	  reported	  in	  Leigh	  Syndrome	  patients	  
and	  thus	  is	  known	  to	  affect	  cytochrome	  c	  oxidase	  biogenesis	  (Teraoka	  et	  al.	  1999).	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Not	   only	   defects	   in	   mitochondrial	   metabolism	   but	   also	   disturbed	   mitochondrial	  
biogenesis	  can	   lead	  to	  mitochondrial	  diseases.	   In	  Barth	  syndrome	  (BTHS),	  an	  X-­‐linked	  
genetic	  disorder,	  mutations	  in	  the	  tafazzin	  gene	  (TAZ)	  cause	  abnormalities	  in	  cardiolipin	  
molecules	   (Barth	   et	   al.	   2004).	   Cardiolipin,	   a	   phospholipid	   found	   in	   mitochondrial	  
membranes,	   is	   closely	   related	   with	   membrane	   dynamics	   and	   energy	   metabolism,	   by	  
providing	  stability	  for	  electron	  transport	  chain	  complexes	  (Vreken	  et	  al.	  2000;	  Kulik	  et	  
al.	  2008).	  
Recently,	  secondary	  mtDNA	  alterations	  are	  also	  speculated	  to	  be	  involved	  in	  aging	  and	  
neurodegenerative	   disorders	   as	   Alzheimers	   disease,	   Parkinsons	   disease,	   Huntingtons	  
disease	   or	   amytrophic	   lateral	   sclerosis.	   Neurons	   are	   highly	   dependent	   on	   oxidative	  
energy	  metabolism.	   Therefore	   a	   common	  mechanism	  of	   neurodegeneration,	   based	   on	  
an	   underlying	   dysfunction	   in	   mitochondrial	   energy	   metabolism,	   is	   under	   discussion	  
(Schon	  &	  Manfredi	  2003;	  Dimauro	  &	  Schon	  2008).	  
	  
	  
	   	  
	   	   1.	  INTRODUCTION	  
	  
15	  
1.2	  Cytochrome	  c	  oxidase	  
1.2.1	  Structure	  and	  function	  
Cytochrome	  c	  oxidase	  (COX),	  the	  terminal	  enzyme	  of	  the	  respiratory	  chain,	  is	  a	  copper-­‐
heme	   a	   terminal	   oxidase,	   composed	   of	   multiple	   subunits	   (11	   in	   S.	   cerevisiae,	   13	   in	  
human)	  of	  dual	  genetic	  origin.	  The	  crystal	  structure	  of	  the	  dimeric	  bovine	  cytochrome	  c	  
oxidase	   revealed	   the	   spatial	   arrangement	   of	   the	   subunits	   and	   the	   positioning	   of	   the	  
cofactors	  (Tsukihara	  et	  al.	  1995;	  Tsukihara	  et	  al.	  1996).	  
The	  three	  core	  subunits	  Cox1,	  Cox2	  and	  Cox3	  are	  deeply	  buried	  in	  the	  complex	  and	  form	  
the	   catalytic	   core	   (FIG	   1.3).	   They	   are	   encoded	   by	   the	  mitochondrial	   genome	   and	   are	  




FIG	  1.3	  	  Monomeric	  bovine	  Cytochrome	  c	  oxidase	  crystal	  structure	  
Shown	   are	   cartoons	   of	   mitochondria-­‐encoded	   bovine	   subunits	   Cox1	   (red),	   Cox2	   (green)	   and	   Cox3	   (yellow).	  
Nuclear-­‐encoded	  subunits	  in	  grey	  (Tsukihara	  et	  al.	  1996).	  (A)	  Side	  view,	  matrix	  at	  the	  bottom	  and	  IMS	  at	  the	  top.	  
(B)	  top	  view	  from	  the	  IMS	  side.	  PBD	  entry	  :	  1OCC,	  analysed	  with	  PyMOL	  software.	  
	  
	  
The	  structure	  of	  the	  metal	  sites	  of	  bovine	  cytochrome	  c	  oxidase	  (Tsukihara	  et	  al.	  1995)	  
furthermore	   revealed	   that	   the	   redox	   cofactors	  heme	  and	   copper	   are	   inserted	   into	   the	  
core	  proteins	  Cox1	  and	  Cox2	  (FIG	  1.4).	  Cytochrome	  c	  oxidase	  transfers	  electrons	  from	  
cytochrome	  c	   to	  molecular	  oxygen	  via	   the	   redox	  active	  metal	   cofactors	   in	   its	   catalytic	  
core.	  Therefore,	  the	  cofactors	  are	  essential	  for	  the	  catalytic	  activity	  of	  the	  enzyme.	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Cox2	   forms	   the	   binding	   pocket	   for	   reduced	   cytochrome	   c	   from	   which	   it	   acquires	  
electrons	  that	  are	  passed	  to	  the	  binuclear	  CuA	  site	  in	  Cox2,	  subsequently	  to	  the	  low	  spin	  
heme	  a	   in	  subunit	  1	  and	  finally	  to	  the	  active	  site	  where	  a	  high	  spin	  heme	  a3	   (in	  Cox1)	  
and	  the	  CuB	  site	  form	  a	  binuclear	  center	  for	  O2	  binding	  (reviewed	  by	  Soto	  et	  al.	  2012).	  In	  
the	   final	   step,	   the	   electrons	   are	   transferred	   to	   molecular	   oxygen	   to	   form	   H2O.	   This	  
electron	   transport	   reaction	   is	   coupled	   to	   proton	  pumping	   from	   the	  matrix	   to	   the	   IMS	  
(Yoshikawa	  et	   al.	   2011).	  The	  precise	   function	  of	  Cox3	   is	  not	   known,	  but	   it	   appears	   to	  
form	   an	   aqueous	   channel,	   which	  may	   allow	   protons	   to	  move	   through	   the	  membrane	  




FIG	  1.4	  Cytochrome	  c	  oxidase	  catalytic	  core	  
Arrangement	   of	   the	   hemes	   and	   copper	   centers	   in	   (bovine)	   cytochrome	   c	   oxidase	   catalytic	   core.	   Shown	   is	   a	  
cartoon	   of	   mitochondria-­‐encoded	   bovine	   subunits	   Cox1	   (transparent	   green)	   and	   Cox2	   (transparent	   purple),	  
heme	  moieties	  (red	  stick	  models)	  and	  copper	  ions	  (orange	  spheres).	  The	  binuclear	  CuA	  center	  is	  located	  in	  Cox2	  
subunit	  and	  is	  the	  entrance	  site	  for	  electrons	  from	  reduced	  cytochrome	  c.	  Electrons	  are	  subsequently	  passed	  to	  
the	   low-­‐spin	  heme	  a	   and	   then	   to	   the	  heterobimetallic	  heme	  a3:CuB	  center	   in	  Cox1	  where	  O2	   reduction	  occurs.	  
Side	  view,	  matrix	  at	  the	  bottom	  and	  IMS	  at	  the	  top.	  PBD	  entry	  :	  1OCC,	  analysed	  with	  PyMOL	  software.	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The	  catalytic	  active	   core	   subunits	  of	   cytochrome	  c	  oxidase	  are	   surrounded	  by	  a	   set	  of	  
nuclear-­‐encoded	   proteins	   (Cox4,	   Cox5a/b,	   Cox6,	   Cox7,	   Cox8,	   Cox9,	   Cox12,	   Cox13	   in	  
yeast).	  The	  surrounding	  structural	  subunits	  fulfill	  functions	  in	  assembly	  and	  stability	  of	  
the	  complex	  as	  well	  as	  in	  modulation	  of	  the	  catalytic	  activity.	  Most	  importantly,	  they	  are	  
speculated	  to	  protect	  the	  core	  from	  oxidative	  damage.	  The	  importance	  of	  these	  subunits	  
is	   demonstrated	   by	   the	   complete	   loss	   of	   COX	   activity	   of	   yeast	   strains	   deleted	   in	   the	  
nuclear	  genes	  encoding	  for	  subunits	  Cox4,	  the	  two	  isoforms	  of	  Cox5	  (Cox5a	  and	  Cox5b),	  
Cox6,	  Cox7,	  and	  Cox9,	   suggesting	  an	  essential	   role	   for	   these	  subunits	   in	  assembly	  and	  
stability	  of	  the	  enzyme	  (reviewed	  by	  Fontanesi	  et	  al.	  2006).	  	  
	  
Assembly	   of	   COX	   is	   thought	   to	   be	   a	   linear	   process	   where	   the	   different	   subunits	   are	  
added	   in	   an	   ordered	   manner.	   Many	   (non-­‐structural)	   factors	   that	   assist	   the	   assembly	  
have	   been	   identified	   in	   yeast	   and	   distinct	   assembly	   intermediates	   can	   be	   resolved	   by	  
BN-­‐PAGE.	   Identification	   and	   characterization	  of	  mammalian	   counterparts	   of	   assembly	  
factors,	   originally	   identified	   in	   yeast,	   are	   under	   ongoing	   research	   (Szklarczyk,	  
Wanschers,	  Cuypers,	  et	  al.	  2012a;	  Mick	  et	  al.	  2012;	  Szklarczyk,	  Wanschers,	  Nijtmans,	  et	  
al.	   2012b;	   Clemente	   et	   al.	   2013).	   The	   vast	   majority	   of	   mitochondrial	   disorders,	  
presented	   with	   COX	   deficiency,	   have	   been	   assigned	   to	   mutations	   in	   these	   ancillary	  
factors,	   among	   them	   mutations	   in	   SURF1	   (required	   for	   formation	   of	   early	  
intermediates)	   (Zhu	   et	   al.	   1998)	   ,	   SCO1	   and	   SCO2	   (required	   for	   copper	   insertion)	  
(Papadopoulou	   et	   al.	   1999;	   Valnot,	   Osmond,	   et	   al.	   2000b),	   in	   COX10	   and	   COX15	  
(required	  for	  heme	  cofactor	  biogenesis)	  (Valnot,	  Kleist-­‐Retzow,	  et	  al.	  2000a;	  Antonicka	  
et	   al.	   2003)	   or	   in	   TACO1	   (required	   for	   expression	   of	   subunits)	   (Weraarpachai	   et	   al.	  
2009).	  
	   	  
	   	   1.	  INTRODUCTION	  
	  
18	  
1.2.2	  Non-­‐protein	  cofactors	  
The	  incorporation	  of	  prosthetic	  groups	  into	  cytochrome	  c	  oxidase	  subunits	  is	  essential	  
for	   the	   catalytic	   activity	   of	   cytochrome	   c	   oxidase.	   In	   addition,	   it	   is	   necessary	   for	   the	  
maturation	  and	  correct	   folding	  of	   the	  Cox1	  polypeptide	   (Carr	  &	  Winge	  2003).	  Despite	  
the	   importance	   of	   the	   non-­‐protein	   cofactors	   of	   cytochrome	   c	   oxidase,	   little	   is	   known	  
about	   when	   and	   how	   the	   metal	   groups	   are	   incorporated	   into	   the	   subunits	   during	  
assembly	  of	  cytochrome	  c	  oxidase.	  
1.2.2.1	  Heme	  a	  biogenesis	  and	  insertion	  
Heme	  a	  is	  a	  prosthetic	  group	  present	  in	  cytochrome	  c	  oxidase.	  Cytochrome	  c	  oxidase	  is	  
the	  only	  enzyme	  within	   the	  cell	   that	   requires	  heme	  a	   as	  a	   cofactor.	  Heme	  a	   is	   formed	  
from	  heme	  b	  (protoheme)	  in	  a	  two-­‐step	  process.	  In	  the	  first	  step,	  catalyzed	  by	  the	  heme	  
o	  synthase	  Cox10	  (in	  yeast),	  heme	  b	  is	  farnesylated.	  In	  a	  second	  step,	  a	  methyl	  group	  in	  
heme	   o	   is	   oxidized	   to	   form	   a	   formyl	   group	   that	   gives	   rise	   to	   heme	   a	   (Caughey	   et	   al.	  
1975).	  This	  reaction	  is	  catalyzed	  by	  the	  heme	  a	  synthase	  Cox15,	  ferredoxin	  (Yah1)	  and	  a	  
ferredoxin	  reductase	  (Arh1)	  (FIG	  1.4).	  Studies	  in	  Bacillus	  subtilis	  have	  provided	  strong	  
evidence	  that	  the	  heme	  a	  synthase	  oxidizes	  heme	  o	  to	  heme	  a	  via	  two	  successive	  mono-­‐




FIG	  1.5	  Biosynthesis	  of	  heme	  o	  and	  heme	  a	  
Chemical	  modifications	  of	  heme	  b	  to	  heme	  a	  via	  heme	  o,	  catalyzed	  by	  the	  enzymes	  heme	  o	  synthase	  (HOS,	  Cox10	  
in	   S.	   cerevisiae)	   and	   heme	   a	   synthase	   (HAS,	   Cox15	   in	   S.	   cerevisiae	   ).	   Ferredoxin	   Yah1	   and	   adrenodoxin	   Arh1	  
supply	  electrons	  for	  Cox15-­‐mediated	  heme	  o	  to	  heme	  a	  conversion.	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Both	   Cox10	   and	   Cox15	   are	   hydrophobic	  multispanning	  membrane	   proteins,	   found	   in	  
the	   inner	   mitochondrial	   membrane	   (Glerum	   &	   Tzagoloff	   1994;	   Barros	   et	   al.	   2001).	  
Because	  the	  heme	  a	  cofactor	  is	  essential	  to	  cytochrome	  c	  oxidase	  and	  Cox10	  and	  Cox15	  
are	  both	  required	   for	   its	  synthesis,	  cox10	  and	  cox15	  deletions	  and	  mutations	   lead	  to	  a	  
deficiency	   in	   respiratory	   growth.	   In	   both	   cases,	   cytochrome	   c	   oxidase	   subunits	   are	  
present	  but	  are	  not	  assembled	  into	  a	  functional	  enzyme	  (Nobrega	  et	  al.	  1990;	  Glerum	  et	  
al.	  1997).	  The	  Cox15	  mutant	  accumulates	  heme	  o	  but	  lacks	  heme	  a	  (Barros	  et	  al.	  2001).	  
	  
Homologs	   of	   the	   yeast	   Cox10	   and	   Cox15	   are	   found	   in	   various	   organisms	   from	  
prokaryotes	   to	   humans.	   The	   human	   homolog	   of	   Cox10	   is	   able	   to	   functionally	  
complement	   the	   yeast	   cox10	   deletion	   (Glerum	   &	   Tzagoloff	   1994).	   Mutations	   in	   the	  
human	  COX10	  and	  COX15	  genes	  lead	  to	  cytochrome	  c	  oxidase	  deficiency	  and	  have	  been	  
associated	   with	   severe	   infantile	   cardiomyopathy,	   tubulopathy,	   leukodystrophy	   and	  
Leigh	  syndrome	  (Valnot,	  Kleist-­‐Retzow,	  et	  al.	  2000a;	  Antonicka	  et	  al.	  2003;	  Moraes	  et	  al.	  
2004;	  Oquendo	  2004;	  Alfadhel	  et	  al.	  2011).	  
	  
Even	  though	  hemylation	  of	  Cox1	   is	  essential,	   little	   is	  known	  about	   the	   insertion	  of	   the	  
two	  heme	  moieties	  into	  Cox1.	  As	  heme	  is	  a	  very	  reactive	  moiety,	  it	  is	  highly	  likely	  that	  a	  
heme-­‐binding	   protein	   escorts	   it	   to	   its	   final	   destination.	   For	   the	   same	   rational,	   the	  
biosynthesis	  of	  heme	  a	  is	  regulated	  by	  downstream	  events	  in	  the	  COX	  assembly	  process	  
in	  order	  to	  prevent	  accumulative	  of	  this	  reactive	  moiety	  (Barros	  &	  Tzagoloff	  2002).	  It	  is	  
not	  clear	   if	   the	   insertion	  of	   the	   two	  hemes	   into	  Cox1	  occurs	  co-­‐translationally	  or	   later	  
(post-­‐translational)	  in	  the	  maturation	  of	  Cox1.	  However,	  it	  is	  believed	  that	  the	  insertion	  
of	  heme	  a3	  has	  to	  occur	  before	  the	  addition	  of	  Cox2	  as	  the	  farnesyl	  group	  of	  this	  heme	  is	  
located	   at	   the	   interface	   between	   the	   two	   subunits	   (see	   also	   FIG	   1.4)	   (Tsukihara	   et	   al.	  
1995).	  
Recent	   analyses	   support	   the	   idea	   that	   the	   bacterial	   homolog	   of	   Shy1	   (Surf1	   in	  
Paracoccus	  denitrificans)	  plays	  a	  role	  in	  the	  insertion	  step	  for	  heme	  a,	  suggested	  by	  the	  
heme-­‐binding	  activity	  of	   a	  bacterial	   homologue.	  However,	   it	   remains	  unclear	  whether	  
the	  bacterial	  homolog	  of	  Shy1	  acts	  as	  a	  “heme-­‐chaperone”	  or	  has	  a	  more	  direct	  role	  in	  
heme	   insertion	   into	   subunit	   1	   of	   cytochrome	   c	   oxidase	   (Bundschuh	   et	   al.	   2009;	  
Hannappel	  et	  al.	  2011;	  Hannappel	  et	  al.	  2012).	  




In	  mitochondria,	  two	  enzymes,	  cytochrome	  c	  oxidase	  and	  superoxide	  dismutase	  (Sod1)	  
receive	   copper	   within	   the	   IMS	   (Cobine	   et	   al.	   2006).	   This	   requires	   a	   specific	   copper	  
transport	   pathway	   to	   this	   compartment	   of	   the	   organelle.	   Copper	   metallation	   of	  
cytochrome	  c	  oxidase	  involves	  the	  copper	  metallo-­‐chaperone	  Cox17,	  a	  small	  hydrophilic	  
protein	  that	  contains	  a	  copper	  binding	  motif	  (Glerum	  et	  al.	  1996).	  The	  dual	  localization	  
of	  Cox17	  in	  the	  cytosol	  and	  within	  mitochondria	  is	  consistent	  with	  the	  proposed	  copper	  
shuttle	   function	   of	   Cox17	   to	  mitochondria	   (Beers	   et	   al.	   1997).	  Within	   the	   IMS,	   Cox17	  
transfers	  copper	  ions	  to	  the	  two	  chaperones	  Sco1	  (and	  its	  paralog	  Sco2)	  or	  Cox11.	  Sco1	  
and	  Cox11,	  two	  mitochondrial	  inner	  membrane	  proteins	  facilitate	  copper	  insertion	  into	  
the	  CuA	  site	  (in	  Cox2)	  and	  into	  the	  CuB	  site	  (in	  Cox1),	  respectively	  (Horng	  et	  al.	  2004).	  
Recent	  investigations	  speculated	  that	  the	  CuB	  site	  formation	  does	  occur	  simultaneously	  
to	   the	   incorporation	   of	   the	   heme	   a3	   moiety	   into	   the	   heterobimetallic	   center.	  
(Khalimonchuk	  et	  al.	  2010).	  Several	  studies	   in	  S.	  cerevisiae	   suggest	   that	  Cox19,	  Cox23,	  
Pet191,	  Cmc1	  and	  Cmc2	  are	  also	  part	  of	  a	  copper	  transfer	  pathway	  towards	  cytochrome	  
c	  oxidase	  (Horn	  &	  Barrientos	  2008).	  
The	  mitochondrial	  copper	  metabolism	  involves	  conserved	  elements.	  Homologues	  of	  the	  
yeast	  genes	  COX11,	  COX17,	  SCO1,	  COX19,	  COX23,	  PET191,	  CMC1	  and	  CMC2	  have	  been	  
identified	   in	   higher	   organisms.	   Mutations	   in	   SCO1	   for	   example	   are	   associated	   with	  
mitochondrial	  disorders	  (Valnot,	  Osmond,	  et	  al.	  2000b).	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1.3	  Early	  steps	  in	  cytochrome	  c	  oxidase	  assembly	  
Cytochrome	  c	  oxidase	  assembly	  is	  a	  highly	  regulated	  process.	  Not	  only	  the	  subunits	  of	  	  
dual	   genetic	   origin	   have	   to	   be	   assembled,	   also	   the	   non-­‐protein	   cofactors	   have	   to	   be	  
inserted	  into	  the	  central	  subunits.	  In	  yeast,	  over	  20	  assembly	  factors	  are	  known	  to	  assist	  
in	   this	   process.	   As	   assembly	   intermediates	   are	   potential	   sources	   of	   reactive	   oxygen	  
species	   (ROS),	   an	   intelligent	   feedback	   regulation	   mechanism	   evolved:	   assembly	  
intermediates	  play	  a	  central	  role	  in	  feedback	  regulation	  of	  mitochondrial	  Cox1	  protein	  
synthesis	   in	   response	   to	   its	   assembly	   state	   (Barrientos	   et	   al.	   2004;	   Mick	   et	   al.	   2007;	  
Pierrel	  et	  al.	  2007;	  Fontanesi	  2013).	  Therefore,	  accumulation	  of	  non-­‐assembled	  Cox1	  is	  
prevented.	   This	   kind	   of	   translational	   regulation	   was	   termed	   control	   by	   epistasis	   of	  
synthesis	   (Choquet	   et	   al.	   2001).	   Most	   unassembled	   Cox1	   (also	   Cox2	   and	   Cox3)	   are	  
degraded	  by	   the	  ATP	  dependent	  AAA	  proteases	  of	   the	   inner	  mitochondrial	  membrane	  
(Langer	  et	  al.	  2001).	  
The	  starting	  point	  of	  the	  assembly	  of	  cytochrome	  c	  oxidase	  is	  the	  mitochondria-­‐encoded	  
subunit	  1	  (Cox1).	  For	  the	  translation	  of	  COX1	  mRNA	  on	  membrane	  bound	  mitochondrial	  
ribosomes,	   two	   translational	   activators,	   Pet309	   and	   Mss51,	   are	   required.	   After	   co-­‐
translational	  membrane	   insertion,	   facilitated	   by	   Oxa1,	   Cox1	   associates	  with	   the	   early	  
assembly	  factors	  Coa3	  and	  Coa14.	  This	  complex	  forms	  the	  platform	  for	  the	  association	  
of	  further	  ancillary	  factors,	  such	  as	  Coa1	  and	  Shy1	  (FIG	  1.6;	  1-­‐5).	  The	  early	  cytochrome	  c	  
oxidase	  assembly	  intermediates	  were	  termed	  COA	  complexes.	  
In	   parallel	   or	   in	   following,	   poorly	   understood	   steps,	  metal	   cofactors	   are	   incorporated	  
into	   the	   catalytic	   core	   before	   the	   first	   nuclear-­‐encoded	   structural	   subunits	   (Cox5	   and	  
Cox6)	  are	  added	  to	  the	  maturing	  enzyme	  complex	  .	  	  
These	   early	   steps	   in	   the	   biogenesis	   of	   cytochrome	   c	   oxidase	   are	   interconnected	  with	  
regulation	   of	   translation:	   binding	   of	   newly	   synthesized	   Cox1	   by	   Coa3	   and	   Cox14	  
stabilizes	  Cox1	  and	  prevents	  degradation	  by	  inner	  membrane	  proteases.	  In	  addition,	  by	  
sequestration	  of	  Mss51	  and	  Coa1	  in	  this	  complex,	  Mss51	  is	  inactivated	  and	  translation	  
of	   Cox1	   is	   shut	   down.	   Upon	   maturation	   of	   the	   assembly	   intermediates,	   Mss51	  












FIG	  1.6	  Early	  steps	  of	  cytochrome	  c	  oxidase	  assembly	  and	  feedback	  regulation	  of	  Cox1	  translation	  
(1)	  Mitochondrial	  splicing	  suppressor	  protein	  51	  (Mss51)	  activates	  COX1	  translation,	  together	  with	  Pet309.	  (2)	  
Cox1	  is	  co-­‐translationally	  inserted	  into	  the	  inner	  membrane	  (IM)	  by	  Oxa1.	  (3)	  Newly	  synthesized	  Cox1	  is	  bound	  
by	  Mss51.	  This	  interaction	  is	  promoted	  by	  early	  assembly	  factors	  (Coa3	  and	  Cox14).	  (4)	  Assembly	  factor	  Coa1	  is	  
recruited	  to	  the	  complex.	  Mss51	  is	  converted	  into	  an	  inactive	  form,	  preventing	  it	  to	  act	  as	  translational	  activator.	  
(5)	  Coa1	  association	  triggers	  binding	  of	  Shy1,	  which	  might	  be	  involved	  in	  insertion	  of	  heme	  cofactors	  into	  Cox1.	  
Addition	  of	  further	  subunits	  (as	  nuclear-­‐encoded	  Cox5	  and	  Cox6)	  leads	  to	  the	  release	  of	  Mss51.	  Mss51	  is	  again	  
available	  to	   initiate	   further	  rounds	  of	  COX1	   translation.	  The	  assembly	   intermediate	   is	   further	  matured	  to	   form	  
the	  active	  cytochrome	  c	  oxidase,	  that	  consists	  of	  11	  structural	  subunits	  in	  yeast.	  
	  
	  
1.3.1.	  Membrane	  insertion	  of	  Cox1	  by	  Oxa1	  
Cox1	   is	   a	   highly	   hydrophobic	   protein	   and	   spans	   the	   inner	   mitochondrial	   membrane	  
with	  12	  trans-­‐membrane	  domains.	  As	  Cox1	  is	  being	  synthesized,	  it	  is	  co-­‐translationally	  
inserted	   into	   the	   inner	  mitochondrial	  membrane	  with	   the	   aid	   of	   the	   Oxa1	  machinery	  
(Hell	  et	  al.	  2001;	  Bonnefoy	  et	  al.	  2009).	  The	  carboxy-­‐terminal	  domain	  of	  Oxa1	  binds	  to	  
mitochondrial	   ribosomes	   (Jia	   et	   al.	   2003)	   near	   their	   exit-­‐tunnel	   (Jia	   et	   al.	   2009;	  
Bonnefoy	   et	   al.	   2009),	   which	   is	   consistent	  with	   a	   co-­‐translational	  mechanism	   for	   the	  
insertion	  of	  proteins,	  synthesized	  at	  mitochondrial	  ribosomes,	  into	  the	  inner	  membrane.	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1.3.2	  Regulation	  of	  Cox1	  translation	  
In	  S.	  cerevisiae,	  translation	  of	  mitochondria-­‐encoded	  mRNAs,	  specifying	  for	  subunits	  of	  
respiratory	   complexes,	   requires	   dedicated	   translational	   activator	   proteins,	   which	  
recognize	   the	   5′	   untranslated	   regions	   (UTRs)	   of	   their	   target	   mRNAs.	   In	   the	   case	   of	  
cytochrome	   c	   oxidase	   subunit	   1,	   Pet309	   and	   the	   mitochondrial	   splicing	   suppressor	  
protein	  51	  (Mss51)	  act	  as	  translational	  activators	  for	  COX1	  mRNA	  (Perez-­‐Martinez	  et	  al.	  
2003;	   Towpik	   2005).	   Genetic	   studies	   show	   interaction	   of	   Mss51	   with	   the	   5´-­‐UTR	   of	  
COX1	   mRNA	   (Perez-­‐Martinez	   et	   al.	   2003;	   Zambrano	   et	   al.	   2007).	   Moreover,	   Mss51	  
interacts	  with	  newly	   synthesized	  but	   unassembled	  Cox1	   (Perez-­‐Martinez	   et	   al.	   2009).	  
Thus,	  Mss51	  interacts	  both	  with	  COX1	  mRNA	  and	  with	  Cox1	  protein	  that	  has	  not	  been	  
assembled	   into	   the	  mature	   cytochrome	  c	   oxidase	   complex.	  These	  dual	   activities	   allow	  
Mss51	   to	   couple	   the	   synthesis	   of	   Cox1	   to	   the	   assembly	   of	   cytochrome	  c	   oxidase	   via	   a	  
regulatory	   feedback	   mechanism	   (Perez-­‐Martinez	   et	   al.	   2003;	   Barrientos	   et	   al.	   2004;	  
Perez-­‐Martinez	  et	  al.	  2009).	  	  
1.3.3	   Coa3	   and	   Cox14	   stabilize	   newly	   synthesized	   Cox1	   and	   regulate	   COX1	  
translation	  
Cox14	  is	  a	  small	  protein	  of	  the	  inner	  mitochondrial	  membrane,	  involved	  in	  translational	  
regulation	   of	  COX1	   and	   the	   assembly	   of	   cytochrome	   c	   oxidase.	   The	  majority	   of	   Cox14	  
associates	   with	   cytochrome	   c	   oxidase	   assembly	   intermediates,	   however	   a	   fraction	   is	  
also	   found	   in	   complex	   III/	   IV	   supercomplexes	   (Glerum	   et	   al.	   1995;	   Barrientos	   et	   al.	  
2004;	   Mick	   et	   al.	   2007).	   Similarly,	   Coa3	   (cytochrome	   c	   oxidase	   assembly	   factor	   3,	  
termed	  Cox25	  in	  another	  study)	  (Fontanesi	  et	  al.	  2011)	   is	  a	  small	  mitochondrial	   inner	  
membrane	   protein	   that	   regulates	   COX1	   translation	   but	   also	   participates	   in	   Cox1	  
stabilization	   and	   cytochrome	   c	   oxidase	   assembly	   (Mick	   et	   al.	   2010;	   Fontanesi	   et	   al.	  
2011).	  Coa3	  was	  identified	  in	  Shy1ProtA	  isolation	  of	  cytochrome	  c	  oxidase	  intermediates	  
(Mick	  et	  al.	  2010).	  The	  same	  study	  also	   found	  that	  Coa3	  and	  Cox14,	  both	  containing	  a	  
single	   transmembrane	   span,	   adopt	   the	   same	   topology	   in	   the	   inner	   mitochondria	  
membrane	  and	  expose	  their	  C-­‐termini	  into	  the	  IMS.	  The	  topology	  of	  Cox14	  is	  in	  contrast	  
to	   a	   previous	   study	   that	   found	   Cox14	   to	   behave	   as	   a	   peripheral	   membrane	   protein	  
(Barrientos	  et	  al.	  2004).	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Newly	   synthesized	   Cox1	   rapidly	   associates	   with	   Cox14	   and	   Coa3,	   two	   small	   inner	  
membrane	  proteins	  with	  domains	  that	  are	  exposed	  to	  the	  mitochondrial	  matrix	  and	  the	  
intermembrane	   space	   (Glerum	   et	   al.	   1995;	   Barrientos	   et	   al.	   2004;	   Mick	   et	   al.	   2010).	  
These	  proteins	  then	  form	  a	  complex	  that	  is	  thought	  to	  keep	  Mss51	  in	  a	  sequestered,	  but	  
still	  active	  state	  (Mick	  et	  al.	  2007).	  Cox14	  and	  Coa3	  are	  essential	  for	  Mss51	  recruitment	  
to	  Cox1,	  a	  first	  step	  and	  prerequisite	  for	  its	  subsequent	  inactivation	  by	  Coa1.	  Therefore,	  
a	   lack	  of	  Coa3	  or	  Cox14	   leads	   to	  uncontrolled	  expression	  of	  COX1	  due	   to	  a	   loss	  of	   the	  
Mss51	   negative	   feedback	   regulation	   (Mick	   et	   al.	   2010).	   In	   consequence,	   unassembled	  
Cox1	  is	  rapidly	  turned	  over	  in	  these	  mutants,	  resulting	  in	  a	  specific	  lack	  of	  cytochrome	  c	  
oxidase	  and	  absence	  of	  respiratory	  growth	  (Mick	  et	  al.	  2010).	  	  
Cox14	   and	   Coa3	   both	   negatively	   regulate	   Cox1	   synthesis,	   however	   the	   proteins	   fulfill	  
distinct	  functions	  as	  overexpression	  of	  either	  Cox14	  in	  coa3Δ	  cells	  or	  of	  Coa3	  in	  cox14Δ	  
cells	  has	  no	  effect	  on	  the	  growth	  phenotype	  (Mick	  et	  al.	  2010).	  
1.3.4	  Coa1	  is	  required	  for	  progression	  of	  COX	  assembly	  
Cytochrome	   c	   oxidase	   assembly	   factor	   1	   (Coa1)	   is	   a	   mitochondrial	   inner	   membrane	  
protein	   required	   for	   assembly	   of	   the	   cytochrome	   c	   oxidase	   complex	   (Sickmann	   et	   al.	  
2003;	   Reinders	   et	   al.	   2006;	   Mick	   et	   al.	   2007;	   Pierrel	   et	   al.	   2007).	   The	   amino-­‐acid	  
sequence	  predicts	  a	  protein	  of	  197	  amino	  acids	  with	  a	  molecular	  mass	  of	  about	  22	  kDa	  
with	   one	   transmembrane	   span	   (Mick	   et	   al.	   2007).	   The	   N-­‐terminus	   of	   Coa1	   is	   rich	   in	  
positively	   charged	   amino	   acids,	   characteristic	   of	   a	   mitochondrial	   presequence.	   A	  
cleavage	   site	   for	   the	  mitochondrial	   processing	   peptidase	   is	   predicted	   adjacent	   to	   the	  
presequence	   (Gakh	   et	   al.	   2002).	   Coa1	   is	   present	   in	   early	   assembly	   intermediates	   of	  
cytochrome	  c	  oxidase	  (COA	  complexes).	  The	  association	  of	  Coa1	  with	  the	  Cox1–Mss51–
Cox14–Coa3	   complex	   in	   wild-­‐type	   cells	   is	   required	   for	   the	   conversion	   of	   Mss51	   to	   a	  
sequestered	   inactive	   state,	   which	   prevents	   Mss51	   from	   activating	   translation	   (see	  
FIG	  1.6;	   4).	  Moreover,	   Coa1	   association	   promotes	   the	   binding	   of	   Shy1	   to	   Cox1,	  which	  
might	  positively	  regulate	  the	  insertion	  of	  the	  heme	  cofactor	  into	  Cox1	  (Mick	  et	  al.	  2011).	  
Cells	  lacking	  Coa1	   have	  a	  specific	  defect	  in	  cytochrome	  c	  oxidase	  assembly	  (Pierrel	  et	  al.	  
2007).	   This	   respiratory	   defect	   in	   coa1Δ	   cells	   is	   suppressed	   by	   high-­‐copy	  MSS51	   and	  
COX10	   (Pierrel	   et	   al.	   2007).	   Translation	   of	   the	   mitochondria-­‐encoded	   subunits	   of	  
cytochrome	   c	   oxidase	   occurs	   normally	   in	   coa1Δ	   cells,	   but	   these	   subunits	   fail	   to	  
accumulate.	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1.3.5	  Additional	  function	  of	  assembly	  factor	  Shy1	  in	  heme	  transfer	  to	  Cox1?	  
Shy1,	   the	   yeast	   homolog	   of	   mammalian	   SURF1	   is	   a	   mitochondrial	   inner	   membrane	  
protein,	   with	   a	   large	   domain,	   exposed	   to	   the	   intermembrane	   space.	   The	   protein	   is	  
essential	   for	   respiratory	   growth	   (Mashkevich	   et	   al.	   1997)	   since	   it	   is	   required	   for	  
regulation	   of	   COX1	   expression	   and	   cytochrome	   c	   oxidase	   assembly	   (Barrientos	   et	   al.	  
2002;	   Mick	   et	   al.	   2007).	   Mutations	   in	   human	   SURF1	   are	   reported	   to	   cause	   Leigh	  
syndrome,	   a	   severe	  neurodegenerative	  disorder	   (Zhu	   et	   al.	   1998;	  Tiranti	   et	   al.	   1998).	  
Similar	   to	   patients	   affected	   in	   SURF1	   function,	   shy1	   mutant	   mitochondria	   are	  
characterized	  by	   reduced	  amounts	  of	  Cox1	   and	   reduced	   levels	   of	   active	   cytochrome	  c	  
oxidase	   (Nijtmans	   et	   al,	   2001;	   Barrientos	   et	   al,	   2002;	  Williams	   et	   al,	   2004).	   Although	  
Shy1	  does	  not	  directly	   regulate	  COX1	   translation,	   it	   is	   implicated	   in	  post-­‐translational	  
steps	   of	   Cox1	   biogenesis	   and	   early	   steps	   of	   cytochrome	   c	   oxidase	   assembly	   through	  
association	   with	   several	   membrane	   protein	   complexes	   (Mashkevich	   et	   al,	   1997;	  
Barrientos	   et	   al,	   2002;	   Perez-­‐Martinez	   et	   al,	   2003;	   Smith	   et	   al,	   2005;	   Zambrano	   et	   al,	  
2007).	  Shy1	  associates	  with	  Cox1	  assembly	  intermediates,	  containing	  the	  translational	  
regulator	  Mss51	  and	  early	  assembly	  factors,	  such	  as	  Coa3,	  Cox14	  and	  Coa1.	  In	  addition,	  
it	   can	   be	   identified	   as	   a	   component	   of	   COA	   complexes	   that	   already	   have	   the	   nuclear-­‐
encoded	   subunit	   Cox5a	   incorporated	   (Mick	   et	   al.	   2007).	   Recent	   analyses	   support	   the	  
idea	   that	   Shy1	   (or	   its	  homologues	   in	  other	  organisms)	  plays	   an	   important	  part	   in	   the	  
insertion	  step	  of	  heme	  a	  into	  Cox1,	  suggested	  by	  the	  heme	  binding	  activity	  of	  a	  bacterial	  
homologue	   Surf1	   (Bundschuh	   et	   al.	   2009;	   Khalimonchuk	   et	   al.	   2010).	   The	   recently	  
identified	   assembly	   factors	   Coa2	   and	   Coa4	   appear	   to	   cooperate	   with	   Shy1	   for	   heme	  
insertion	  into	  Cox1	  (Pierrel	  et	  al.	  2008;	  Bestwick,	  Jeong,	  et	  al.	  2010a).	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1.3.6	  Early	  COX	  assembly	  steps	  in	  higher	  eukaryotes	  
Mutations	  in	  known	  human	  COX	  assembly	  factors	  (SURF1,	  SCO1,	  COX10,	  COX15)	  lead	  to	  
severe	   mitochondrial	   disorders	   (described	   in	   section	   1.1.6).	   Analyses	   of	   patients	  
suffering	   from	   mitochondrial	   encephalo-­‐myopathies,	   such	   as	   Leigh	   Syndrome,	  
contributed	   significantly	   to	   our	   current	   knowledge	   on	   human	   respiratory	   chain	  
biogenesis.	  	  
However,	  many	  of	   the	  early	  assembly	   factors	   studied	   in	  yeast	   lack	  robust	  mammalian	  
homologs	  and	  their	  identification	  is	  a	  topic	  of	  recent	  research:	  An	  in	  silico	  analysis	  that	  
aimed	   to	   identify	   proteins	   with	   sequence	   similarity	   to	   these	   yeast	   factors	   revealed	  
potential	  candidates,	  among	  them	  predicted	  homologs	  of	  multiple	  genes	  that	  control	  the	  
COX1	  translation	  process	  in	  fungi	  (C7orf44,	  CCDC56,	  C12orf62)	  (Szklarczyk,	  Wanschers,	  
Cuypers,	  et	  al.	  2012a).	  The	  same	  study	  confirmed	  that	  C12orf62	  is	  a	  protein	  involved	  in	  
the	   assembly	   of	   cytochrome	   c	   oxidase	   in	   vivo.	   Moreover	   in	   a	   patient,	   a	   mutation	   in	  
C12orf62	  was	  reported	  to	  cause	  Fatal	  Neonatal	  Lactic	  Acidosis.	  Patient	  fibroblasts	  show	  
impaired	   cytochrome	   c	   oxidase	   assembly.	   C12orf62	   is	   speculated	   to	   be	   required	   for	  
coordination	   of	   the	   early	   steps	   of	   COX	   assembly	   with	   the	   translation	   of	   COX1	  
(Weraarpachai	  et	  al.	  2012).	  
The	   newly	   identified	   human	   assembly	   factor	  MITRAC12	   (previously	   termed	   CCDC56)	  
was	   found	   to	   interact	   with	   newly	   synthesized	   COX1	   in	   assembly	   intermediates.	  
Surprisingly,	   TIM21,	   a	   subunit	   of	   the	   presequence	   translocase	   of	   the	   inner	  
mitochondrial	   membrane	   is	   also	   present	   in	   these	   assembly	   intermediates,	   termed	  
MITRAC	  complexes.	  MITRAC12	   is	   required	   for	  efficient	  COX1	   synthesis	  and	  assembles	  
with	  other	   assembly	   factors	   such	   as	   SURF1,	  COX15,	  C12orf62	   and	  C7orf44/MITRAC15	  
(Mick	  et	  al.	  2012).	  Mitochondrial	  COX1	  translation	  is	  regulated	  by	  the	  MITRAC	  complex	  
and	   links	   the	   TIM23-­‐dependent	   protein	   import	   to	   the	   assembly	   of	   respiratory-­‐chain	  
complexes.	  
A	  homolog	  or	  ortholog	  of	  Mss51	  has	  not	  been	  identified	  so	  far.	  However,	  conservation	  
of	   the	   translational	   regulation	   mechanism	   in	   the	   mammalian	   system	   is	   difficult	   to	  
imagine	   due	   to	   the	   lack	   of	   extended	   5´-­‐UTR	   regions	   for	   binding	   of	   any	   regulating	  
proteins.	   Therefore,	   the	   general	   existence	   of	   mRNA-­‐specific	   translational	   factors	   in	  
mammalian	   mitochondria	   is	   a	   subject	   of	   speculation.	   If	   these	   factors	   exist	   in	   the	  
mammalian	  system,	  they	  are	  likely	  to	  interact	  with	  the	  coding	  sequence.	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1.4	  Research	  objectives	  
	  
Cytochrome	  c	  oxidase	  assembly	  from	  multiple	  subunits	  of	  dual	  genetic	  origin	  is	  a	  highly	  
complicated	  and	  regulated	  process.	   In	  yeast,	  over	  20	  assembly	   factors	  are	   involved	   in	  
translation	   of	   mitochondria-­‐encoded	   subunits	   as	   well	   as	   in	   their	   assembly	   and	  
maturation.	  Significant	  amount	  of	  data	  concerning	  early	  steps	  of	  COX	  assembly	  has	  been	  
accumulated;	   however	   the	   understanding,	   especially	   of	   the	   mechanism	   of	   cofactor	  
insertion,	  is	  far	  from	  being	  complete.	  	  
The	  aim	  of	  this	  study	  was	  to	  analyse	  different	  stages	  in	  the	  early	  steps	  of	  COX	  assembly	  
in	   order	   to	   extend	   our	   understanding	   of	   these	   processes	   in	   the	   yeast	   Saccharomyces	  
cerevisiae.	   The	   investigation	   has	   a	   great	   biomedical	   relevance	   since	   lesions	   affecting	  
conserved	   human	   COX	   assembly	   factors	   (e.g.	   SURF1,	   SCO1,	   COX10,	   COX15)	   result	   in	  
severe	  mitochondrial	  disorders	  such	  as	  Leigh	  syndrome.	  
	  
This	   study	   dissected	   the	   importance	   of	   close	   proximity	   of	   the	   two	   Oxa1	   domains	   in	  
respect	   to	   COX	   assembly	   by	   using	   linker	   insertion	   mutants.	   Therefore,	   assembly	   of	  
radiolabeled	  subunits	  of	  cytochrome	  c	  oxidase	  into	  complexes	  was	  analysed.	  	  
In	  addition,	  the	  translational	  regulation	  process	  of	  COX1	  was	  investigated	  by	  isolation	  of	  
Mss51-­‐containing	   complexes.	   In	   order	   to	   decrease	   sample	   variation,	   the	   purification	  
was	  performed	  after	  stable	  isotope	  labeling	  with	  amino	  acids	  in	  cell	  culture	  (SILAC).	  
Furthermore,	  this	  study	  analysed	  a	  mutation	  affecting	  a	  conserved	  amino	  acid	  in	  SURF1,	  
transferred	  to	  its	  yeast	  homolog	  Shy1.	  The	  investigated	  SURF1Y274D/Shy1Y344D	  missense	  
mutation	  has	  been	  reported	  in	  Leigh	  Syndrome	  patients	  and	  thus	  is	  known	  to	  affect	  COX	  
biogenesis.	   Using	   strains,	   expressing	   Shy1YD,	   the	   coupling	   of	  COX1	   translation	   to	   COX	  
assembly	  was	  addressed.	  	  
The	   last	  part	   of	   the	   study	  aimed	   to	   get	   a	  better	  understanding	  of	   the	   exact	  molecular	  
role	   of	   Shy1	   in	   assembly	   of	   cytochrome	   c	   oxidase.	   It	   was	   previously	   speculated	   that	  
heme	  a	  gets	  inserted	  into	  Cox1	  within	  the	  assembly	  intermediate	  complexes,	  most	  likely	  
via	   Shy1	  and	   its	   bacterial	   homolog	   Surf1.	  Therefore,	   Shy1	   containing	   complexes	  were	  
characterized	  in	  an	  unbiased	  manner.	  For	  this	  purpose,	  native	  isolation	  and	  separation	  
of	  assembly	  intermediate	  complexes	  using	  BN-­‐PAGE	  was	  combined	  with	  analysis	  of	  the	  
components	   by	  mass	   spectrometry	   and	  Western	   blotting.	   The	   finding	   that	   Cox15,	   the	  
heme	  a	  insertase	  interacts	  with	  Shy1	  and	  COA	  complexes	  lead	  to	  additional	  analyses	  of	  




2	  MATERIALS	  AND	  METHODS	  
2.1	  Materials	  
2.1.1	  Chemicals	  
All	   standard	   chemicals	   were	   purchased	   from	   AppliChem	   (Darmstadt),	   Merck	  
(Darmstadt),	  Roth	   (Karlsruhe),	   SERVA	  (Heidelberg)	  or	  Sigma-­‐Aldrich	   (Taufkirchen)	   in	  
analytical	  grade	  purity.	  Exceptions	  and	  special	  chemicals	  are	  listed	  in	  Table	  7.	  
2.1.2	  Enzymes	  
TABLE	  1:	  Enzymes	  and	  suppliers	  
	  





Proteinase	  K	   Roche	  
AcTEV	  protease	  	   Invitrogen	  
Zymolyase	  20T	   Seikagaku	  Biobusiness	  
2.1.3	  Kit	  systems	  
TABLE	  2:	  Kits	  used	  in	  this	  study	  
	  
Kit	   Supplier	  
	  
Flexi®	  Rabbit	  Reticulocyte	  Lysate	  System	  
	  
Promega	  
KOD	  Hot	  Start	  DNA	  polymerase	   Novagen	  
MEGAclear™	  Kit	   Ambion	  (Life	  technologies)	  
mMESSAGE	  mMACHINE®	  SP6	  Kit	  	   Ambion	  (Life	  technologies)	  
QuickChange®	  Site-­‐Directed	  Mutagenesis	  Kit	  	   Stratagene/	  Agilent	  
TNT®	  Quick	  coupled	  Transcription/Translation	  Systems	   Promega	  
Wizard®	  Plus	  SV	  Minipreps	  DNA	  Purification	  System	   Promega	  
Wizard®	  SV	  Gel	  and	  PCR	  Clean-­‐Up	  System	   Promega	  
	  
Kit	  systems	  were	  used	  according	  to	  the	  manufacturers	  specifications.	  
	   	   2.	  MATERIALS	  AND	  METHODS	  
29	  
2.1.4	  Buffers	  and	  solutions	  
TABLE	  3:	  Composition	  of	  buffers	  and	  solutions	  
	  
Buffer/solution	   Composition	  
	  
Acetate	  buffer	  	  
	  
0.5	  M	  NH4CH3COOH	  /	  CH3COOH,	  pH	  3.4	  
Blotting	  buffer	   20	  mM	  Tris,	  0.02%	  SDS,	  150	  mM	  glycine,	  20%	  ethanol	  
BN	  acrylamide	  solution	   48%	  acrylamide,	  1,5%	  bisacrylamide	  (32:1)	  
BN	  Anode	  buffer	   50	  mM	  Bis-­‐Tris/HCl	  (pH	  7.0)	  
BN	  Cathode	  buffer	   50	   mM	   tricine,	   15	   mM	   Bis-­‐Tris,	   0.02%	   Coomassie	  
Brilliant	  Blue	  G-­‐250	  
BN	  gel	  buffer	  (3x)	   200	   mM	   6-­‐aminohaxanoic	   acid,	   150	   mM	   Bis-­‐Tris/HCl	  
(pH	  7.0)	  
BN	  sample	  buffer	  (10x)	   5%	  Coomassie	  brilliant	  blue	  G-­‐250,	  500	  mM	  	  
6-­‐aminohaxanoic	  acid,	  100	  mM	  Bis-­‐Tris/HCl	  (pH	  7.0)	  
Coomassie	  destainer	   30%	  ethanol,	  10%	  acetic	  acid	  
Coomassie	  stainer	   40%	   ethanol,	   10%	   acetic	   acid,	   0.15%	   Coomassie	  
Brilliant	  Blue	  R250	  
Digitonin	  buffer	   20	  mM	  Tris/HCl	   (pH	  7.4),	   100	  mM	  NaCl,	   10%	  glycerol,	  
5	  mM	  EDTA,	  2	  mM	  PMSF,	  1%	  digitonin	  
Digitonin	  wash	  buffer	   20	   mM	   Tris/HCl	   (pH	   7.4),	   0.1	   M	   NaCl,	   10%	   glycerol,	  
5	  mM	  EDTA,	  2	  mM	  PMSF,	  0.3%	  digitonin	  
SEM	   250	  mM	  sucrose,	  1	  mM	  EDTA,	  10	  mM	  MOPS	  
SDS	  loading	  buffer	  	  
	  
10%	  glycerol,	  2%	  SDS,	  0.01%	  Bromphenol	  blue,	  	  
1%	  β-­‐mercaptoethanol,	  60	  mM	  Tris,	  pH	  6.8	  
SDS	  resolving	  gel	  buffer	  (5x)	   1.87	  M	  Tris/HCl	  (pH	  8.8)	  
SDS	  running	  buffer	   25	  mM	  Tris,	  192	  mM	  glycine,	  0.1%	  SDS	  
SDS	  stacking	  gel	  buffer	  (10x)	   0.8	  M	  Tris/HCl	  (pH	  6.8)	  
TBS-­‐T	   20	  mM	  Tris/HCl	  (pH	  7.5),	  125	  mM	  NaCl,	  0.1%	  Tween20	  
TE	  buffer	   10	  mM	  Tris/HCl	  (pH	  7.5),	  1	  mM	  EDTA	  
TAE	  buffer	   40	  mM	  Tris/acetate	  (pH	  8.0),	  2	  mM	  EDTA	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2.1.5	  Culture	  Media	  
TABLE	  4:	  Composition	  of	  culture	  media	  used	  in	  this	  study	  
	  




1%	  bacto	  tryptone,	  0.5%	  yeast	  extract,	  1%	  NaCl,	  pH	  7.0	  
LB-­‐Amp	   1%	   bacto	   tryptone,	   0.5%	   yeast	   extract,	   1%	   NaCl,	   100mg/ml	  
ampicillin,	  pH	  7.0	  
SD-­‐His	   0.67%	  yeast	  nitrogen	  base,	  0.07%	  CSM-­‐His,	  2%	  glucose	  
SD-­‐Ura	   0.67%	  yeast	  nitrogen	  base,	  0.07%	  CSM-­‐Ura,	  2%	  glucose	  
SGal-­‐Trp	   0.67%	  yeast	  nitrogen	  base,	  0.07%	  CSM-­‐Trp,	  2%	  galactose	  
SGal-­‐Ura	   0.67%	  yeast	  nitrogen	  base,	  0.07%	  CSM-­‐Ura,	  2%	  galactose	  
SG-­‐His	   0.67%	  yeast	  nitrogen	  base,	  0.07%	  CSM-­‐His,	  3%	  glycerol	  
SILAC	   0.67%	   yeast	   nitrogen	   base,	   20mg/l	   histidine,	   20mg/l	   tryptophane,	  
20mg/l	   adenine,	   20mg/l	   methionine,	   20mg/l	   uracil,	   30mg/l	  
isoleucine,	   30mg/l	   tyrosine,	   50mg/l	   phenylalanine,	   100mg/ml	  
leucine,	   150mg/l	   valine,	   200mg/l	   threonine,	   200mg/l	   proline,	  
20mg/l	   (heavy	  or	   light,	   respectively)	   lysine,	  20mg/l	   (heavy	  or	   light,	  
respectively)	  arginine	  
2x	  YPAD	   2%	   yeast	   extract,	   4%	   peptone,	   4%	   glucose,	   100mg/l	   adenine	  
hemisulfate,	  pH	  6.0	  
YPD	   1%	  yeast	  extract,	  2%	  peptone,	  2%	  glucose	  
YPGal	   1%	  yeast	  extract,	  2%	  peptone,	  2%	  galactose	  
YPG	   1%	  yeast	  extract,	  2%	  peptone,	  3%	  glycerol,	  pH	  5.0	  
	  
All	  media	  were	  either	  autoclaved	  or	   filter-­‐sterilized.	  For	  solid	  media	  plates,	  2.5%	  agar	  
was	  added	  before	  autoclaving.	  
2.1.6	  Cell	  lines	  
All	   yeast	   (Saccharomyces	   cerevisiae)	   strains	   used	   in	   this	   study	   were	   derivatives	   of	  
YPH499	   (Sikorski	   &	   Hieter	   1989),	   with	   the	   exception	   of	   cox1-­‐	   (derivative	   of	   777-­‐3A)	  
(Netter	   et	   al.	   1982),	   cox2-­‐	   (derivative	   of	   AB1-­‐4D)	   (Kruszewska	   et	   al.	   1980)	   and	  
mba1Δoxa1Δ	   (derivative	   of	   W303-­‐1A)	   (Thomas	   &	   Rothstein	   1989).	   Escherichia	   coli	  




TABLE	  5:	  Genotype	  and	  source	  of	  yeast	  strains	  used	  in	  this	  study	  
	  




MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801	  
	  
Sikorski	  &	  Hieter	  1989	  
Shy1ProtA	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  shy1::shy1-­‐TEV-­‐
ProtA-­‐7HIS-­‐HIS3MX6	  
Mick	  et	  al.	  2007	  
shy1Δ	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  shy1::HIS3MX6	   Mick	  et	  al.	  2007	  
cox1-­‐	   MATα,	  ade1	  op1;	  cox1-­‐G421	   Netter	  et	  al.	  1982	  
cox2-­‐	   MATα,	  ade1	  op1	  met3;	  cox2-­‐V25	   Kruszewska	  et	  al.	  1980	  
cyt1Δ	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  cyt1::HIS3MX6	   Vukotic	  et	  al.	  2012	  
Coa3HA	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  coa3::coa3-­‐3HA-­‐
HIS3MX6	  
Mick	  et	  al.	  2010	  
coa3Δ	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  coa3::	  HIS3MX6	   Mick	  et	  al.	  2010	  
cox14Δ	   MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox14::	  
HIS3MX6	  
Mick	  et	  al.	  2010	  
Mss51HA	   MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	  mss51::mss51-­‐
3HA-­‐	  HIS3MX6	  
Mick	  et	  al.	  2010	  
shy1Δ	  +	  pRS416	  
	  
MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  shy1::HIS3MX6;	  
[pRS416]	  
Reinhold	  et	  al.	  2011	  
shy1Δ	  +	  Shy1WT	  
	  
MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  shy1::HIS3MX6;	  
[pRS416-­‐SHY1]	  
Reinhold	  et	  al.	  2011	  
shy1Δ	  +	  Shy1YD	  
	  
MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  shy1::HIS3MX6;	  
[pRS416-­‐SHY1Y344D]	  
Reinhold	  et	  al.	  2011	  
mba1Δ	  oxa1Δ + pRS424	   MATa,	   ade2-­‐1	   his3-­‐11,15	   leu2-­‐3,	   112	   ura3-­‐1	   trp1-­‐1;	   mba1::	   HIS3MX6;	  
oxa1::LEU2	  [pRS424]	  
Keil	  et	  al.	  2012	  
mba1Δ	  oxa1Δ + Oxa1WT	   MATa,	   ade2-­‐1	   his3-­‐11,15	   leu2-­‐3,	   112	   ura3-­‐1	   trp1-­‐1;	   mba1::	   HIS3MX6;	  
oxa1::LEU2	  [pRS424-­‐OXA1]	  
Keil	  et	  al.	  2012	  
mba1Δ	  oxa1Δ + Oxa1100	   MATa,	   ade2-­‐1	   his3-­‐11,15	   leu2-­‐3,	   112	   ura3-­‐1	   trp1-­‐1;	   mba1::	   HIS3MX6;	  
oxa1::LEU2	  [pRS424-­‐OXA1100]	  
Keil	  et	  al.	  2012	  
mba1Δ	  oxa1Δ + Oxa1200	   MATa,	   ade2-­‐1	   his3-­‐11,15	   leu2-­‐3,	   112	   ura3-­‐1	   trp1-­‐1;	   mba1::	   HIS3MX6;	  
oxa1::LEU2	  [pRS424-­‐OXA1200]	  
Keil	  et	  al.	  2012	  





Strains	   Genotype	   Reference	  or	  source	  
	  
coa1Δ 	  (BBY06)	  
	  




coa1Δ Mss51SF	  (BBY09)	   MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   coa1::klTRP1;	  
mss51::mss51-­‐STreP-­‐FLAG-­‐	  HIS3MX6	  
This	  study	  
coa1Δ arg4Δ	  (BBY12)	   MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   coa1::klTRP1;	  
arg4::natNT2	  
This	  study	  
coa1Δ	   Mss51SF	   arg4Δ	  
(BBY13)	  
MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   coa1::klTRP1;	  
mss51::mss51-­‐STreP-­‐FLAG-­‐	  HIS3MX6;	  arg4::natNT2	  
This	  study	  
cox6Δ	  (BBY19)	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  cox6::klTRP1	   This	  study	  
Shy1ProtA	  cox6Δ	  (BBY20)	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  shy1::shy1-­‐TEV-­‐
ProA-­‐7HIS-­‐HIS3MX6;	  cox6::klTRP1	  
This	  study	  
Mss51HA	  shy1Δ+ 	  pRS416	  
(BBY03)	  
MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  mss51::mss51-­‐
3HA-­‐	  HIS3MX6;	  shy1::klTRP1	  [pRS416]	  
This	  study	  
Mss51HA	  shy1Δ+ 	  Shy1FLAG	   MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  mss51::mss51-­‐
3HA-­‐	  HIS3MX6;	  shy1::klTRP1	  [pRS416-­‐SHY1FLAG]	  
D.	  Mick,	  unpublished	  
Mss51HA	  shy1Δ+ 	  
Shy1(YD)FLAG	  
MATa,	  ade2-­‐101	  his3-­‐Δ200	   leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	   lys2-­‐801;	  mss51::mss51-­‐
3HA-­‐	  HIS3MX6;	  shy1::klTRP1	  [pRS416-­‐	  SHY1(Y344D)FLAG]	  
D.	  Mick,	  unpublished	  
Cox15ProtA	  (BBY02)	   MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox15::cox15-­‐
TEV-­‐ProA-­‐7HIS-­‐HIS3MX6	  
This	  study	  
Cox15FLAG	  (BBY32)	   MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox15::cox15-­‐
FLAG-­‐HIS3MX6	  
This	  study	  
cox15Δ  (BBY14)	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  cox15::klTRP1	   This	  study	  
cox15Δ +	  pRS416 
(BBY16)	  
MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox15::klTRP1	  
[pRS416]	  
This	  study	  
cox15Δ +	  Cox15WT   
(BBY17)	  
MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox15::klTRP1	  
[pRS416-­‐COX15]	  
This	  study	  
cox15Δ +	  Cox15H368M	  
(BBY18)	  	  
MATa,	   ade2-­‐101	   his3-­‐Δ200	   leu2-­‐Δ1	   ura3-­‐52	   trp1-­‐Δ63	   lys2-­‐801;	   cox15::klTRP1	  
[pRS416-­‐COX15H368M]	  
This	  study	  
cox10Δ  (BBY14)	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  cox10::klTRP1	   This	  study	  
Shy1ProtA/rho0	  (BBY47)	   MATa,	  ade2-­‐101	  his3-­‐Δ200	  leu2-­‐Δ1	  ura3-­‐52	  trp1-­‐Δ63	  lys2-­‐801;	  shy1::shy1-­‐TEV-­‐
ProtA-­‐7HIS-­‐HIS3MX6	  /rho0	  
This	  study	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2.1.7	  Plasmids	  
All	  plasmids	  used	   in	   this	   study	  are	   listed	   in	   table	  6.	  Plasmids	  generated	   for	   this	   study	  
were	   obtained	   by	   site	   directed	   mutagenesis	   of	   	   parental	   plasmids,	   as	   described	   in	  
section	  2.4.7.	  Plasmids	  were	  propagated	  in	  E.coli	  XL1-­‐blue	  cells.	  
	  
TABLE	  6:	  Plasmids	  used	  in	  this	  study	  
	  









pDaM20	  (Shy1WT)	   pRS416	   SHY1	  b	   Reinhold	  et	  al.	  2011	  
pDaM23	  (Shy1Y344D)	  	   pDaM20	   SHY1-­‐(T1030G)	   Reinhold	  et	  al.	  2011	  
pDaM55	  (Cox15WT)	   pRS416	   COX15	  a	   D.	  Mick,	  unpublished	  
pBB06	  (Cox15H368M)	   pDaM55	   COX15-­‐(CAT1102ATG)	   This	  study	  
C21	  (Cox5a)	   pGEM4	  	   COX5A	   AG	  Rehling	  (C21)	  
	  
a:	  including	  262bp	  upstream	  and	  292bp	  downstream	  of	  the	  open	  reading	  frame	  
b:	  including	  372bp	  upstream	  and	  363bp	  downstream	  of	  the	  open	  reading	  frame	  
2.1.8	  Antibodies	  
Polyclonal	  primary	  antibodies	  were	  raised	  in	  rabbit	  either	  against	  a	  C-­‐terminal	  peptide	  
or	   against	   the	   whole	   protein.	   Secondary	   antibodies	   against	   rabbit	   immunoglobulin,	  
coupled	  to	  horseradish-­‐peroxidase	  were	  used	  for	  Western	  blot	  detection.	  	  
Monoclonal	  primary	  antibodies	  against	  FLAG	  and	  HA	  were	  purchased	  and	  detected	  with	  
IgG	  goat	  anti	  mouse,	  coupled	  to	  HRP.	  	  
For	  detection	  of	  protein	  A,	  Peroxidase	  anti-­‐peroxidase	  (PAP)	  soluble	  complex,	  produced	  
in	   rabbit	   was	   purchased	   and	   signals	  were	   enhanced	   by	   secondary	   antibodies	   against	  
rabbit	  immunoglobulin,	  coupled	  to	  horseradish-­‐peroxidase.	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2.1.9	  Special	  chemicals	  
TABLE	  7:	  Special	  chemicals	  and	  their	  suppliers	  
	  
Chemical	   Supplier	  
	  
Anti-­‐	  HA,	  mouse	  monoclonal	  antibody	  
	  
Roche	  
ATP	   Roche	  
Coomassie	  brilliant	  blue	  G250/	  R250	   Serva	  
Creatine	  phosphate	   Roche	  
Desthiobiotin	   IBA	  
Digitonin	   Calbiochem	  
Dropout	  mixes	  (CSM-­‐His/CSM-­‐Trp/CSM-­‐Ura)	   MP	  Biomedicals	  
ECL	  Western	  Blotting	  detection	  reagent	   GE-­‐Healthcare	  
FLAG	  agarose,	  FLAG	  peptide	   Sigma	  
GeneRuler	  DNA	  Ladder	  Mix	  	   Fermentas	  
Goat	  anti	  rabbit	  HRP	   Dianova	  
Goat	  anti	  mouse	  HRP	   Dianova	  
Herring	  sperm	  DNA	   Promega	  
HMW	  calibration	  Kit	   GE	  Healthcare	  
IgG	  (human)	   Sigma	  
IgG	  standard	  (bovine)	   Biorad	  
L-­‐Lysine:2HCl	  (U-­‐13C6,	  99%;	  U-­‐15N2,	  99%)	   Cambridge	  Isotope	  Laboratories	  
L-­‐Arginine:HCl	  (U-­‐13C6,	  99%;	  U-­‐15N4,	  99%)	   Cambridge	  Isotope	  Laboratories	  
Monoclonal	  anti-­‐FLAG	  antibody	  (mouse)	   Sigma	  
NADH	   Roche	  
Ni-­‐NTA	  agarose	   Qiagen	  
Oligonucleotides	   Metabion	  
Peroxidase	  anti-­‐peroxidase,	  antibody	  (PAP)	   Sigma	  
PEG-­‐4000	   Applichem	  
Peptone,	  yeast	  extract,	  YNB	  w/o	  aa	   BD	  
ProteinA-­‐seharose	   GE-­‐	  Healthcare	  
Streptactin	  Sepharose	   IBA	  
SDS	  marker	  broad	  range	   Biorad	  
[35S]-­‐methionine	   Hartmann	  Analytics	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2.2	  Cultivation	  of	  yeast	  
2.2.1	  Growth	  condition	  and	  media	  
In	   general,	   yeast	   (Saccharomyces	   cerevisiae)	   cells	   were	   grown	   in	   rich	   liquid	  media	   at	  
30	  °C	  with	   agitation	   (160-­‐220	   rpm).	   Synthetic	  medium	  was	   used	   to	   select	   for	   genetic	  
markers	   and	   for	   growth	   of	   strains	   containing	   plasmids.	   Compositions	   of	   the	   different	  
media	   are	   listed	   in	   table	   4.	   For	   solid	   media	   plates,	   2.5%	   agar	   was	   added	   prior	   to	  
sterilization	  and	  preparation	  of	   the	  plates.	  Yeast	  cells	  were	  streaked	  onto	  appropriate	  
solid	  media	  plates	  from	  cryo	  stocks	  and	  grown	  for	  2-­‐3	  days	  at	  30	  °C.	  For	  liquid	  cultures,	  
yeast	  cells	  were	  inoculated	  with	  biomass	  picked	  from	  solid	  media	  or	  from	  a	  pre-­‐culture	  
(1:10	   or	   1:20).	   Cell	   density	   was	   monitored	   by	   measuring	   optical	   density	   at	   600	   nm	  
(OD600).	   All	  media	   and	   solutions	   used	   in	   handling	   of	   yeast	   were	   either	   autoclaved	   or	  
filter-­‐sterilized.	  
2.2.2	  Yeast	  cryo	  stocks	  
For	  yeast	  stock	  preservation,	  yeast	  cells	  were	  picked	  from	  solid	  media,	  resuspended	  in	  
2x	  YPAD,	  containing	  20%	  glycerol	  and	  stored	  at	  -­‐80	  °C.	  
2.2.3	  Growth	  test	  of	  yeast	  strains	  
To	  assess	  the	  growth	  of	  yeast	  strains,	  serial	  10-­‐fold	  dilutions	  of	  an	  overnight	  yeast	  pre-­‐
culture	   were	   spotted	   on	   solid	   media,	   supplemented	   with	   different	   carbon	   sources.	  
Plates	  were	  incubated	  for	  2-­‐5	  days	  at	  different	  temperatures.	  Subsequently,	  plates	  were	  
scanned	  (Epson	  Perfection	  V750	  Pro)	  for	  documentation	  of	  growth.	  
2.2.4	  Generation	  of	  rho0	  yeast	  strains	  	  
Yeast	  cells	  were	  grown	  in	  YPD	  media,	  containing	  25	  µg/ml	  ethidiumbromide	  (EtBr)	  and	  
diluted	  (1:60)	  in	  fresh	  YPD	  with	  EtBr	  every	  day.	  After	  3	  days,	  cells	  were	  plated	  on	  YPD	  
solid	  media	  plates	  without	  EtBr,	   incubated	   for	  2	  days	  and	  single	  colonies	  were	  picked	  
(modified	  from	  Simon	  &	  Faye	  1984).	  The	  absence	  of	  mitochondrial	  DNA	  was	  verified	  by	  
the	   absence	   of	   growth	   on	   glycerol	   plates	   (non-­‐fermentable	   carbon	   source)	   and	   the	  
absence	  of	  various	  mitochondrially	  encoded	  proteins,	  assessed	  by	  Western	  blot	  analysis	  
of	  whole	  cell	  extracts.	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2.3	  Cultivation	  of	  E.	  coli	  
In	  general,	  E.	  coli	  cells	  were	  grown	  at	  37	  °C	  in	  LB	  medium,	  supplemented	  with	  100	  mg/l	  
ampicillin,	  with	   shaking	   for	   selection	  of	   plasmids	   carrying	   an	  AmpR	  marker.	   For	   solid	  
media	   plates,	   1.5%	   agar	   was	   added	   prior	   to	   sterilization	   and	   preparation	   of	   the	   LB-­‐
plates.	  For	  liquid	  cultures,	  E.	  coli	  cells	  were	  inoculated	  with	  biomass	  picked	  from	  solid	  
media	   or	   from	   a	   pre-­‐culture	   (1:100	   to	   1:1000).	   Cell	   density	   was	   monitored	   by	  
measuring	  optical	  density	  at	  600	  nm	  (OD600).	  For	  stock	  preservation,	  1	  ml	  liquid	  E.	  coli	  
culture	  was	  mixed	  with	  200	  µl	  of	  80%	  glycerol	  and	  stored	  at	  -­‐80	  °C.	  
2.4	  Molecular	  biology	  methods	  
2.4.1	  Amplification	  of	  DNA	  fragments	  by	  PCR	  
DNA	  fragments	  were	  amplified	  by	  PCR	  using	  KOD	  Hot	  Start	  DNA	  polymerase	  (Novagen)	  
according	   to	   the	  manufacturers	   specifications	   in	   50	  µl	   scale	   (for	   standard	   reactions).	  
100	  ng	  of	  yeast	  genomic	  DNA	  or	  10	  ng	  of	  plasmid	  DNA	  were	  used	  as	  template.	  Cycling	  
conditions	  were	  adjusted	  to	  the	  length	  of	  the	  fragment	  and	  melting	  temperature	  of	  the	  
primer	  pair.	  
2.4.2	  Purification	  of	  plasmids	  
Plasmids	  were	  purified	  from	  E.	  coli	  using	  Wizard®	  Plus	  SV	  Minipreps	  DNA	  Purification	  
System	   (Promega),	   according	   to	   the	   manufacturers	   specifications.	   Following	   the	  
purification,	   concentration	   of	   the	   nucleic	   acid	   solution	  was	  measured.	   Plasmids	  were	  
stored	  in	  dH2O	  at	  -­‐20	  °C.	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2.4.3	  Preparation	  of	  yeast	  genomic	  DNA	  
Yeast	  cells	  were	  inoculated	  in	  YPGal	  and	  grown	  overnight.	  After	  determination	  of	  OD600,	  
2.5	  OD600	  were	  isolated	  by	  centrifugation	  (2	  min,	  20000	  xg,	  at	  RT).	  The	  supernatant	  was	  
discarded,	   the	  pellet	  was	  resuspended	  in	  150	  µl	  solution	  A	  (50	  mM	  Tris/HCl	  (pH	  7.4),	  
10	  mM	  EDTA,	  0,3%	  β-­‐mercaptoethanol,	  0.5	  mg/ml	  zymolyase)	  and	   incubated	  at	  37	  °C	  
for	  1	  h	  on	  a	   thermomixer	   (350	  rpm).	  After	  addition	  of	  SDS	   to	  a	   final	   concentration	  of	  
1%,	   0.5	   volumes	   of	   8	   M	   ammoniumacetate	   were	   added,	   mixed	   thoroughly	   and	  
incubated	   at	   -­‐20	  °C	   for	   15	   minutes.	   The	   lysate	   was	   cleared	   by	   centrifugation	  
(14000	  rpm,	   15	   min,	   4	  °C)	   and	   180	   µl	   of	   the	   supernatant	   were	   taken	   and	   DNA	   was	  
precipitated	  by	  addition	  of	  120	  µl	  isopropanol.	  After	  centrifugation	  (14000	  rpm,	  15	  min,	  
4	  °C)	   the	   pellet	   was	   washed	   with	   70%	   EtOH	   once	   and	   dried.	   After	   resuspension	   in	  
appropriate	  volume	  of	  TE	  buffer,	  the	  yeast	  genomic	  DNA	  was	  stored	  at	  -­‐20	  °C.	  
2.4.4	  DNA	  electrophoresis	  
DNA	  fragments	  were	  separated	  by	  horizontal	  agarose	  gel	  electrophoresis.	  1%	  agarose	  
gels	   were	   prepared	   in	   TAE	   buffer	   and	   supplemented	   with	   ethidiumbromide.	   DNA	  
samples	   were	   mixed	   with	   loading	   dye	   (4x	   stock:	   40	   %	   saccharose,	   1%	   OrangeG).	  
Electrophoresis	  was	  performed	   in	  TAE	  buffer	   for	  20-­‐30	  min	  at	  100	  V.	  GeneRuler	  DNA	  
Ladder	  Mix	  (Fermentas)	  was	  used	  as	  a	  standard.	  Separation	  of	  the	  DNA	  fragments	  was	  
documented	  using	  a	  UV-­‐transilluminator.	  
2.4.5	  Determination	  of	  nucleic	  acid	  concentrations	  
DNA	   and	   RNA	   concentrations	   were	   measured	   with	   NanoVue	   spectrometer	  
(GE	  Healthcare)	   at	   260	   nm.	   One	   OD260	   was	   assumed	   to	   correspond	   to	   50	   µg/ml	   for	  
dsDNA	  and	  to	  40	  µg/ml	  for	  RNA.	  
2.4.6	  Sequencing	  of	  DNA	  
Sequencing	   of	   DNA	  was	   performed	   by	   GATC	   Biotech	   (Konstanz).	   Sequences	   obtained	  
were	  viewed	  and	  compared	  using	  GeniousPro	  (Version	  5.3.6,	  Biomatters).	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2.4.7	  Site-­‐directed	  mutagenesis	  of	  plasmids	  
Site-­‐directed	   mutagenesis	   was	   performed	   using	   the	   QuickChange®	   Site-­‐Directed	  
Mutagenesis	  Kit	  (Stratagene/Agilent)	  according	  to	  the	  manufacturers	  specifications.	  To	  
mutate	  a	  single	  amino	  acid	  in	  COX15,	  30	  ng	  of	  COX15WT,	  cloned	  into	  pRS416	  was	  used	  as	  
template.	  Overlapping	  primers	  were	  designed	  with	  the	  desired	  mutation	  in	  the	  middle	  
of	   each	   primer	   (forward:	   5’-­‐	   CAG	   TTG	   GTC	   ATG	   AGG	   ACA	   TGT	   GCG	   TAC	   GTT	   G,	   CAT	  
replaced	   by	  ATG;	   reverse:	   5’-­‐	   C	   ACA	  TGT	  CCT	  CAT	  GAC	  CAA	  CTG	  AAC	  TGT	  AAC,	   ATG	  
replaced	  by	  CAT). Cycling	   conditions:	   initial	   denaturation	   (95	  °C,	   30	   sec),	   followed	  by	  
20	   cycles	   of	   denaturation	   (95	  °C,	   30	   sec),	   annealing	   (55	  °C,	   1	   min)	   and	   amplification	  
(68	  °C,	  8	  min).	  To	  digest	  methylated,	  non	  mutated	  parental	  DNA	  template,	  the	  reaction	  
was	  treated	  with	  DpnI	  at	  37	  °C	  for	  1	  h.	  The	  mutated	  plasmid	  was	  transformed	  into	  XL1-­‐
Blue	   supercompetent	   cells,	   supplied	   with	   the	   kit,	   according	   to	   the	   general	   E.	   coli	  
transformation	  protocol	  (see	  section	  2.4.9)	  with	  the	  following	  modifications:	  cells	  were	  
left	  on	  ice	  for	  30	  min	  prior	  to	  transformation	  and	  heat	  shock	  was	  performed	  for	  45	  sec	  
instead	  of	  2	  min.	  The	  mutagenesis	  was	  verified	  by	  sequencing. 
2.4.8	  Chromosomal	  deletion	  and	  tagging	  of	  yeast	  genes	  
Chromosomal	   deletions	   as	  well	   as	   tagged	   versions	   of	   yeast	   genes	  were	   generated	   by	  
introduction	   of	   the	   klTRP1,	  HIS3MX6	   or	   natNT2	   cassettes	   using	   PCR	   based	   strategies	  
(Knop	  et	  al.	  1999;	  Janke	  et	  al.	  2004).	  Cox15FLAG	  was	  generated	  using	  pYM2.1	  vector	  (D.	  
Mick,	   Rehling	   lab).	   Mss51SF	   was	   generated	   using	   a	   modified	   pYM2.1	   vector,	   kindly	  
provided	   by	   J.	   Melin	   (Rehling	   lab).	   Briefly,	   the	   streptavidin-­‐FLAG	   tag	   from	   pESG-­‐
IBA_168	   (cut	   with	   XhoI	   and	   BglII)	  was	   ligated	   into	   pYM2.1,	   cut	   with	   SalI	   and	   BglII	  
(Alkhaja	  et	  al.	  2012).	  
Yeast	   strains	   were	   transformed	   with	   PCR-­‐amplified	   integration-­‐cassettes	   using	   the	  
lithium	  acetate	  method,	  as	  described	  in	  section	  2.4.10.	  Integration	  into	  the	  genome	  was	  
confirmed	  by	  PCR	  or	  Western	  blot	  analysis	  of	  the	  target	  protein.	  The	  strains	  generated	  
in	  this	  study	  are	  listed	  in	  table	  5.	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2.4.9	  Transformation	  of	  E.	  coli	  
100	   µl	   of	   rubidium	   chloride	   (RuCl)	   competent	   E.	   coli	   cells	   were	   thawed	   on	   ice	   and	  
incubated	  with	   50	   ng	   plasmid	   for	   15	  min	   on	   ice.	   The	   reaction	  was	   subjected	   to	   heat	  
shock	   at	   42	  °C	   for	   2	  min	   and	   subsequently	   cooled	   down	   on	   ice	   for	   3	  min.	   1ml	   of	   LB	  
media,	  pre-­‐warmed	   to	  37	  °C,	  was	  added	  and	  bacteria	  were	  allowed	   to	  grow	   for	  1	  h	  at	  
37	  °C	  with	  shaking.	  The	  transformed	  cells	  were	  centrifuged	  down	  (10000	  rpm,	  5	  min	  at	  
RT),	   resuspended	   in	   200	   µl	   LB	   and	   plated	   onto	   LB-­‐Amp	   agar	   plates.	   Plates	   were	  
incubated	  at	  37	  °C	  over	  night	  until	  appearance	  of	  single	  colonies.	  
2.4.10	  Transformation	  of	  S.	  cerevisiae	  
Yeast	   cells	   were	   transformed	   by	   the	   LiOAc	   method	   (Ito	   et	   al.	   1983;	   Schiestl	   &	   Gietz	  
1989;	  Gietz	  &	   Schiestl	   2007).	   Cells	  were	   inoculated	   on	   the	   day	   before	   transformation	  
from	  a	   fresh	  agar	  plate	   into	  2x	  YPAD	  and	  grown	  overnight.	  On	   the	  next	  day,	   the	  main	  
culture	  was	   inoculated	  with	   the	   pre-­‐culture	   to	   an	  OD600	   of	   0.5	   and	   allowed	   to	   double	  
twice.	   At	   OD600=	   2,	   the	   yeast	   cells	   were	   harvested	   (4000	   rpm,	   3	  min,	   18	  °C),	   washed	  
once	  with	   0.5	   volumes	   of	   sterile	  water	   and	   once	  with	   0.5	   volumes	   of	   transformation	  
buffer	  (0.1	  M	  LiOAc,	  0.1	  mM	  EDTA,	  5	  mM	  Tris/HCl	  pH	  8.0).	  The	  cells	  were	  subsequently	  
resuspended	   in	   transformation	   buffer	   (1/50	   volumes	   of	   the	   original	   culture)	   and	  
aliquoted	   to	   100	   µl	   per	   reaction.	   To	   each	   reaction,	   1/10	   volume	   of	   carrier	   DNA	  
(10	  mg/ml	   herring	   sperm	  DNA,	   boiled	   at	   95	  °C	   for	   10	  min	   prior	   to	   addition)	   and	   the	  
target	   DNA	   (1-­‐2	   µg	   PCR	   product/	   30	   ng	   plasmid	   DNA)	   was	   added.	   For	   a	   control	  
reaction,	   the	   target	   DNA	   was	   replaced	   by	   the	   same	   volume	   of	   sterile	   water.	   After	  
addition	  of	  600	  µl	  40%	  PEG-­‐4000	  in	  transformation	  buffer,	  the	  mixture	  was	  incubated	  
at	  30	  °C	  for	  30	  min.	  Heat	  shock	  was	  performed	  at	  42	  °C	  for	  15	  min	  after	  addition	  of	  68	  µl	  
DMSO.	  Cells	  were	  harvested	  by	  centrifugation	  (2000	  rpm,	  2	  min	  at	  RT),	  resuspended	  in	  
200	  µl	   1	  M	   sorbitol	   and	   plated	   onto	   appropriate	   selective	  media	   plates	   under	   sterile	  
conditions.	  Plates	  were	  incubated	  at	  30	  °C	  until	  appearance	  of	  colonies	  (usually	  3	  days),	  
then	   single	   colonies	   were	   picked	   and	   re-­‐streaked	   onto	   selective	   media	   plates.	   All	  
solutions	  used	  for	  this	  procedure	  were	  either	  autoclaved	  or	  filter-­‐sterilized.	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2.5	  Biochemical	  methods	  
2.5.1	  SDS-­‐PAGE	  
SDS-­‐PAGE	   was	   performed	   to	   separate	   proteins	   according	   to	   their	   molecular	   weight	  
under	   denaturing	   conditions	   by	   one-­‐dimensional	   SDS-­‐Polyacrylamide	   gel	  
electrophoresis	  (SDS-­‐PAGE),	  originally	  developed	  by	  Laemmli	  (1970).	  Gels	  used	  in	  this	  
study	   contained	   0.1%	   SDS	   and	   4%	   acrylamide	   for	   the	   stacking	   gel	   and	   12.5-­‐17%	  
acrylamide	   for	   the	   separating	   gel	   (depending	   on	   the	   size	   of	   proteins	   to	   separate).	  
Acrylamide	   stock	   solution	   used	   to	   prepare	   gels	   contained	   30%	  
acrylamide/bisacrylamide	  (37.5	  :	  1).	  Samples	  were	  mixed	  with	  SDS	  loading	  buffer	  and	  
incubated	   at	   25	  °C	   for	   15	   min	   prior	   to	   loading.	   Electrophoresis	   was	   performed	   in	  
custom-­‐made	   midi	   gel	   systems	   (250	   V,	   30	   mA	   per	   gel).	   As	   a	   standard,	   SDS-­‐PAGE	  
standard	  Broad	  Range	  (Biorad)	  was	  used.	  
2.5.2	  Urea-­‐SDS-­‐PAGE	  
For	   better	   separation	   and	   resolution	   in	   the	   low	   molecular	   range	   (below	   10	   kDa),	  	  	  	  	  	  	  
SDS-­‐PAGE	   gels,	   containing	   urea	   were	   used.	   Handling	   and	   electrophoresis	   conditions	  
were	   basically	   identical	   to	   SDS-­‐PAGE	   gels.	   The	   resolving	   gel	   contained	   5.4	   M	   urea,	  
0.09%	  SDS,	  17.5%	  acrylamide,	   0.23%	  bisacrylamide.	  The	   stacking	   gel	   contained	  5.5%	  
acrylamide/0.07%	   bisacrylamide,	   0.12%	   SDS,	   3.6	   M	   urea.	   The	   running	   buffer	   was	  
composed	  of	   50	  mM	  Tris,	   192	  mM	  glycine,	   0.1%	  SDS.	  Electrophoresis	  was	  performed	  
for	  4-­‐5	  h.	  
2.5.3	  BN-­‐PAGE	  
For	   separation	   of	   native	   protein	   complexes,	   Blue	   Native	   polyacrylamide	   gel	  
electrophoresis	   (BN-­‐PAGE)	  was	   basically	   performed	   as	   described	   earlier	   (Schägger	  &	  
Jagow	  1991;	  Wittig	  et	  al.	  2006).	  Prior	   to	   the	  gel	  run,	  mitochondria	  were	  solubilized	   in	  
digitonin	  solubilization	  buffer,	   containing	  1%	  digitonin,	  at	  a	   concentration	  of	  1mg/ml.	  
To	   ensure	   proper	   solubilization,	   mitochondria	   were	   re-­‐isolated	   by	   centrifugation	  
(14000	  rpm,	  10	  min,	  4	  °C)	  and	  resuspended	  by	  pipetting	  up	  and	  down	  12	  times	  using	  a	  
small	   tip.	   After	   incubation	   of	   the	   samples	   for	   30	   min	   on	   ice,	   insoluble	   material	   was	  
removed	  by	  centrifugation	  (14000	  rpm,	  15	  min,	  4	  °C).	  The	  supernatant	  was	  mixed	  with	  
BN	  loading	  dye	  to	  a	  final	  concentration	  of	  1x.	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4-­‐10%	  or	  4-­‐13%	  gradient	  gels	  with	  4%	  stacking	  gel	   in	  a	  Hoefer	  gel	   system,	  equipped	  
with	  a	  cooling	  device	  to	  allow	  electrophoresis	  at	  4	  °C	  were	  used	  in	  this	  study.	  All	  buffers	  
were	   precooled	   to	   4	  °C	   and	   gel	   loading	   was	   performed	   in	   a	   cold	   room	   at	   4	  °C.	  
Electrophoresis	  was	  performed	  with	  anode	  buffer,	  containing	  Coomassie	  at	  200	  V	  and	  
15	  mA	  per	  gel	   for	  2	  h.	  Anode	  buffer	  was	  replaced	  by	  anode	  buffer	  without	  Coomassie	  
and	  electrophoresis	  was	  continued	  at	  600V	  and	  15	  mA	  per	  gel	  (3-­‐4	  h).	  Replacement	  of	  
the	  anode	  buffer	  was	  omitted	  if	  the	  gel	  was	  not	  intended	  for	  Western	  blotting.	  Following	  
the	  gel	  run,	  the	  gel	  was	  either	  stained	  with	  Coomassie	  or	  subjected	  to	  Western	  blotting.	  
As	  a	  standard,	  the	  HMW	  calibration	  kit	  (GE	  Healthcare)	  was	  used.	  
For	   analysis	   of	   steady	   state	   protein	   levels	   of	   structural	   subunits	   of	   respiratory	   chain	  
complexes,	  15-­‐20	  µg	  of	  mitochondria	  were	  loaded	  per	  lane.	  For	  analysis	  of	  steady	  state	  
levels	  of	   less	  abundant	  proteins	  (e.g.	  COX	  assembly	  factors),	  50-­‐70	  µg	  of	  mitochondria	  
were	  loaded	  per	  lane.	  For	  analysis	  of	  elution	  of	  protein	  complex	  isolations,	  the	  amount	  
loaded	   per	   lane	   varied,	   but	   usually	   corresponded	   to	   a	   starting	   material	   between	  	  	  	  	  	  	  	  
250-­‐500µg	  of	  mitochondria.	  
2.5.4	  Determination	  of	  protein	  concentrations	  
Protein	   concentrations	  were	   determined	   by	   Bradford	   analysis	   (Bradford	   1976)	   using	  
Roti-­‐quant	   (Roth)	   according	   to	   the	   manufacturers	   specifications	   with	   bovine	   IgG	  
(Biorad)	   as	   a	   standard.	   Absorbance	   of	   the	   protein	   solutions	   was	   measured	   using	   a	  
BioPhotometer	   (Eppendorf)	   at	   595	  nm.	   Protein	   concentrations	  were	   calculated	   based	  
on	  the	  IgG	  standard.	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2.5.5	  Yeast	  whole	  cell	  extracts	  
For	   analysis	   of	   proteins	   on	   a	   whole	   cell	   level,	   whole	   cell	   extracts	   were	   prepared	  
essentially	  as	  described	  earlier	  (Yaffe	  &	  Schatz	  1984).	  In	  detail,	  yeast	  cells	  were	  grown	  
in	   YPGal	   overnight.	   After	   determination	   of	   OD600,	   2	   OD600	   were	   isolated	   by	  
centrifugation	  (14000	  rpm,	  1	  min	  at	  RT).	  The	  cells	  were	  resuspended	   in	  dH2O,	  148	  µl	  
2	  M	  NaOH	  and	  12	  µl	  β-­‐mercaptoethanol	  were	  added	  and	  the	  mixture	   incubated	  on	   ice	  
for	   10	   min.	   Trichloracetic	   acid	   (TCA)	   was	   added	   to	   a	   final	   concentration	   of	   7%	   and	  
incubated	  on	  ice	  for	  10	  min.	  Precipitated	  material	  was	  pelleted	  by	  centrifugation	  (2	  min,	  
14000	  rpm,	  4	  °C)	  and	  the	  pellet	  resuspended	  in	  SDS	  sample	  buffer.	  The	  pH	  of	  the	  whole	  
cell	  lysate	  was	  adjusted	  to	  a	  neutral	  pH	  (indicated	  by	  the	  blue	  colour	  of	  the	  SDS	  loading	  
buffer)	  by	  titration	  with	  1	  M	  Tris	  (pH	  11.5).	  Before	  the	  samples	  were	  subjected	  to	  SDS-­‐
PAGE,	  debris	  was	  removed	  by	  centrifugation	  (14000	  rpm,	  1	  min	  at	  RT).	  
2.5.6	  Western	  Blotting	  
After	   separation	   by	   polyacrylamide	   gelelectrophoresis,	   proteins	  were	   transferred	   and	  
immobilized	   onto	   PVDF	   membranes	   (Millipore)	   using	   semidry	   blotting	   chambers	  
(Peqlab).	   PVDF	   membranes	   were	   pre-­‐activated	   by	   short	   incubation	   in	   MeOH.	   The	  
membrane	  was	  subsequently	  soaked	  in	  blotting	  buffer,	  together	  with	  gels	  and	  Whatman	  
paper.	  After	  assembly	  of	  the	  blotting	  sandwich,	  transfer	  was	  performed	  at	  25	  V	  and	  250	  
mA	  for	  90	  min	  (following	  SDS-­‐PAGE)	  or	  for	  120	  min	  (following	  BN-­‐PAGE	  and	  Urea-­‐SDS-­‐
PAGE).	  	  
2.5.7	  Coomassie	  staining	  
Proteins	  on	  PVDF	  membranes	  or	   in	  polyacrylamide	  gels	  were	  stained	  with	  Coomassie	  
Brilliant	   Blue	   R-­‐250	   for	   2	   min	   (membranes)	   or	   for	   1h	   (gels).	   After	   staining,	   marker	  
bands	  were	   labeled	  on	   the	  membrane	  and	  membranes	  were	  destained	   for	  5	  min,	  gels	  
for	  up	  to	  1	  h.	  Additionally,	  PVDF	  membranes	  were	  completely	  destained	  in	  MeOH.	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2.5.8	  Immunodecoration	  of	  proteins	  on	  PVDF	  membranes	  
Destained	  PVDF	  membranes	  were	  blocked	  using	  5%	  milk	  powder	   in	  TBS-­‐T	   for	  1	  h	   at	  
room	  temperature	  or	  over	  night	  at	  4	  °C.	  Following	  blocking	  of	  non-­‐specific	   interaction	  
sites,	  membranes	  were	   incubated	   in	   primary	   antibody	   solution	   (in	   5%	  milk	   in	   TBS-­‐T	  
likewise)	  for	  1h	  ,	  washed	  3	  times	  for	  10	  min	  in	  fresh	  TBS-­‐T.	  Subsequently,	  membranes	  
were	  incubated	  in	  appropriate	  secondary	  antibody,	  coupled	  to	  HRP	  (solution	  prepared	  
1:5000-­‐	  1:10000	  in	  5%	  milk	  in	  TBS-­‐T)	  for	  1h,	  followed	  by	  3	  washes	  for	  15	  min	  in	  TBS-­‐T.	  
All	   incubation	   and	   washing	   steps	   were	   performed	   at	   room	   temperature	   and	   under	  
agitation.	   For	   detection	   and	   visualization	   of	   antibody-­‐protein	   complexes,	   enhanced	  
chemiluminescence	  reagent	  (GE	  Healthcare)	  were	  added	  to	  the	  membranes	  and	  signals	  
were	  detected	  on	  medical	  X-­‐ray	  films	  (Foma).	  
2.5.9	  Detection	  of	  radiolabeled	  proteins	  by	  autoradiography	  
For	  detection	  of	   radiolabeled	  proteins,	   SDS-­‐	  or	  BN-­‐PAGE	  gels	  were	  dried	   in	  a	  vacuum	  
gel	   drier	   at	   65	  °C	   for	   2	   h.	   Dried	   gels	   were	   exposed	   to	   Storage	   Phosphor	   Screens	   (GE	  
Healthcare)	   for	   a	   few	   hours	   up	   to	   several	   days	   and	   signals	   were	   digitized	   using	  
Storm820	  scanner	  (GE	  Healthcare).	  
2.5.10	  Steady	  state	  protein	  analyses	  
For	   steady	   state	   analysis	   of	  mitochondrial	   proteins	   by	   SDS-­‐PAGE,	  mitochondria	  were	  
diluted	   to	   different	   concentrations	   so	   that	   identical	   volumes	   could	   be	   loaded	   per	   gel	  
lane.	  Following	  SDS-­‐PAGE,	  various	  mitochondrial	  proteins	  from	  different	  compartments	  
were	  analysed	  by	  Western	  blotting.	  	  
For	   analysis	   of	   steady	   state	   protein	   levels	   by	   BN-­‐PAGE,	   15-­‐20	   µg	   of	   solubilized	  
mitochondria	   were	   loaded	   per	   lane,	   if	   structural	   subunits	   of	   respiratory	   chain	  
complexes	  were	  assessed.	  For	  analysis	  of	  steady	  state	   levels	  of	   less	  abundant	  proteins	  
(e.g.	  COX	  assembly	  factors),	  50-­‐70	  µg	  of	  mitochondria	  were	  loaded	  per	  lane.	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2.6	  Isolation	  of	  yeast	  mitochondria	  
Mitochondria	  were	  prepared	  essentially	  as	  described	  previously	  (Meisinger	  et	  al.	  2006).	  
In	  brief,	  yeast	  cells	  were	  grown	  in	  appropriate	   liquid	  media	  at	  30	  °C	  to	  OD600=	  2.	  Cells	  
were	   harvested	   (4700	   rpm,	   15	  min,	   18	  °C),	  washed	  with	  H2O,	   resuspended	   in	   2	  ml/g	  
wet	  cell	  weight	  of	  DTT	  buffer	  (100	  mM	  Tris/H2SO4,	  pH	  9.4,	  10	  mM	  DTT)	  and	  incubated	  
under	  mild	  agitation	  (90	  rpm)	  at	  30	  °C	  for	  20	  min.	  Cells	  were	  pelleted	  (4000	  rpm,	  8	  min,	  
18	  °C),	  washed	  with	  zymolyase-­‐buffer	  (1.2	  M	  Sorbitol,	  20	  mM	  KPi,	  pH	  7.4),	  resuspended	  
in	  7	  ml/g	  wet	  cell	  weight	  of	  zymolyase-­‐buffer,	  supplied	  with	  4	  mg	  zymolyase/g	  wet	  cell	  
weight	  to	  digest	  cell	  walls.	  After	  incubation	  (90	  rpm,	  60	  min,	  30	  °C),	  spheroplasts	  were	  
isolated	   (3000	   rpm,	   10	  min,	   18	  °C),	   washed	  with	   zymolyase-­‐buffer	   and	   subsequently	  
resuspended	  in	  chilled	  homogenisation	  buffer	  (0.6	  M	  sorbitol,	  10	  mM	  Tris/HCl,	  pH	  7.4,	  
1	  mM	  EDTA,	  0.1%	  BSA,	  1	  mM	  PMSF).	  After	  homogenization	  with	  a	  douncer	  (12	  times,	  
650	  rpm),	  cell	  debris	  was	  removed	  by	  centrifugation	  (3000	  rpm,	  5	  min,	  4	  °C,	   followed	  
by	  4000	  rpm,	  10	  min,	  4	  °C).	  Mitochondria	  (crude	  membrane	  fraction)	  were	  obtained	  by	  
centrifugation	   (12000	   rpm,	   15	   min,	   4	  °C).	   This	   pellet	   was	   washed	   once	   and	   finally	  
resuspended	   in	   SEM.	   Protein	   concentration	   was	   determined	   by	   Bradford	   analysis,	  
mitochondria	  were	  snap-­‐frozen	  in	  liquid	  N2	  at	  a	  concentration	  of	  10	  mg/ml	  in	  SEM	  and	  
stored	  at	  -­‐80	  °C	  until	  further	  processing.	  
	   	   2.	  MATERIALS	  AND	  METHODS	  
45	  
2.7	  Purification	  of	  protein	  complexes	  
2.7.1	  IgG-­‐Chromatography	  
IgG-­‐chromatography	  was	  performed	  essentially	  as	  described	  previously	  (Rehling	  et	  al.	  
2003).	  In	  detail,	  for	  native	  complex	  isolation,	  human	  IgGs	  (Sigma-­‐Aldrich)	  were	  coupled	  
to	  CNBr-­‐activated	  sepharose	  (GE	  Healthcare)	  according	  to	  manufacturers	  specifications.	  
Mitochondria	  from	  wild	  type	  (WT)	  and	  ProteinA	  tagged	  strains	  were	  solubilized	  on	  ice	  
in	  1ml/mg	  solubilisation	  buffer	  (containing	  1%	  digitonin)	  for	  30	  min.	  After	  removal	  of	  
unsolubilized	  material	   by	   centrifugation	   (15	  min,	   20000	   g,	   4	  °C),	   a	   sample	  was	   taken	  
and	   the	   mitochondrial	   extract	   applied	   to	   IgG-­‐sepharose	   for	   2	   h	   at	   4	  °C	   with	   mild	  
agitation.	  After	   extensive	  washing	  with	  wash	  buffer	   (20	  mM	  Tris/HCl	   (pH	  7.4),	   0.1	  M	  
NaCl,	   10%	   glycerol,	   5	  mM	  EDTA,	   2	  mM	  PMSF,	   0.3%	   digitonin),	   AcTEV	   (Tobacco	   Etch	  
Virus)	   protease	   (Invitrogen,	   10	   U/µl)	   was	   added	   and	   incubated	   over	   night	   at	   4	  °C	   to	  
cleave	   ProteinA	   tagged	   protein	   off	   the	   sepharose.	   TEV	   protease,	   carrying	   a	  
polyhistidine,	  was	  removed	  by	  addition	  of	  Ni-­‐NTA	  (Qiagen),	  pre-­‐equilibrated	  with	  wash	  
buffer.	   The	   cleaved	   native	   complexes	   were	   eluted,	   mixed	   with	   appropriate	   loading	  
buffer	  and	   further	  analysed	  by	  SDS-­‐	  or	  BN-­‐PAGE.	  Samples	   that	  were	  only	  analysed	  by	  
SDS-­‐PAGE	  were	  directly	  eluted	  with	  SDS	  loading	  buffer	  instead.	  
2.7.2	  Crosslinking	  of	  antibodies	  to	  sepharose	  	  
Coa3/	   Coa1	   or,	   as	   a	   control,	   Ylh47-­‐specific	   antisera	   (raised	   in	   rabbit)	   was	   bound	   to	  
ProteinA-­‐sepharose	  (GE	  Healthcare)	  in	  0.1	  M	  potassium	  phosphate	  buffer,	  (pH	  7.4)	  for	  1	  
h	   at	   room	   temperature	   and	   subsequently	   cross-­‐linked	   with	   5	   mg/ml	   dimethyl	  
pimelimidate	   (DMP)	   solution	   in	   0.1	   M	   sodium	   borate	   (pH	   9.0)	   for	   30	   min	   at	   room	  
temperature.	   The	   crosslinker	  was	   quenched	  with	   1	  M	   Tris/HCl	   (pH	   7.4).	   Beads	  were	  
washed	  with	   TBS	   several	   times	   and	   stored	   in	   TBS,	   supplemented	  with	   2	  mM	   sodium	  
azide	  at	  4	  °C	  until	  use	  for	  co-­‐immunoprecipitation.	  After	  co-­‐immunoprecipitation,	  beads	  
were	  washed	  three	  times	  with	  acetate	  buffer	  (pH	  3.4),	  three	  times	  with	  TBS,	  stored	  as	  
described	  and	  were	  reused	  up	  to	  7	  times.	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2.7.3	  Co-­‐immunoprecipitation	  
Co-­‐immunoprecipitation	   was	   performed	   as	   described	   (Hutu	   et	   al.	   2008;	   Mick	   et	   al.	  
2010),	  with	  minor	  changes.	  After	  mitochondria	  were	  solubilized	  and	  the	  lysate	  cleared	  
as	  described	  above,	  an	  input	  sample	  was	  taken.	  The	  mitochondrial	  lysate	  was	  split	  and	  
bound	   to	   control	   and	  Coa3	   or	   Coa1	   coupled	   sepharose	   for	   90	  min	   at	   4	  °C	   under	  mild	  
agitation.	   After	   washing	   with	   digitonin	   wash	   buffer	   as	   described	   in	   section	   2.7.1,	  
proteins	  were	  eluted	  with	  0.1	  M	  Glycin	  (pH	  2.8)	  and	  immediately	  neutralized	  with	  1	  M	  
Tris	  (pH	  11.5).	  Eluates	  and	  the	  total	  sample	  were	  analysed	  by	  SDS-­‐PAGE	  and	  Western	  
blotting.	  
2.7.4	  FLAG-­‐isolation	  
For	   isolation	   of	   native	   complexes	   via	   FLAG-­‐tagged	   proteins,	   mitochondria	   were	  
solubilized	   in	  digitonin	   solubilization	  buffer	   as	  described	  above.	  An	   input	   sample	  was	  
taken.	  Mitochonrial	  lysate	  was	  bound	  to	  pre-­‐equilibrated	  FLAG-­‐agarose	  (Sigma)	  for	  1	  h	  
at	  4	  °C.	  The	  unbound	  material	  was	  removed	  and	  the	  agarose	  washed	  10	  times	  with	  cold	  
digitonin	  wash	  buffer.	  Bound	  protein	  complexes	  were	  eluted	  by	  incubation	  with	  FLAG-­‐
peptide	  (200	  µg/ml	  in	  digitonin	  wash	  buffer)	  for	  10	  min	  at	  4	  °C	  and	  shaking	  (900	  rpm).	  
Subsequently,	  samples	  were	  mixed	  with	  appropriate	   loading	  dye	  and	  analysed	  by	  BN-­‐	  
or	  SDS-­‐PAGE,	  followed	  by	  Western	  blotting.	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2.7.5	  Strep-­‐Isolation	  
For	   isolation	   of	   native	   complexes	   via	   Strep-­‐tagged	   proteins,	   mitochondria	   were	  
solubilized	   in	   digitonin	   solubilization	   buffer	   and	   cleared	   as	   described	   above.	   In	   input	  
sample	  was	   taken.	  Mitochondrial	   lysate	  was	   bound	   to	   pre-­‐equilibrated	   Strep-­‐Tactin®	  
Sepharose	  (IBA)	  for	  1	  h	  at	  4	  °C.	  The	  unbound	  material	  was	  removed	  and	  the	  sepharose	  
washed	   extensively	   with	   cold	   digitonin	   wash	   buffer.	   Bound	   protein	   complexes	   were	  
eluted	  by	  incubation	  with	  elution	  buffer	  (5	  mM	  desthiobiotin	  in	  digitonin	  wash	  buffer)	  
for	  15	  min	  at	  12	  °C	  and	   shaking	   (900	   rpm).	  For	   further	  analysis,	   samples	  were	  either	  
mixed	   with	   appropriate	   loading	   dye	   and	   subjected	   to	   BN-­‐	   or	   SDS-­‐PAGE	   followed	   by	  
Western	   blotting	   or	   samples	   were	   precipitated,	   using	   TCA	   and	   subjected	   to	   mass	  
spectrometry.	  In	  brief,	  TCA	  (to	  a	  final	  concentration	  of	  15%)	  and	  sodium	  desoxycholate	  
(to	  0.0125%	  final	  concentration)	  was	  added	  and	  samples	  were	  incubated	  for	  30	  min	  on	  
ice.	  After	  centrifugation	  (14000	  rpm,	  30	  min,	  4	  °C),	   the	  pellet	  was	  washed	  twice	  using	  
ice-­‐cold	   acetone,	   dried	   and	   resuspended	   in	   20	  mM	   Tris/HCl	   (pH	   7.4),	   100	  mM	  NaCl,	  
10	  %	  glycerol,	  5	  mM	  EDTA.	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2.8	  In	  vitro	  import	  
2.8.1	  In	  vitro	  labeling	  of	  precursor	  proteins	  
2.8.1.1	  In-­‐vitro	  transcription	  
RNA	   was	   transcribed	   from	   DNA	   template	   using	   SP6	   RNA	   polymerase.	   PCR	   products,	  
amplified	   from	   yeast	   genomic	   DNA,	   served	   as	   templates.	   The	   SP6	   promotor	   was	  
introduced	  during	  PCR	  with	  the	  primers.	  The	  purified	  PCR	  product	  was	  used	  for	  in	  vitro	  
transcription	   using	   mMESSAGE	   mMACHINE®	   SP6	   Kit	   (Ambion)	   according	   to	   the	  
manufacturers	  specification.	  Resulting	  RNA	  was	  purified	  using	  MEGAclear	  kit	  (Ambion)	  
and	  stored	  in	  dH2O	  at	  -­‐80	  °C.	  
2.8.1.2	  In-­‐vitro	  translation	  
Proteins	   were	   labeled	   with	   [35S]-­‐methionine	   by	   in	   vitro	   translation	   of	   purified	   RNA	  
using	   Flexi	   Rabbit	   Reticulocyte	   Lysate	   System	   (Promega	   ).	   For	   translation	   of	   Cox13	  
RNA,	   33µl	   of	   lysate	   was	   mixed	   with	   1µl	   of	   amino	   acid	   mix	   (-­‐Met),	   1	   µg	   RNA,	   1,4	   µl	  
potassium	   chloride	   (2.5	  M),	   1	  µl	  magnesium	   acetate	   (25	  mM)	   and	  H2O	   (up	   to	   45	  µl).	  
After	   short	   pre-­‐warming	   at	   30	  °C,	   the	   translation	   reaction	  was	   started	   by	   addition	   of	  
5	  µl	   [35S]-­‐methionine	  (=	  50	  µCi).	  Following	   in	  vitro	   translation	  for	  90	  min	  at	  30	  °C,	   the	  
reaction	  was	  stopped	  by	  addition	  of	  excess	  methionine	  (20	  mM)	  and	  sucrose	  (250	  mM)	  
and	  placed	  on	  ice.	  Lysate	  was	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  °C.	  
2.8.1.3	  Coupled	  in	  vitro	  transcription/translation	  
Coupled	   in	   vitro	   transcription/translation	   was	   performed	   with	   the	   TNT	   SP6	   Quick	  
Coupled	   Transcription/Translation	   System	   (Promega).	   The	   open	   reading	   frame	   of	  
COX5A	  was	   cloned	   into	   pGEM4Z	   under	   control	   of	   the	   SP6	   promotor	   and	   the	   plasmid	  
was	   isolated.	  50	  µl	   lysate	  was	  mixed	  with	  0.5	  µg	  plasmid	  DNA	  and	  pre-­‐warmed	   for	  2	  
min	  at	  30	  °C.	  The	  reaction	  was	  started	  by	  addition	  of	  5	  µl	   [35S]-­‐methionine	  (=	  50	  µCi),	  
incubated	  for	  90	  min	  at	  30	  °C	  and	  stopped	  by	  addition	  of	  sucrose	  (250	  mM)	  and	  placed	  
on	  ice.	  Lysate	  was	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  °C.	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2.8.2	  In	  vitro	  import	  into	  isolated	  mitochondria	  
Radiolabeled	  precursor	  proteins	  were	  in	  vitro	  imported	  into	  energized	  mitochondria	  as	  
described	  previously	  (Wiedemann	  et	  al.	  2006).	  For	  import,	  isolated	  yeast	  mitochondria	  
were	   resuspended	   in	   import	   buffer	   (250	   mM	   sucrose,	   10	   mM	   MOPS/KOH,	   pH	   7.2,	  
80	  mM	  KCl,	  2	  mM	  KH2PO4,	  5	  mM	  MgCl2,	  5	  mM	  methionine,	  3%	  BSA,	  2	  mM	  NADH,	  2	  mM	  
ATP,	  5	  mM	  creatine	  phosphate,	  0.1	  mg/ml	  creatine	  kinase)	  at	  0.5	  mg/ml.	  After	  addition	  
of	  5-­‐10%	  lysate,	  import	  was	  performed	  at	  25	  °C	  for	  indicated	  times.	  Import	  was	  stopped	  
by	   addition	   of	   1%	   AVO	   mix	   (2.5	   mM	   antimycin	   A,	   0.25	   mM	   valinomycin,	   5	   mM	  
oligomycin	   in	   ethanol).	   In	   negative	   controls,	   samples	  were	   treated	  with	   AVO	   prior	   to	  
import.	   If	   not	   indicated	  otherwise,	   unimported	  precursor	  was	  digested	  by	   addition	  of	  
proteinase	   K	   (50	  µg/ml)	   for	   10	  min	   on	   ice.	   Digestion	  was	   subsequently	   inhibited	   by	  
PMSF	   (4	  mM).	   After	   in	   vitro	   import,	  mitochondria	  were	   reisolated,	  washed	  with	   SEM	  
buffer	   and	   processed	   for	   SDS-­‐	   or	   BN-­‐PAGE	   analysis,	   followed	   by	   detection	   of	  
radiolabeled	  proteins	  by	  digital	  autoradiography.	  	  
2.9	  Stable	  isotope	  labeling	  with	  amino	  acids	  in	  cell	  culture	  (SILAC)	  
For	   SILAC,	   yeast	   strains	   auxotroph	   for	   lysine	   and	   arginine	   were	   used.	   As	   YPH499	   is	  
already	  auxotroph	  for	  lysine,	  arg4,	  one	  gene	  in	  the	  arginine	  biosynthesis,	  was	  deleted	  in	  
coa1Δ	   and	   in	   coa1Δ,	   expressing	   Mss51-­‐StrepFLAG	   to	   generate	   the	   strains	   for	   SILAC	  
labeling.	   Both	   resulting	   strains	   were	   grown	   both	   on	   media	   containing	   heavy	   amino	  
acids	  as	  well	  as	  on	  media	  containing	  normal	  (light)	  amino	  acids	  in	  order	  to	  perform	  the	  
experiment	   in	   forward	   and	   reverse	   manner.	   For	   the	   forward	   experiment,	   the	   tagged	  
strains	  was	  grown	  on	  media,	  containing	  heavy	  amino	  acids;	  the	  untagged	  control	  strains	  
on	  media	  containing	  light	  amino	  acids	  and	  vice	  versa	  for	  the	  reverse	  experiment.	  Yeast	  
cells	  were	  grown	  in	  SILAC	  media	  (see	  table	  4),	  supplied	  with	  2%	  galactose	  at	  30	  °C	  as	  
described	   above.	   High	   concentration	   of	   proline	   (200	   mg/l)	   was	   used	   to	   prevent	   the	  
conversion	   of	   (heavy)	   arginine	   into	   proline.	   Mitochondrial	   preparation	   followed	   the	  
procedure	  described	  in	  section	  2.6.	  Prior	  to	  complex	  isolation,	  mitochondria	  from	  cells	  
grown	  on	  light	  and	  heavy	  media	  were	  mixed	  in	  a	  1:1	  ratio	  and	  solubilized	  together.	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2.10	  Mass	  spectrometry	  and	  data	  analysis	  
Mass	   spectrometry,	   including	   in-­‐gel	   digestion,	   data	   analysis	   and	   visualization	   was	  
performed	  in	  the	  Bioanalytical	  Mass	  spectrometry	  Group	  of	  Prof.	  Urlaub	  at	  the	  MPI	  BPC	  
(Göttingen),	  mainly	  by	  Monika	  Raabe	  and	  Dr.	  Miroslav	  Nikolov.	  
2.10.1	  Mass	  spectrometry	  of	  native	  protein	  complexes	  
For	  Shy1	  interactome	  analysis,	  eluted	  proteins	  were	  mixed	  with	  10x	  BN	  loading	  dye	  and	  
separated	   on	   a	   4-­‐13%	   gradient	   BN-­‐PAGE	   gel.	   Directly	   following	   the	   gel	   run,	   the	  
corresponding	  gel	  lane	  was	  cut	  into	  23	  gel	  slices	  of	  equal	  size.	  Prior	  in-­‐gel	  digestion,	  gel	  
slices	   were	   washed	   three	   times	   in	   5	   mM	   ammonium	   bicarbonate/	   50%	   acetonitrile	  
buffer	   (pH	   8.0)	   and	   proteins	   therein	   in-­‐gel	   digested	   with	   trypsin	   (Promega)	   as	  
described	   (Shevchenko	   et	   al.	   2006).	   Chymotrypsin	   was	   used	   as	   protease	   instead	   of	  
trypsin	   in	   replicate	   experiments.	   Tryptic/chymotryptic	   peptides	   from	   each	   gel	   slice	  
were	   analysed	   as	   described	   (Thakar	   et	   al.	   2013)	   by	   nanoflow	   HPLC	   (Agilent	   1100,	  
Agilent	  Technologies)	  coupled	  to	  nanoelectrospray	  LTQ-­‐Orbitrap	  XL	  mass	  spectrometer	  
(Thermo	  Fischer	  Scientific).	  	  
The	   raw	   MS	   files	   from	   the	   mass	   spectrometer	   were	   analysed	   by	   MaxQuant	   and	  
Andromeda	   using	   UniProt	   S.	   cerevisiae	   protein	   database	   (version	   29.11.11).	   Results	  
from	  MaxQuant	  were	  analysed	  and	  visualized	  with	  R	  as	  described	  (Nikolov	  et	  al.	  2011).	  
“Match	  between	  runs”	  option	   in	  MaxQuant	  was	  selected	   in	  replicate	  analysis	   to	  detect	  
low	  abundant/hydrophobic	  peptides	  of	  Cox15.	  
2.10.2	  Mass	  spectrometry	  of	  SILAC	  samples	  
For	   SILAC	   interactome	   analysis,	   samples	   and	   data	   were	   processed	   and	   analysed	   as	  
described	   ins	   section	  2.10.1	  with	   some	  modifications:	   eluted	  proteins	  were	   separated	  
on	   4-­‐12%	   gradient	   SDS-­‐PAGE	   gels	   (Invitrogen)	   and	   stained	  with	   Colloidal	   Coomassie	  
Blue.	   Each	   gel	   lane	  was	   cut	   into	   23	   equal	   gel	   slices	   and	   proteins	   therein	  were	   in-­‐gel	  
digested	   with	   trypsin	   (Promega),	   omitting	   additional	   wash	   steps	   described	   above.	  
Tryptic	   peptides	   from	   each	   gel	   slice	   were	   analysed	   by	   nanoflow	   HPLC	   coupled	   to	  
nanoelectrospray	  LTQ-­‐Orbitrap	  XL	  mass	  spectrometer.	  Raw	  MS	  data	  was	  analysed	  with	  
MaxQuant	  and	  Andromeda	  assuming	  standard	  SILAC	  workflow	  with	  mixed	  heavy-­‐	  and	  
light-­‐labeled	  samples.	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2.10.3	  SILAC	  incorporation	  efficiency	  
For	   calculation	   of	   SILAC	   incorporation	   efficiency,	   only	   heavy	   samples	  were	   analysed:	  
whole	  cell	  extracts	  were	  separated	  by	  SDS-­‐PAGE	  and	  stained	  with	  Colloidal	  Coomassie	  
Blue.	   One	   band	  was	   randomly	   selected	   and	   cut	   out	   from	   the	   gel.	   Proteins	   in	   this	   gel	  
piece	  were	  in-­‐gel	  digested	  with	  trypsin	  (Promega),	  and	  analysed	  as	  described	  for	  SILAC	  
interactome	   analysis	   (section	  2.10.2).	   Raw	  MS	  data	  was	   analysed	  with	  MaxQuant	   and	  
Andromeda	   assuming	   standard	   SILAC	   workflow	   with	   mixed	   heavy-­‐	   and	   light-­‐labeled	  
samples.	   Standard	   MaxQuant	   settings	   were	   used,	   except	   for	   the	   Re-­‐quantify	   option,	  
which	  was	  disabled.	  The	  density	  functions	  of	  the	  resulting	  SILAC	  ratios	  for	  Arg-­‐	  and	  Lys-­‐
containing	  peptides	  were	  calculated	  and	  plotted	  separately	  and	  combined	  using	  R.	  The	  







3.1	  Translational	  regulation	  and	  early	  steps	  of	  COX	  assembly	  	  
3.1.1	  COX	  assembly	  in	  Oxa1	  linker	  mutants	  
3.1.1.1	  Steady	  state	  protein	  levels	  are	  affected	  in	  Oxa1	  linker	  mutants	  
Oxa1	  acts	  very	  early	  in	  the	  biogenesis	  of	  cytochrome	  c	  oxidase	  as	  the	  insertase	  for	  the	  
three	   mitochondria-­‐encoded	   subunits	   of	   cytochrome	   c	   oxidase	   (Hell	   et	   al.	   2001).	   To	  
fulfill	   this	   function,	   the	   Oxa1	   protein	   contains	   two	   functional	   domains:	   a	   N-­‐terminal	  
insertase	  domain	  and	  a	  C-­‐terminal	  ribosome	  binding	  domain	  (Bonnefoy	  et	  al.	  2009;	  Jia	  
et	   al.	   2009).	   To	   test	   the	   importance	   of	   the	   close	   contact	   of	   the	   ribosome	   and	   the	  
insertion	  site,	  Oxa1	  versions	  with	  a	  linker	  of	  different	  length	  between	  the	  two	  domains	  
were	  constructed	  (Keil	  et	  al.	  2012).	  For	  the	   linkers	  regions,	  100	  or	  200	  residues	  of	  an	  
intrinsically	  unstructured	  region	  on	  the	  basis	  of	  nucleofilament	  Nsp1	  were	  inserted	  into	  
Oxa1	  (Keil	  et	  al.	  2012).	  The	  constructs,	  expressed	  in	  yeast	  strains	  lacking	  the	  ribosome	  
receptor	   Mba1,	   showed	   a	   length-­‐dependent	   growth	   phenotype	   on	   non-­‐fermentable	  
media	   (YPG),	   as	   well	   as	   reduced	   oxygen	   consumption,	   indicating	   a	   deficiency	   in	  
mitochondrial	  respiration	  (Keil	  et	  al.	  2012).	  It	  is	  known	  that	  Oxa1	  plays	  a	  crucial	  role	  in	  
the	  biogenesis	  of	  cytochrome	  c	  oxidase	  (Altamura	  et	  al.	  1996).	  To	  assess	  the	  respiratory	  
defect,	   yeast	   cells	  were	   grown	   on	   SGal-­‐Trp	   at	   30	  °C	   and	   after	  mitochondria	   isolation,	  
steady	   state	   levels	   of	   mitochondrial	   proteins	   were	   analysed	   by	   SDS-­‐	   and	   BN-­‐PAGE,	  
followed	   by	   Western	   blotting	   (FIG	   3.1).	   On	   SDS-­‐PAGE,	   Oxa1	   linker	   constructs	   were	  
detected	   at	   the	   expected	   size	   and	   Oxa1	   protein	   levels	   were	   comparable	   to	   wild-­‐type	  
mitochondria.	  As	  a	  control,	  an	  empty	  vector	  was	  transformed	  into	  mba1Δoxa1Δ	  cells.	  In	  
accordance	   with	   published	   data,	   Cox1	   and	   Cox2	   were	   undetectable	   in	   mitochondria	  
isolated	   from	   this	   strain,	   due	   to	   proteolytic	   instability	   (Preuss	   et	   al.	   2001).	   In	  
mba1Δoxa1Δ	   cells,	   expressing	   one	   of	   the	   Oxa1	   variants,	   Cox1	   protein	   level	   was	  
drastically	   reduced	   while	   Cox2	   showed	   only	   a	   moderate	   reduction.	   The	   nuclear-­‐
encoded	  subunit	  Cox4,	  as	  well	  as	  cytochrome	  c	  oxidase	  assembly	   factors	  (Coa1,	  Coa3)	  
were	  unaffected.	  Furthermore,	  Atp5	  (component	  of	  F1FO-­‐ATP-­‐synthase)	  and	  the	  matrix	  
protein	  Aco1	  remained	  unaltered	  (FIG	  3.1;	  A).	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To	   investigate	   the	   effects	   of	   Oxa1100	   and	   Oxa1200	   on	   mitochondrial	   respiratory	   chain	  
complex	   formation,	   digitonin	   solubilized	   mitochondria	   prepared	   from	   the	   described	  
strains	   were	   subjected	   to	   native	   gelelectrophoresis.	   This	   analysis	   revealed	   strongly	  
reduced	   levels	   of	   supercomplexes.	   Mitochondria	   lacking	   Oxa1	   and	   Mba1	   contained	  
almost	  no	  detectable	  supercomplexes.	  
Upon	  expression	  of	  wild	  type	  Oxa1,	  the	  different	  respiratory	  chain	  supercomplexes	  III2,	  
III2IV,	   III2IV2,	  V	  and	  V2	  were	  present.	  Upon	  expression	  of	   a	   linker	  variant	  of	  Oxa1,	   the	  
supercomplexes	   containing	   cytochrome	   c	   oxidase	   (III2IV	   and	   III2IV2)	   were	   severely	  




FIG	  3.1	  Analysis	  of	  steady	  state	  protein	  levels	  and	  OXPHOS	  complexes	  in	  Oxa1	  linker	  mutants	  
(A)	  Isolated	  mitochondria	  from	  mba1Δoxa1Δ cells,	  expressing	  either	  Oxa1	  wild	  type	  (Oxa1WT)	  or	  one	  of	  the	  two	  
linker	   mutant	   version	   of	   Oxa1	   (Oxa1100	   /	   Oxa1200),	   were	   separated	   by	   SDS-­‐PAGE,	   followed	   by	  Western	   blot	  
analysis	  for	  various	  mitochondrial	  proteins.	  (B)	  Digitonin	  extracts	  of	  mitochondria	  were	  analysed	  by	  BN-­‐PAGE	  
and	  Western	  blotting	   for	  components	  of	  cytochrome	  c	  oxidase	  (Cox1,	  Cox2,	  Cox4),	   the	  cytochrome	  bc1	   comlex	  
(Rip1)	  or	  the	  ATPase	  (Atp5).	  
	  
	  
Thus,	   the	   growth	   phenotype	   is	   caused	   by	   reduced	   levels	   of	   cytochrome	   c	   oxidase.	  
Furthermore,	   we	   concluded	   from	   these	   results	   that	   insertion	   of	   a	   flexible	   linker	   into	  
Oxa1	   (in	   mutants	   lacking	   Mba1)	   interferes	   with	   the	   biogenesis	   or	   the	   stability	   of	  
cytochrome	   c	   oxidase.	   We	   could	   also	   show	   that	   this	   effect	   is	   more	   severe	   with	  
increasing	  linker	  length.	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3.1.1.2	  Assembly	  of	  Cox5a/Cox13	  is	  disturbed	  in	  Oxa1	  mutants	  
Oxa1	  is	  required	  for	  membrane	  insertion	  of	  Cox2	  (He	  &	  Fox	  1997).	  It	  was	  shown	  by	  our	  
collaborators	   that	   processing	   of	   Cox2	   was	   not	   affected	   in	   the	   linker	   mutants	   and	  
therefore	   the	   defect	   in	   biogenesis	   of	   cytochrome	   c	   oxidase	  was	   not	   due	   to	   defects	   in	  
translation	   or	   maturation	   of	   newly	   synthesized	   Cox2.	   As	   the	   observed	   cytochrome	   c	  
oxidase	   defects	   could	   not	   be	   caused	   by	   reduced	   synthesis	   or	   disturbed	   membrane	  
insertion,	   we	   asked	   whether	   further	   downstream	   events	   were	   affected	   in	   the	   linker	  
mutants	   which	   would	   point	   to	   a	   role	   of	   Oxa1	   in	   later	   steps	   of	   cytochrome	   c	   oxidase	  
assembly.	   To	   test	   this	   hypothesis,	   we	   imported	   two	   radiolabeled	   subunits	   of	  
cytochrome	  c	  oxidase	  (Cox5a	  and	  Cox13)	  into	  isolated	  mitochondria	  and	  followed	  their	  
assembly	   into	   supercomplexes	   using	   BN-­‐PAGE	   (FIG	   3.2).	   We	   selected	   these	   two	  
different	   subunits	   because	   Cox5a	   is	   known	   to	   assemble	   predominantly	   into	   COA	  
complexes,	   whereas	   the	   late	   subunits,	   like	   Cox13,	   assemble	   directly	   into	  
supercomplexes	   in	   association	  with	   the	   cytochrome	  bc1	   dimer	   (Brandner	   et	   al.	   2005;	  




FIG	  3.2	  Import	  and	  assembly	  of	  radiolabeled	  Cox5a	  and	  Cox13	  into	  Oxa1	  linker	  mutants.	  
Import	  and	  assembly	  of	  (A)	  radiolabeled	  Cox5a	  (5	  %)	  and	  of	  (B)	  radiolabeled	  Cox13	  (10	  %).	  Lower	  panels:	  total	  
import	  efficiency,	  analysed	  using	  SDS-­‐PAGE.	  Upper	  panels:	  assembly	  of	  imported	  precursors	  into	  COX	  assembly	  
intermediates	  (250	  and	  300	  kDa	  complexes,	  for	  Cox5a	  only)	  and	  supercomplexes	  (III2IV	  and	  III2IV2).	  precursor	  
(p),	  mature	  (m).	   Import	   for	   indicated	  times	   in	  presence	  or	  absence	  of	  mitochondrial	  membrane	  potential	   (+/-­‐
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Import	   of	   the	   nuclear-­‐encoded	   subunits	   Cox5a	   (FIG	   3.2;	   A)	   and	   Cox13	   (FIG	   3.2;	   B)	  
occurred	   at	   the	   same	   rate	   into	   strains	   expressing	  wild	   type	  or	  mutant	   forms	  of	  Oxa1,	  
since	  a	  matured	  PK	  resistant	  product	  was	  detected	  in	  equal	  amounts	  (m,	  lower	  panels).	  
In	   contrast,	   import	   into	   mba1Δoxa1Δ	   was	   severely	   reduced,	   already	   indicated	   by	  
reduced	   steady	   state	   protein	   levels	   and	   the	   absence	   of	   supercomplexes	   in	   this	   strain	  
(see	  FIG	  3.1).	  In	  contrast	  to	  import	  rates,	  the	  assembly	  of	  both	  radiolabeled	  cytochrome	  
c	  oxidase	  subunits	  occurred	  with	  reduced	  kinetics	  in	  dependence	  of	  the	  linker	  length.	  
In	   conclusion,	   insertion	   of	   a	   linker	   into	   the	   OXA1	   sequence	   caused	   a	   cytochrome	   c	  
oxidase	  assembly	  defect,	  which	  was	  dependent	  on	  the	  length	  of	  the	  linker	  domain.	  This	  
finding	   illustrated	   that	   spatial	   proximity	   of	   the	  mitochondrial	   ribosome	   to	   the	   site	   of	  
membrane	  insertion	  is	  important	  for	  later	  steps	  of	  COX	  assembly.	  	  
These	   results	   were	   published	   in	   collaboration	   with	   the	   group	   of	   Prof.	   Herrmann,	  
Kaiserslautern	  (Keil	  et	  al.	  2012).	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3.1.2	  Isolation	  of	  new	  interaction	  partners	  of	  Mss51	  
3.1.2.1.	  C-­‐terminally	  tagged	  Mss51	  is	  fully	  functional	  
Mss51	   is	   not	   only	   a	   translational	   activator	   of	   Cox1	   but	   acts	   also	   in	   early	   steps	   of	  
cytochrome	   c	   oxidase	   assembly	   (reviewed	   in	   Mick	   et	   al.	   2011).	   In	   order	   to	   identify	  
factors	  that	  support	  Mss51	  in	  execution	  of	  these	  functions,	  we	  set	  out	  to	  isolate	  native	  
protein	   complexes	   containing	   Mss51.	   To	   enrich	   cytochrome	   c	   oxidase	   assembly	  
intermediates	   at	   a	   very	   early	   stage,	   experiments	   were	   performed	   in	   a	   coa1Δ yeast	  
strain.	   Mss51	   was	   tagged	   chromosomally	   with	   a	   Strep-­‐FLAG	   tag.	   To	   test	   the	  
functionality	   of	   Mss51-­‐Strep-­‐FLAG	   (Mss51SF),	   growth	   behavior	   of	   this	   strain	   was	  
compared	  to	  a	  wild-­‐type	  yeast	  strain	  (FIG	  3.3;	  A).	  Both	  strains	  showed	  identical	  growth	  
behavior	  on	  fermentable	  and	  non-­‐fermentable	  media.	  In	  the	  coa1Δ	  background,	  growth	  
on	   non-­‐fermentable	  media	  was	   absent	   as	   expected	   (Pierrel	   et	   al.	   2007)	   but	   a	   tagged	  
version	  of	  Mss51	  did	  not	  alter	  growth	  behavior	  on	  YPD.	  Mitochondria	   from	  wild	   type	  
and	   Mss51SF,	   grown	   on	   YPG,	   were	   prepared	   and	   steady	   state	   protein	   levels	   were	  




FIG	  3.3	  Analysis	  of	  growth	  behavior	  and	  steady	  state	  protein	  levels	  of	  strains	  with	  tagged	  Mss51	  	  
(A)	  Growth	   test	  on	   fermentable	  and	  non-­‐fermentable	   full	  media.	  Cells	  were	  spotted	   in	   serial	  10-­‐fold	  dilutions	  
and	  incubated	  at	  indicated	  temperatures.	  (B)	  Indicated	  amounts	  of	  isolated	  mitochondria	  (Mito)	  from	  different	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To	  detect	  Mss51,	   an	   antibody	  directed	   against	   the	  whole	  protein	  was	   generated,	   thus	  
allowing	  the	  detection	  of	   the	  wild	  type	  and	  tagged	  versions	  of	  Mss51.	  Mss51SF	  protein	  
levels	  appeared	  reduced,	  compared	  to	  untagged	  Mss51.	  However,	  steady	  state	  levels	  of	  
all	  other	  mitochondrial	  proteins	  tested	  were	  identical	  in	  both	  strains	  (FIG	  3.3;	  B).	  
In	  summary,	  a	  C-­‐terminal	  tag	  on	  Mss51	  did	  not	  alter	  growth	  behavior	  nor	  steady	  state	  
protein	  levels	  and	  we	  therefore	  concluded	  that	  it	  is	  fully	  functional	  and	  can	  be	  used	  for	  
further	  experiments.	  
3.1.2.2	  SILAC-­‐labeling	  efficiency	  
To	   assess	   the	   incorporation	   of	   heavy	   arginine	   and	   lysine	   into	   yeast	   proteins,	  
arg4Δcoa1Δ	  cells,	  expressing	  Mss51SF,	  were	  grown	  on	  SILAC	  media	  for	  five	  population	  
doublings.	   Whole	   cell	   extracts	   were	   prepared	   and	   the	   incorporation	   efficiency	  
(maximum	  value	  of	  each	  density	  function)	  was	  determined	  (FIG	  3.4).	  
	  
	  
FIG	  3.4	  Efficiency	  of	  incorporation	  of	  heavy	  amino	  acids	  into	  yeast	  proteins	  	  
(A)	  Density	  function	  of	  SILAC	  ratios	  for	  heavy	  arginine	  (red)	  and	  lysine	  (green)	  containing	  peptides	  separately,	  
and	  combined	  (black)).	  (B)	  Density	  function	  of	  SILAC	  ratios	  for	  light	  peptides,	  labeled	  as	  in	  (A).	  Total	  number	  of	  
peptides	  used	  for	  the	  calculation	  (N).	  Figure	  prepared	  by	  M.	  Nikolov.	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The	  maximum	  value	  of	  each	  density	  function	  was	  used	  as	  incorporation	  efficiency	  and	  
resulted	   in	   96.2%	   for	   heavy	   arginine,	   95.1%	   for	   heavy	   lysine	   and	   95.7%	   for	   heavy	  
arginine/lysine	   combined.	   At	   the	   same	   time,	   1.5%	   of	   peptides	   still	   contained	   light	  
arginine	  and	  2.1%	   light	   lysine	  (1.8%	  peptides	  with	  arginine/lysine	  combined).	  Taking	  
into	  account	  the	  purity	  of	  the	  deployed	  amino	  acids	  (99%	  enrichment),	  almost	  complete	  
incorporation	   of	   the	   supplemented	   heavy	   amino	   acids	   into	   the	   yeast	   proteins	   was	  
achieved	   and	   stable	   isotope	   labeling	   with	   amino	   acids	   in	   yeast	   culture	   (SILAC)	   was	  
successful.	  
3.1.2.3	  Interaction	  partners	  of	  Mss51	  by	  SILAC	  
Interaction	   partners	   found	   by	  mass	   spectrometry	   after	   native	  Mss51SF	   isolation	  were	  
Mss51	  (bait	  protein),	  Ssc1,	  Shy1,	  Oms1,	  Cox5a,	  Cox6	  and	  Cox1.	  All	  proteins	  were	  found	  
to	  be	  enriched	   in	   the	   forward	  as	  well	  as	   in	   the	  reverse	  experiment	  using	  SILAC	  ratios	  
(log2	  H/L	  and	  log2	  L/H)	  of	  above	  2	  in	  both	  experiments	  (FIG	  3.5).	  One	  has	  to	  note	  that	  
by	  isolating	  Mss51	  complexes	  from	  coa1Δ,	  we	  accumulate	  one	  very	  prominent	  complex	  




FIG	  3.5	  Stable	  isotope	  labeling	  with	  amino	  acids	  in	  cell	  culture	  (SILAC)	  
(A)	  Scheme	  of	  Mss51	   isolation,	   combined	  with	  SILAC	   (Representation	  of	   forward	  experiment.	  For	   the	   reverse	  
experiment,	  arg4Δcoa1ΔMss51SF	  was	   grown	  of	   light	  media	   and	  arg4Δcoa1Δ	   on	  heavy	  media)	   (B)	   Scatter	  plot	  
representation	   of	   normalized	   heavy/light	   (forward	   experiment)	   and	   light/heavy	   (reverse	   experiment)	   SILAC	  
ratios	  after	   isolation	  of	  Mss51SF	  (via	  Strep-­‐tag)	   from	  arg4Δcoa1Δ.	  Enriched	  proteins	  are	  displayed	  as	  red	  dots,	  
other	  proteins	  in	  grey.	  
	  
	  
	   	   3.	  RESULTS	  
	   59	  
Ssc1	   was	   described	   before	   to	   interact	   with	   Mss51	   and	   Mss51-­‐containing	   complexes	  
(Fontanesi	   et	   al.	   2010).	   Copurification	   of	  Mss51	   and	   Shy1	  was	   also	   published	   by	   our	  
laboratory	   (Mick	  et	   al.	   2007;	  Mick	  et	   al.	   2010).	  However	  we	  are	   the	   first	   to	   report	   an	  
interaction	   of	   Oms1	   with	   the	   translational	   activator	   Mss51.	   Oms1	   was	   originally	  
identified	  as	  a	  multicopy	  suppressor	  of	  respiratory	  defects,	  caused	  by	  OXA1	  mutations	  
(Lemaire	   et	   al.	   2004).	   Isolation	   of	   Cox1	   is	   in	   accordance	   with	   the	   current	   model	   of	  
cytochrome	  c	  oxidase	  assembly,	  however	  the	  isolation	  of	  Cox5a/Cox6	  from	  cytochrome	  
c	  oxidase	  assembly	  intermediates	  in	  coa1Δ	  was	  surprising	  (compare	  FIG	  1.6).	  
In-­‐gel	  digestion,	  mass	  spectrometry,	  data	  analysis	  and	  visualization	  (also	  for	  the	  results	  
presented	   in	   section	   3.1.2.2)	  was	   performed	   in	   the	   Bioanalytical	  Mass	   spectromentry	  
Group	   of	   Prof.	   Urlaub	   at	   the	   MPI	   BPC	   (Göttingen),	   mainly	   by	   Monika	   Raabe	   and	   Dr.	  
Miroslav	  Nikolov.	  
3.1.2.4	  Confirmation	  of	  SILAC	  results	  by	  Western	  Blot	  analysis	  
To	  confirm	  the	  results	  obtained	  by	  mass	  spectrometry	  analysis,	  proteins	  eluted	  under	  
native	   conditions	  were	   also	   analysed	  by	  Western	  blotting	   after	   separation	  by	   SDS-­‐	   or	  
BN-­‐PAGE	  (FIG	  3.6;	  A	  and	  B).	   Isolation	  of	  Mss51SF	  was	  successful	   in	   terms	  of	  efficiency	  
and	  purity:	  except	  for	  a	  minor	  amount	  of	  Ssc1,	  no	  proteins	  were	  isolated	  from	  wild	  type	  
mitochondria	   (control),	   indicating	   a	   high	   specificity	   of	   the	   isolation.	   Co-­‐isolation	   of	  
Cox1,	  Cox5a,	  Shy1	  and	  Ssc1	  was	  confirmed.	  Due	  to	  the	  lack	  of	  specific	  antibodies	  against	  
Oms1,	  Western	  Blots	  could	  not	  be	  probed	  for	  the	  protein.	  Control	  proteins	  (translocase	  
of	   the	   inner	   membrane	   component	   Tim50,	   soluble	   matrix	   protein	   Aco1,	   F1FO-­‐ATP-­‐
synthase	  component	  Atp5)	  were	  not	  found	  to	  precipitate	  with	  Mss51.	  In	  addition,	  Coa3	  
and	   Cox14	   were	   found	   to	   specifically	   co-­‐isolate	   with	   Mss51,	   a	   finding	   in	   accordance	  
with	  previously	  published	  results	  (Barrientos	  et	  al.	  2004;	  Pierrel	  et	  al.	  2007;	  Mick	  et	  al.	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FIG	  3.6	  Analysis	  of	  eluates	  from	  Mss51SF	  purification	  by	  Western	  blotting	  
(A)	  Native	  purification	  of	  Mss51SF	  containing	  complexes	  by	  Strep-­‐isolation.	  SDS-­‐PAGE	  and	  Western	  blot	  analysis	  
of	  total	  samples	  and	  eluates.	  Amount	  of	  total	  sample	  loaded	  corresponds	  to	  3%	  of	  the	  eluate	  (B)	  Native	  eluted	  
proteins	   (as	   in	  A)	  were	  analysed	  by	  BN-­‐PAGE	  and	  Western	  blotting.	  As	  a	   control,	  purification	  was	  performed	  
from	  solubilized	  wild	  type	  mitochondria.	  	  
	  
	  
Tryptic	  peptides	  of	  Coa3	  and	  Cox14	  were	  also	  found	  in	  the	  SILAC	  analysis	  (see	  section	  
3.1.2.3),	  however	  could	  not	  be	  illustrated	  in	  the	  scatter	  plot	  as	  the	  amount	  of	  peptides	  
was	  not	   sufficient	   to	  determine	  a	   reliable	  heavy/light	  SILAC	  ratio.	  As	  Coa3	  and	  Cox14	  
are	  both	  proteins	   of	   a	   very	   small	  molecular	  weight	   (9.8	   kDa	  or	  7.9	   kDa,	   respectively)	  
with	   one	   hydrophobic	   domain	   that	   spans	   the	   inner	   mitochondrial	   membrane,	  
insufficient	  tryptic	  digestion	  is	  speculated	  to	  account	  for	  the	  small	  amount	  of	  peptides	  
obtained.	  	  
After	  separation	  of	  the	  eluates	  by	  BN-­‐PAGE,	  the	  eluted	  proteins	  presented	  as	  one	  single	  
entity	  at	  approximately	  220	  kDa.	  We	  could	  confirm	  the	  presence	  of	  Mss51,	  Cox1,	  Cox14	  
and	  Cox5	  by	  Western	  blotting.	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3.1.3	  Nuclear-­‐encoded	  subunits	  Cox5a	  and	  Cox6	  in	  early	  COX	  assembly	  
3.1.3.1	  Import	  and	  assembly	  of	  radiolabeled	  Cox5a	  into	  COX	  assembly	  mutants	  
Using	   steady	   state	   analysis	   of	   respiratory	   chain	   complexes	   in	   mitochondria	   from	  
different	  COX	  assembly	  mutants,	  we	   found	  an	  assembly	   intermediate	  of	   cytochrome	  c	  
oxidase	  accumulating	  in	  coa1Δ,	  but	  also	  in	  shy1Δ cells	  (FIG	  3.7,	  A).	  This	  COA	  complex	  is	  
of	   approximately	   220	   kDa	   in	   size,	   identical	   to	   the	   complex	   isolated	   via	  Mss51SF	   from	  
coa1Δ.	   In	   shy1Δ,	   this	   intermediate	   was	   slightly	   shifted	   towards	   a	   higher	   molecular	  
weight,	  giving	  a	  hint	  towards	  the	  presence	  of	  Coa1	  in	  this	  complex.	  In	  coa3Δ	  and	  cox14Δ,	  
no	  complexes	  could	  be	  detected	  due	  to	  the	  absence	  of	  Cox1,	  which	  is	  in	  accordance	  with	  
previous	   findings	   (Merz	   &	   Westermann	   2009;	   Mick	   et	   al.	   2010).	   Decoration	   against	  
F1FO-­‐ATP-­‐synthase	   subunit	   Atp5	   was	   used	   to	   ensure	   equal	   loading.	   To	   confirm	   the	  
presence	   of	   Cox5a	   in	   cytochrome	   c	   oxidase	   assembly	   intermediates	   accumulating	   in	  
coa1Δ and	  shy1Δ,	   we	   imported	   radiolabeled	   Cox5a	   and	   followed	   its	   assembly	   into	  




FIG	  3.7	  Analysis	  of	  accumulated	  COA	  complexes	  for	  presence	  of	  Cox5a	  
(A)	  50µg	  mitochondria,	  isolated	  from	  indicated	  strains	  were	  separated	  by	  4-­‐13%	  BN-­‐PAGE,	  followed	  by	  Western	  
blot	   analysis	   and	   probing	   for	   Cox1	   and	   Atp5.	   (B)	   Import	   and	   assembly	   of	   radiolabeled	   Cox5a	   into	   isolated	  
mitochondria	  from	  indicated	  strains.	  5%	  lysate.	  Lower	  panel:	  total	  import	  efficiency,	  by	  SDS-­‐PAGE.	  Upper	  panel:	  
assembly	   of	   imported	   precursors	   into	   COX	   assembly	   intermediates	   and	   supercomplexes	   (III2IV	   and	   III2IV2),	  
resolved	  by	  4-­‐13%	  BN-­‐PAGE.	  Import	  for	  45	  min	  in	  presence	  of	  mitochondrial	  membrane	  potential.	  Unimported	  
precursor	  was	  digested	  with	  PK.	  precursor	  (p),	  mature	  (m).	  	  
	  
	  
	   	   3.	  RESULTS	  
	   62	  
Import	  occurred	  with	   identical	  efficiency	   into	  mitochondria	   from	  all	  strains,	  as	   judged	  
by	   the	   amount	   of	  matured	   and	   PK-­‐protected	   Cox5a	   (FIG	   3.7;	   B,	   lower	   panel).	   In	  wild	  
type	   mitochondria,	   Cox5a	   assembled	   into	   one	   prominent	   COA	   complex	   of	   around	  
220	  kDa	   in	   size	   and	   into	   the	   two	   supercomplexes,	   containing	   cytochrome	   c	   oxidase	  
(III2V	  and	  III2V2).	  In	  coa1Δ,	  Cox5a	  assembled	  only	  into	  the	  COA	  complex,	  due	  to	  a	  lack	  of	  
mature	   oxidase	   already	   observed	   on	   steady	   state	   levels	   (FIG	   3.7;	   A)	   and	   published	  
previously	  (Pierrel	  et	  al.	  2007;	  Mick	  et	  al.	  2007).	  The	  COA	  complex,	  observed	  in	  coa1Δ,	  
migrated	  slightly	  faster	  compared	  to	  wild	  type	  indicating	  a	  lower	  molecular	  weight.	  As	  
mentioned	  above,	  we	  speculated	  that	  this	  size	  shift	  was	  due	  to	  the	  absence	  of	  the	  Coa1	  
protein.	   In	  shy1Δ,	  we	  also	  observed	  an	  accumulating	  complex,	  containing	  radiolabeled	  
Cox5a	  of	  approximately	  220	  kDa.	  
In	  conclusion,	  we	  showed	  the	  presence	  of	  Cox5a	  in	  the	  220	  kDa	  complex,	  accumulating	  
in	   coa1Δ. This	   finding	   confirmed	   the	   results	   from	   SILAC	   analysis.	   Furthermore,	   we	  
speculated	  that	  in	  shy1Δ	  cells,	  a	  similar	  COA	  complex	  is	  accumulating,	  which	  differs	  only	  
in	  the	  presence	  or	  absence	  of	  the	  Coa1	  protein.	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3.1.3.2	  Requirement	  of	  Cox6	  for	  recruitment	  of	  Shy1	  to	  COA	  complexes	  
The	  presented	  data	  raised	  the	  question	  if	  Cox5a	  is	  required	  for	  the	  recruitment	  of	  Shy1	  
to	  the	  COA	  complexes.	  As	  Cox5	  is	  present	  in	  two	  isoforms	  (Cox5a	  and	  Cox5b),	  we	  made	  
use	  of	  the	  fact	  that	  Cox6	  is	  needed	  to	  stabilize	  both	  isoforms	  of	  Cox5	  by	  protecting	  them	  
from	   proteolytic	   instability.	   In	   cox6Δ,	   only	   trace	   amounts	   of	   Cox5a	   or	   Cox5b	   were	  
detectable	  (Glerum	  &	  Tzagoloff	  1997;	  Church	  et	  al.	  2005).	  Therefore,	  we	  performed	  the	  
following	  studies	  in	  mitochondria	  isolated	  from	  cox6Δ,	  grown	  on	  YPGal.	  To	  test	  whether	  
Cox6	   is	   required	   to	   recruit	   Shy1	   to	   COA	   complexes,	   we	   followed	   two	   independent	  
approaches.	  	  
First,	   we	   isolated	   native	   complexes,	   containing	   Shy1-­‐ProteinA	   (Shy1ProtA)	   using	   IgG-­‐
chromatography	  from	  digitonin	  solubilized	  mitochondria	  (FIG	  3.8,	  A).	  This	  experiment	  
was	   performed	   in	   a	   wild	   type	   (FIG	   3.8;	   A,	   lanes	   5	   and	   6)	   as	   well	   as	   in	   a	   cox6Δ	  
background	   (FIG	   3.8;	   A,	   lanes	   3	   and	   4).	   As	   a	   control,	   IgG-­‐chromatography	   was	   also	  
performed	   from	   cox6Δ,	   without	   a	   tagged	   Shy1	   version	   present	   (FIG	   3.8,	   A;	   lanes	   1	  
and	  2).	  In	  total	  samples	  of	  cox6Δ,	  we	  observed	  no	  Cox6	  and	  only	  trace	  amounts	  of	  Cox5,	  
Cox1	  or	  Cox2.	  Steady	  state	  levels	  of	  other	  proteins	  were	  comparable	  to	  wild	  type	  levels.	  
Isolation	   efficiency	   of	   Shy1ProtA	  was	   identical	   in	  wild	   type	   and	   cox6Δ	  mitochondria.	   In	  
wild	   type	  mitochondria,	   all	   known	   components	   of	   COA	   complexes	   (Coa3,	   Cox1,	   Cox5,	  




FIG	  3.8	  Cox6	  is	  required	  for	  recruitment	  of	  Shy1	  to	  COAs	  	  
(A)	  Mitochondria	  from	  cox6Δ	  and	  TEV-­‐ProteinA-­‐7His	  tagged	  Shy1	  (Shy1ProtA)	  in	  wild	  type	  or	  cox6Δ	  background	  
were	   solubilized	   in	   1%	  digitonin	   buffer	   and	   subjected	   to	   IgG-­‐chromatography.	  After	   acidic	   elution,	   the	   eluate	  
was	   separated	   on	   SDS-­‐PAGE	   and	   analysed	   by	   Western	   blotting,	   (total	   1.5%,	   eluate	   100%)	   (B)	   Co-­‐
immunoprecipitation	   of	   Coa3	   (and	   control)	   from	   digitonin-­‐solubilized	   mitochondria,	   isolated	   from	  wild	   type	  
(WT)	  and	  cox6Δ	  were	  analysed	  by	  SDS-­‐PAGE	  and	  Western	  blotting	  (total	  8%,	  eluate	  100%).	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In	  contrast,	  in	  cox6Δ,	  none	  of	  the	  mentioned	  cytochrome	  c	  oxidase	  assembly	  factors	  or	  
early	  assembling	  subunits	  were	  found	  to	  co-­‐isolate	  with	  Shy1ProtA.	  In	  both	  cases,	  none	  of	  
the	   tested	  control	  proteins	  (Cox2,	  Cox4,	  Aco1,	  Por1,	  Mdm38,	  Tom70)	  were	  copurified.	  
Thus,	  we	  concluded	  that	  Cox6	  is	  required	  for	  the	  association	  or	  recruitment	  of	  Shy1	  to	  
COA	  complexes.	  
In	  the	  second	  approach,	  we	  performed	  co-­‐immunoprecipitation	  against	  Coa3	  to	  isolate	  
COA	   complexes	   (FIG	   3.8,	   B).	   This	   experiment	   was	   performed	   with	   solubilized	  
mitochondria,	   isolated	   from	  wild	   type	   yeast	   cells	   (FIG	  3.8;	   B,	   lanes	   1-­‐3),	   compared	   to	  
mitochondria	   derived	   from	   cox6Δ	   cells	   (FIG	   3.8,	   B;	   lanes	   4-­‐6).	   As	   a	   control,	   co-­‐
immunoprecipitation	   was	   performed	   using	   antiserum	   against	   Yhl47.	   Antibodies	  
directed	   against	   Coa3	   efficiently	   precipitated	   Coa3	   both	   from	   wild	   type	   and	   cox6Δ	  
mitochondria.	  With	  Cox14,	  Shy1,	  Cox1,	  Cox5,	  Mss51	  and	  Coa1,	  COA	  components	  were	  
recovered	   from	   wild	   type	   mitochondria,	   in	   accordance	   with	   previously	   published	  
results	  (Mick	  et	  al.	  2010;	  Reinhold	  et	  al.	  2011;	  Fontanesi	  et	  al.	  2011).	  In	  addition,	  minor	  
amounts	  of	  Cox6	  were	  copurified.	  Other	  subunits	  of	  cytochrome	  c	  oxidase	  that	  assemble	  
later	  to	  the	  maturing	  enzyme	  (Cox2,	  Cox4)	  were	  not	  identified	  in	  the	  eluates.	  All	  control	  
proteins	  tested	  (Aco1,	  Por1,	  Atp5	  or	  Tom70)	  were	  not	  found	  to	  co-­‐isolate,	  underlining	  
specificity	   of	   the	   detected	   proteins.	   However,	   we	   noticed	   differences	   between	   the	  
isolation	   from	   wild	   type	   and	   cox6Δ:	   Shy1	   was	   not	   found	   in	   the	   eluate,	   despite	  
comparable	  levels	  of	  the	  protein	  in	  total	  samples	  of	  wild	  type	  and	  cox6Δ.	  Furthermore,	  
Cox5	   and	   Cox6	   could	   not	   be	   detected	   in	   the	   eluate	   from	   cox6Δ,	   a	   finding	   that	   is	  
explained	   by	   the	   absence	   of	   Cox6	   and	   the	  minor	   residual	   amount	   of	   Cox5	   present	   at	  
steady	  state	   levels	   in	  cox6Δ	  mitochondria.	  Despite	   the	  small	  amount	  of	  Cox1	   in	  cox6Δ,	  
the	   remaining	   protein	   was	   present	   in	   Coa3-­‐containing	   complexes,	   indicating	   the	  
accumulation	  of	  Cox1-­‐containing	  assembly	  intermediates	  in	  cox6Δ.	  Taken	  together,	  we	  
present	  additional	  evidence	  that	  in	  the	  absence	  of	  Cox5	  and	  Cox6,	  Shy1	  was	  not	  present	  
in	  COA	  complexes.	  
In	  conclusion,	  we	  could	  show	  the	  requirement	  of	  Cox6	  (and	  of	  Cox5	  indirectly)	  for	  the	  
recruitment	  of	  Shy1	  to	  COA	  complexes	  by	  two	  independent	  methods.	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3.1.4	  Studying	  defects	   in	  COX	  assembly	  in	  Leigh	  syndrome:	  Characterization	  of	  a	  
SHY1	  point	  mutation	  (transferred	  from	  patient	  SURF1	  mutation)	  
3.1.4.1	  Growth	  behaviour	  of	  Shy1YD	  is	  affected	  
Cytochrome	  c	  oxidase	  deficiency	   is	  one	  of	   the	  major	  causes	  of	  Leigh	  syndrome,	  a	   fatal	  
encephalopathy	  of	   infancy.	  Mutations	   in	  SURF1	  are	   the	  most	  prevalent	   cause	  of	  Leigh	  
syndrome	   with	   isolated	   COX	   deficiency	   (Péquignot	   et	   al.	   2001).	   In	   patients,	   various	  
mutations	  were	   found,	   amongst	   others	   a	   point	  mutation	   leading	   to	   an	   exchange	   of	   a	  
conserved	   tyrosine	   at	   position	   274.	  We	   used	   the	   yeast	   homolog	   of	   SURF1,	   Shy1	   as	   a	  
model	  to	  study	  the	  corresponding	  Y344D	  exchange.	  For	  this	  purpose,	  shy1Δ	  (or	  shy1Δ,	  
expressing	  Mss51HA	   for	   later	   detection	   purposes)	   cells,	   carrying	   an	   empty	   plasmid	   or	  
expressing	  the	  wild	  type	  or	  mutant	  form	  of	  Shy1	  were	  generated.	  Strains	  expressing	  the	  
mutant	   form	   of	   Shy1	   from	   a	   plasmid	   under	   its	   endogenous	   promotor	   showed	   a	   cold	  
sensitive	   respiratory	   deficiency	   with	   slightly	   reduced	   growth	   on	   non-­‐fermentable	  




FIG	  3.9	  Analysis	  of	  growth	  behavior	  and	  steady	  state	  protein	  levels	  of	  strains	  with	  a	  Shy1	  point	  mutation	  
(Shy1YD)	  
(A)	  Serial	  dilutions	  of	  Mss51HAshy1Δ	  cells,	  containing	  an	  empty	  plasmid	  (-­‐)	  or	  expressing	  Shy1WT	  or	  Shy1YD	  were	  
spotted	   onto	   fermentable	   (YPD)	   or	   non	   fermentable	   (YPG)	   solid	   medium	   and	   incubated	   at	   indicated	  
temperatures.	  (B)	  Indicated	  amounts	  of	  mitochondria,	  isolated	  from	  strains	  described	  in	  (A),	  grown	  at	  30	  °C	  in	  
SGal-­‐Ura,	  were	  analysed	  by	  SDS-­‐PAGE	  and	  Western	  blotting	  using	  indicated	  antibodies	  against	  COX	  subunits	  and	  
assembly	   factors	   as	  well	   as	   control	  proteins.	   (C)	  30	  µg	  mitochondria,	   isolated	   from	   shy1Δ	   cells,	   containing	  an	  
empty	  plasmid	  (-­‐)	  or	  expressing	  Shy1WT	  or	  Shy1YD,	  grown	  in	  SGal-­‐Ura	  at	  30	  or	  19	  °C.	  Separation	  by	  4-­‐13%	  BN-­‐
PAGE,	  followed	  by	  Western	  blotting	  against	  Cox1,	  redecoration	  with	  Tim54	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To	  assess	  this	  phenotype	  in	  a	  more	  direct	  way,	  cells	  from	  described	  strains	  were	  grown	  
in	  SGal-­‐Ura	  at	  30	  °C	  and	  steady	  state	  proteins	   levels	  were	  analysed	  by	  SDS-­‐PAGE	  (FIG	  
3.9;	  B	  and	  Reinhold	  et	  al.	  2011).	  At	  30	  °C,	  we	  observed	  reduced	  levels	  of	  mitochondria-­‐
encoded	   cytochrome	   c	   oxidase	   core	   components,	   such	   as	   Cox1	   and	   Cox2	   in	   Shy1YD	  
mitochondria,	   compared	   to	   wild	   type	   mitochondria	   (Bestwick,	   Jeong,	   et	   al.	   2010a;	  
Reinhold	   et	   al.	   2011).	   Control	   proteins	   of	   the	   different	   mitochondrial	   sub-­‐
compartments,	   as	  well	   as	   a	  number	  of	   early	   assembly	   factors	   such	  as	  Coa1,	  Coa3	  and	  
Mss51,	  were	  unaltered	  in	  the	  tested	  mitochondria.	  
To	   analyse	   the	   cold	   sensitive	   phenotype	   in	  more	   detail,	  mitochondria	  were	   prepared	  
from	   cells	   grown	   on	   SGal-­‐Ura	   at	   permissive	   (30	  °C)	   and	   non-­‐permissive	   (19	  °C)	  
temperatures.	   Subsequently,	   steady	   state	   levels	   of	   cytochrome	   c	   oxidase,	   using	  
antibodies	   against	   Cox1	   were	   analysed	   (FIG	   3.9;	   C	   and	   Reinhold	   et	   al.	   2011).	   As	  
reported	   previously,	   in	   shy1Δ,	   no	   mature	   cytochrome	   c	   oxidase	   was	   detected	  
(Mashkevich	   et	   al.	   1997;	   Nijtmans	   et	   al.	   2001).	   In	   Shy1YD,	   only	   a	   reduced	   amount	   of	  
cytochrome	   c	   oxidase	   could	   be	   detected,	   confirming	   the	   results	   of	   the	   SDS-­‐PAGE	  
analysis	   (FIG	  3.9,	  B).	   Consistent	  with	   the	   temperature	   sensitive	   growth,	   cytochrome	  c	  
oxidase	   levels	   in	   Shy1YD,	   grown	   at	   19	  °C	   were	   hardly	   detectable.	   Redecoration	   with	  
antibodies	   against	   Tim54	  was	   used	   to	   ensure	   equal	   loading	   (complex	   of	   300	   kDa,	   in	  
Shy1WT	  overlapping	  with	   the	   signal	  of	  Cox1	  monomer).	  Taken	   together,	  we	  concluded	  
that	   the	   respiratory	   deficiency	   observed	   in	   Shy1YD	   was	   caused	   by	   a	   reduction	   of	  
cytochrome	  c	  oxidase;	  especially	  of	  its	  mitochondria-­‐encoded	  subunits.	  
	  
In	  Reinhold	  et	  al.	  (2011),	  we	  reported	  that	  import	  efficiency	  and	  stability	  of	  Shy1YD	  was	  
not	   affected,	   compared	   to	   wild	   type	   Shy1	   (the	   same	   was	   true	   for	   SURF1Y274D,	   which	  
accumulated	   in	   a	   cytochrome	   c	   oxidase	   assembly	   intermediate).	   Furthermore,	   the	  
topology	  of	  Shy1YD	  in	  the	  membrane	  was	  not	  altered.	  However,	  Shy1YD	  uncouples	  Cox1	  
expression	   from	   COX	   assembly:	   even	   though	   COX	   assembly	   was	   disturbed	   in	   Shy1YD	  
cells,	  Cox1	  translation	  rate	  was	  found	  to	  be	  comparable	  to	  wild	  type.	  Using	  pulse-­‐chase	  
experiments,	  we	  could	  show	  that	  newly	  synthesized	  Cox1	  was	  very	  instable	   ,	  resulting	  
in	  reduced	  steady	  state	  levels	  of	  Cox1.	  (Generation	  of	  the	  mutant	  form	  of	  Shy1,	  import	  
and	  stability	  assays,	  membrane	  topology	  determination,	  in	  vivo	  labeling	  of	  translational	  
products	  and	  chase	  experiments	  were	  performed	  by	  Dr.	  R.	  Reinhold	  in	  the	  Department	  
of	  Cellular	  Biochemistry,	  Göttingen).	  
	   	   3.	  RESULTS	  
	   67	  
3.1.4.2	  Accumulation	  of	  COA	  complexes	  in	  Shy1(YD)FLAG	  mitochondria	  
In	  cells	  expressing	  Shy1YD,	  Cox1	  translation	  was	  not	  shut	  down	  although	  cytochrome	  c	  
oxidase	  assembly	  was	  defective.	  By	  Coa3	  and	  Coa1	  co-­‐immunoprecipitation,	  we	  could	  
not	   show	   accumulation	   of	   COA	   complexes,	   judged	   from	   SDS-­‐PAGE	   (Reinhold	   et	   al.	  
2011).	  Hence,	  we	  concluded	  that	  Mss51	  was	  not	  sequestered	  by	  Shy1YD	  but	  was	  rather	  
active	   and	   able	   to	   constantly	   trigger	   translation	   of	  COX1	  mRNA.	   However,	   due	   to	   the	  
denaturing	  (acidic)	  elution	  after	  co-­‐immunoprecipitation,	  eluates	  could	  not	  be	  analysed	  
by	  BN-­‐PAGE.	  	  
In	  order	  to	  investigate	  the	  reason	  for	  the	  normal	  Cox1	  synthesis	  rate	  in	  more	  detail,	  we	  
set	   out	   to	   isolate	   the	   mutant	   and	   wild	   type	   Shy1	   and	   subsequently	   identify	   its	  
interaction	  partners	   in	  native	  complexes	  by	  BN-­‐PAGE.	  For	   this	  purpose,	  we	  generated	  
plasmids,	   containing	   FLAG-­‐tagged	   versions	   of	   Shy1WT	   or	   Shy1YD	   (plasmids	   were	  
generated	  by	  Dr.	  D.	  Mick	  in	  the	  Department	  of	  Cellular	  Biochemistry,	  Göttingen).	  These	  
plasmids	  (and	  an	  empty	  vector	  control)	  were	   transformed	   into	  shy1Δ cells,	  expressing	  
Mss51HA.	  The	  Mss51HA	  background	  was	  chosen	   for	  detection	  purposes	  as	  an	  antibody,	  
recognizing	   native	   Mss51,	   was	   not	   available	   at	   that	   time.	   After	   FLAG-­‐isolation	   under	  
native	   conditions,	  we	   analysed	   the	   eluate	   using	   SDS-­‐PAGE	   and	  Western	   blotting	   (FIG	  




FIG	  3.10	  Native	  isolation	  of	  Shy1FLAG	  /	  Shy1(YD)FLAG	  
(A)	  Western	  blot	  analysis	  of	  elution	  of	  FLAG-­‐isolation	  from	  digitonin	  lysed	  mitochondria	  from	  indicated	  strains.	  
Native	  elution	  via	  FLAG	  peptide.	  Amount	  of	  protein	  loaded	  in	  the	  total	  and	  unbound	  (=unb.)	  samples	  correspond	  
to	  9%	  of	   the	   elution.	   (B)	  The	  native	   elution	   from	   (A)	  was	  analysed	  by	  4-­‐13%	  BN-­‐PAGE,	   followed	  by	  Western	  
blotting.	   Decoration	   against	   FLAG	   and	   HA	   with	   monoclonal	   antibodies,	   decoration	   for	   Cox1	   with	   polyclonal	  
antibodies.	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The	   isolation	   efficiency	   of	   Shy1YD	  was	   comparable	   to	   the	  wild	   type	   version.	  However,	  
the	  amount	  of	  Cox1,	   isolated	  with	   the	  mutant	   form	  was	   significantly	  higher	   (compare	  
FIG	  3.10;	  B,	  lane	  6	  to	  lane	  5)	  than	  in	  wild	  type,	  which	  is,	  to	  a	  lesser	  extent,	  also	  true	  for	  
the	  amount	  of	  co-­‐isolated	  Mss51.	  Subsequently,	  to	  resolve	  these	  differences,	  the	  eluates	  
were	  separated	  on	  a	  native	  gel.	  Shy1WT	  was	  found	  in	  COA	  complexes	  (identified	  by	  the	  
presence	   of	   Cox1,	   Mss51	   and	   Shy1)	   but	   predominantly	   in	   a	   70	   kDa	   complex.	   To	   our	  
surprise,	  Shy1YD	  was	  in	  contrast	  mainly	  present	  in	  accumulated	  COA	  complexes.	  
In	  contrast	  to	  our	  previous	  work	  (Reinhold	  et	  al.	  2011),	  we	  found	  the	  accumulation	  of	  
COA	  complexes	  containing	  Shy1	  and	  Mss51.	  This	  intermediate	  could	  not	  be	  detected	  at	  
steady	  state	  levels	  (Fig	  3.9;	  C)	  but	  becomes	  visible	  after	  enrichment	  via	  FLAG	  isolation.	  
We	  speculated	  that	  Mss51	  is	  sequestered	  in	  this	  complex	  but	  the	  mutant	  form	  of	  Shy1	  
was	  not	  able	  to	  transform	  it	  into	  its	  inactive	  form,	  hence	  Mss51	  was	  still	  able	  to	  initiate	  
further	  rounds	  of	  Cox1	  synthesis.	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3.2	  Mapping	  Shy1-­‐containing	  COA	  complexes:	  Association	  of	  heme	  a	  synthase	  
with	  Shy1	  
3.2.1	  Isolation	  of	  interaction	  partners	  of	  Shy1ProtA	  	  
Shy1	  is	  required	  for	  Cox1	  biogenesis	  and	  hence	  is	  part	  of	  early	  assembly	  intermediates	  
in	   yeast,	   termed	   COA	   (Mick	   et	   al.	   2007;	   Pierrel	   et	   al.	   2007;	   Fontanesi	   et	   al.	   2011).	  
Furthermore,	   Shy1	   plays	   a	   central	   role	   in	   early	   assembly	   steps	   of	   Cox1	   during	  
cytochrome	   c	   oxidase	   maturation.	   Previous	   analyses	   found	   Shy1	   in	   several	   distinct	  
mitochondrial	   protein	   complexes,	   most	   of	   which	   have	   been	   resolved	   by	   BN-­‐PAGE	  
analyses	  (Nijtmans	  et	  al.	  2001;	  Mick	  et	  al.	  2007;	  Mick	  et	  al.	  2010;	  Fontanesi	  et	  al.	  2011).	  
However,	  a	  comprehensive	  analysis	  of	  the	  protein	  composition	  of	  these	  complexes	  was	  
still	  lacking.	  	  
To	   assess	   the	   composition	   of	   these	   intermediates,	  we	   isolated	   assembly	   intermediate	  
complexes	  in	  their	  native	  state	  and	  analysed	  the	  components	  utilizing	  a	  combination	  of	  
Western	  blotting	  and	  mass	  spectrometry.	  For	  this	  purpose,	  we	  used	  a	  functional	  fusion	  
construct	  of	  Shy1	  (Mick	  et	  al.	  2007).	  Shy1	  was	  chromosomally	  tagged	  with	  a	  protein	  A	  
tag	   at	   the	   C-­‐terminus	   (Shy1ProtA)	   that	   can	   be	   cleaved	   by	   TEV	   (tobacco	   etch	   virus)	  
protease	  treatment	  to	  release	  native	  Shy1-­‐containing	  complexes.	  Shy1ProtA	  was	  purified	  
by	   IgG-­‐chromatography	   from	   isolated	   wild	   type	   or	   Shy1ProtA	   mitochondria	   after	   mild	  
solubilization	   in	   digitonin-­‐containing	   buffer.	   Subsequently,	   Shy1	   and	   its	   associated	  
proteins	  were	  cleaved	  from	  the	  resin	  by	  TEV	  protease	  treatment	  and	  analysed	  either	  by	  





FIG	  3.11	  Isolation	  of	  Shy1ProtA	  via	  IgG	  chromatography	  
(A)	  Schematic	  illustration	  of	  the	  native	  purification	  of	  Shy1ProtA	  by	  IgG-­‐chromatography	  and	  different	  analytical	  
methods	   used.	   (B)	   Total	   samples,	   TEV-­‐cleaved	   elution	   and	   supernatant	   (=unb.)	   of	   IgG-­‐chromatography	   from	  
mitochondria,	  isolated	  from	  wild	  type	  and	  Shy1ProtA	  were	  analysed	  by	  SDS-­‐PAGE,	  followed	  by	  Western	  blotting.	  
Amounts	  of	  protein	  loaded	  in	  the	  total	  samples	  correspond	  to	  5.5%	  of	  the	  elution.	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This	  approach	  allowed	  efficient	  purification	  of	  Shy1	  from	  mitochondrial	  extracts,	  which	  
we	  assessed	  by	  SDS-­‐PAGE	  and	  Western	  blotting	  of	  the	  different	  fractions	  (FIG	  3.11;	  B)	  
since	   complete	   depletion	   of	   Shy1	   from	   the	   extract	   was	   achieved.	   After	   TEV	   cleavage,	  
Shy1	  migrates	  at	  lower	  molecular	  weight	  in	  an	  SDS	  gel	  but	  due	  to	  a	  short	  linker	  between	  
the	   protein	   and	   the	   TEV	   site,	   still	   runs	   slightly	   different	   from	   wild	   type	   Shy1.	   No	  
unspecific	  binding	  was	  observed	  as	  judged	  by	  the	  absence	  of	  control	  proteins	  (Atp5	  and	  
Por1)	  in	  the	  eluate	  fraction.	  	  
Based	   on	   the	   successful	   small	   scale	   isolation,	  we	  performed	   IgG-­‐chromatography	   in	   a	  
preparative	   way.	   The	   native	   elution	   was	   split	   in	   two	   unequal	   amounts	   and	   both	  
seperated	   by	   BN-­‐PAGE.	   The	   smaller	   fraction	   of	   the	   elution	  was	   analysed	   by	  Western	  
blot	   and	   revealed	   several	   distinct	   complexes,	   containing	   Shy1	   in	   the	   range	   of	   80-­‐





FIG	  3.12	  Mapping	  of	  Shy1	  containing	  complexes	  by	  mass	  spectrometry	  
(A)	  A	  fraction	  of	  native	  eluted	  proteins	  of	  a	  preparative	  isolation	  of	  Shy1ProtA,	  analysed	  by	  4-­‐13%	  BN-­‐PAGE	  and	  
Western	   blotting	   for	   Shy1ProtA-­‐containing	   complexes.	   As	   a	   control,	   solubilized	   wild-­‐type	   mitochondria	   were	  
loaded	  (6.5%	  of	  eluate).	  (B)	  Majority	  of	  eluted	  proteins	  from	  (A)	  was	  separated	  by	  4-­‐13%	  BN-­‐PAGE,	  followed	  by	  
mass	  spectrometry.	  Heat	  map	  illustrating	  normalized	  peptide	  numbers	  of	  proteins	  co-­‐isolated	  with	  Shy1ProtA	  in	  
individual	   gel	   slices.	   Positions	   of	  marker	   bands	  were	   estimated	   from	   their	   running	  distances	   in	   a	   Coomassie-­‐
stained	   gel	   lane.	   In-­‐gel	   digestion,	   mass	   spectrometry,	   data	   analysis	   and	   visualization	   was	   performed	   in	   the	  
Bioanalytical	  Mass	  spectrometry	  Group	  of	  Prof.	  Urlaub	  at	  the	  MPI	  BPC	  (Göttingen),	  mainly	  by	  Monika	  Raabe	  and	  
Dr.	  Miroslav	  Nikolov.	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As	   a	   control,	   total	  mitochondrial	   extract	  was	   loaded.	   In	   accordance	  with	   results	   from	  
SDS-­‐PAGE,	   the	   elution	   from	   IgG	   sepharose,	   incubated	   with	   solubilized	   wild	   type	  
mitochondria,	  contained	  no	  Shy1	  complexes.	  To	  define	  the	  protein	  composition	  of	  Shy1	  
containing	  complexes	  in	  an	  unbiased	  manner,	  the	  majority	  of	  the	  elution,	  separated	  by	  
BN-­‐PAGE,	   was	   analysed	   by	   mass	   spectrometry.	   The	   gel	   lane	   was	   cut	   into	   23	   pieces	  
which	   were	   independently	   subjected	   to	   in-­‐gel	   trypsin	   digestion,	   followed	   by	   mass	  
spectrometry	  (for	  detailed	  results,	  see	  Table	  S1	  in	  supplemental	  material,	  Bareth	  et	  al.	  
2013).	   A	   heatmap,	   illustrating	   normalized	   peptide	   numbers	   of	   selected	   proteins	   in	  
individual	  gel	  slices	  revealed	  the	  distribution	  of	  several	  Shy1-­‐containing	  complexes	  (FIG	  
3.12;	  B).	  Cytochrome	  c	  oxidase	  assembly	  factors,	  such	  as	  Coa3,	  Cox14,	  Coa1	  and	  Mss51,	  
were	  found	  in	  COA	  complexes,	  together	  with	  Shy1,	  migrating	  at	  270-­‐350	  kDa.	  Cox1	  and	  
Cox5a	  were	  predominantly	  present	   in	  COA	  complexes	  but	  were	  also	   found	   in	  the	  high	  
molecular	  weight	  range.	  It	  has	  been	  previously	  published	  that	  a	  fraction	  of	  respiratory	  
chain	  supercomplexes	  are	  co-­‐isolated	  with	  Shy1	  (Mick	  et	  al.	  2007;	  Vukotic	  et	  al.	  2012),	  a	  
fact	  that	  is	  not	  fully	  understood	  but	  is	  supported	  by	  the	  presence	  of	  components	  of	  bc1	  
complex	  (Rip1,	  Qcr8).	  	  
Interestingly,	  we	  observed	  distinct	  complexes	  of	  the	  heme	  a	  synthase	  Cox15	  with	  Shy1.	  
This	   finding	   agreed	  with	   our	   previous	   observation	   that	   Cox15	   could	   be	   identified	   by	  
mass	   spectrometry	   in	   Shy1	   complexes	  purified	   from	  digitonin-­‐solubilized	  membranes	  
(Mick	  et	  al.	  2007).	  However,	  to	  our	  surprise,	  Cox15	  was	  not	  only	  found	  in	  low	  molecular	  
complexes	  with	   Shy1	   but	  was	   also	   associated	  with	   COA	   complexes.	   To	   confirm	   these	  
unexpected	   result,	  we	   performed	   an	   independent	   experiment	   and	   analysed	   the	   Shy1-­‐
containing	   complexes,	   separated	   by	   BN-­‐PAGE	  with	   available	   antibodies	   (FIG	   3.13).	   In	  
agreement	  with	  mass	  spectrometric	  data,	  Shy1,	  Mss51,	  Coa3	  and	  Cox14,	  together	  with	  
the	  structural	  subunits	  Cox1	  and	  Cox5a,	  were	  detected	  in	  COA	  complexes	  but	  not	  in	  the	  
smaller	   complexes.	   This	   finding	   suggested	   novel	   complexes,	   composed	   of	   Shy1	   and	  
Cox15	  that	  lack	  known	  assembly	  factors	  or	  structural	  subunits	  of	  COX.	  In	  order	  to	  detect	  
Cox15,	  we	  generated	  a	  polyclonal	  antiserum	  in	  rabbit,	  directed	  against	  an	  epitope	  at	  the	  
C-­‐terminus	  of	   the	  Cox15	  protein.	  We	  detected	  Cox15	   in	   complexes	   that	  were	   isolated	  
with	   Shy1ProtA	   on	   BN-­‐PAGE.	   Although	   the	   majority	   of	   Cox15	   was	   found	   in	   the	   faster	  
migrating	   complexes	   that	   lack	   COA	   components	   or	   structural	   COX	   subunits,	   a	   minor	  
fraction	  of	  Cox15	  co-­‐migrated	  with	  COA	  complexes	  (FIG	  3.13).	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FIG	  3.13	  Mapping	  of	  Shy1	  containing	  complexes	  by	  Western	  blotting	  
Western	   blot	   analysis	   of	   protein	   complexes	   after	   IgG	   chromatography	   from	   isolated	   wild	   type	   (WT)	   and	  
Shy1ProtA	  mitochondria,	  separated	  by	  4-­‐13%	  BN-­‐PAGE.	  Two	  independent	  experiments	  are	  shown.	  
	  
	  
The	  heme	  a	  synthase	  Cox15	  is	  required	  for	  the	  hydroxylation	  of	  heme	  o	  to	  form	  heme	  a,	  
which	   is	   an	   essential	   prosthetic	   group	   for	   cytochrome	   c	  oxidase	   (Barros	   et	   al.	   2001).	  
Two	   heme	   a	   molecules	   generated	   by	   this	   pathway	   are	   incorporated	   into	   the	   Cox1	  
subunit	   of	   COX,	   however	   this	   process	   is	   not	   understood.	   A	   study	   in	   the	   bacterium	  
P.	  denitrificans	   indicated	   that	   Surf1	   (a	   homolog	   of	   yeast	   Shy1)	   is	   capable	   of	   binding	  
heme	  a	  in	  vitro,	  thus	  linking	  its	  function	  to	  the	  heme	  incorporation	  step	  for	  Cox1	  during	  
cytochrome	  c	  oxidase	  biogenesis	  (Bundschuh	  et	  al.	  2009).	  
The	   presented	   data	   allowed	   us	   to	   speculate	   that	   the	   transfer	   of	   heme	   a	   into	   Cox1	   is	  
achieved	  by	  a	  cooperated	  action	  of	  Shy1	  and	  Cox15.	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3.2.2	  A	  C-­‐terminal	  tag	  on	  Cox15	  affects	  its	  association	  with	  COA	  complexes	  
3.2.2.1	  Growth	  behaviour	  of	  strains	  with	  C-­‐terminally	  tagged	  Cox15	  
In	   order	   to	   follow	   the	   association	   of	   Cox15	   with	   COA	   complexes,	   we	   integrated	   a	  
Protein	  A	  or	  FLAG	  tag-­‐encoding	  cassette	  into	  the	  chromosomal	  COX15	  locus.	  This	  allows	  
the	   purification	   of	   native	   Cox15-­‐containing	   complexes.	   To	   test	   whether	   the	   tagged	  
versions	   of	   Cox15	   were	   functional,	   we	   analysed	   the	   growth	   of	   the	   strains	   on	  
fermentable	  and	  non-­‐fermentable	  carbon	  sources	  at	  different	  temperatures	  (FIG	  3.14).	  
Growth	  of	  the	  tested	  strains	  was	  identical	  to	  wild	  type	  on	  both	  carbon	  sources	  and	  at	  all	  
temperatures	  tested.	  As	  a	  control,	  the	  respiratory	  deficient	  strain	  coa3Δ	  was	  used	  (Merz	  
&	  Westermann	  2009;	  Mick	  et	  al.	  2010;	  Fontanesi	  et	  al.	  2011).	  Hence	  we	  concluded	  that	  





FIG	  3.14	  Analysis	  of	  growth	  behavior	  of	  strains	  with	  C-­‐terminally	  tagged	  Cox15	  
Serial	   dilutions	   of	  wild	   type	   cells,	   cells	   expressing	   Cox15ProtA	   or	   Cox15FLAG	   and	   coa3Δ cells	  were	   spotted	   onto	  
fermentable	  (YPD)	  or	  non	  fermentable	  (YPG)	  solid	  medium	  and	  incubated	  at	  indicated	  temperatures.	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3.2.2.2	  COA	  components	  are	  not	  co-­‐isolated	  with	  Cox15ProtA	  
Next,	  we	   isolated	  mitochondria	   from	  wild	   type	  and	  Cox15ProtA	  cells,	  grown	  on	  YPG.	  To	  
confirm	  the	  co-­‐purification	  of	  Cox15	  with	  Shy1,	  we	  performed	  the	  reverse	  experiment	  
and	   purified	   complexes	   via	   Cox15ProtA.	   After	   solubilization	   of	   mitochondria	   with	  
digitonin,	   Cox15ProtA-­‐containing	   complexes	   were	   isolated	   by	   IgG-­‐chromatography,	  
followed	  by	  TEV	  cleavage	  (FIG	  3.15).	  The	  native	  eluates	  were	  separated	  by	  SDS-­‐PAGE,	  
followed	   by	  Western	   blotting	   for	   Cox15,	   Shy1,	   COA	   components	   and	   control	   proteins	  
(FIG	  3.15;	  A).	  Cox15ProtA	  was	   isolated	  efficiently	  and	  Shy1	  was	  recovered	  as	  suggested	  
by	   the	   Shy1ProtA	   isolation.	   However,	   components	   of	   COA	   complexes,	   such	   as	   Coa1	   or	  




FIG	  3.15	  Native	  isolation	  of	  Cox15ProtA	  	  interaction	  partners	  via	  IgG-­‐chromatography	  
(A)	  Total	  samples	  and	  TEV-­‐cleaved	  elution	  of	  IgG-­‐chromatography	  from	  mitochondria,	   isolated	  from	  wild	  type	  
and	  Cox15ProtA	  were	  analysed	  by	  SDS-­‐PAGE,	  followed	  by	  western	  blotting.	  Amounts	  of	  protein	  loaded	  in	  the	  total	  
samples	  correspond	  to	  6.25%	  of	  the	  elution.	  (B)	  A	  fraction	  of	  native	  eluted	  proteins	  from	  (A),	  analysed	  by	  4-­‐13%	  
BN-­‐PAGE	   and	   Western	   blotting	   for	   Cox15ProtA-­‐containing	   complexes.	   As	   a	   control,	   solubilized	   wild-­‐type	  
mitochondria	  were	  loaded	  (9.5%	  of	  eluate).	  
	  
	  
In	  addition,	  BN-­‐PAGE	  analysis	  of	  the	  eluates	  revealed	  a	  130	  kDa	  and	  a	  170	  kDa	  complex	  
but	  no	  high	  molecular	  weight	  complexes	  (FIG	  3.15;	  B).	  This	  experiment	  confirmed	  the	  
interaction	  of	  Shy1	  and	  Cox15	  seen	  by	  mass	   spectrometry	  and	  BN-­‐PAGE.	  At	   the	   same	  
time,	   the	   absence	   of	   COA	   complexes	   contradicted	   the	   results	   obtained	   by	   mass	  
spectrometry	   but	   is	   in	   accordance	   with	   previous	   results,	   obtained	   by	   purification	   of	  
epitope	   tagged	   Cox15	   that	   could	   not	   identify	   Cox15	   in	   complex	  with	   Cox1	   (Bestwick,	  
Khalimonchuk,	  et	  al.	  2010b;	  Khalimonchuk	  et	  al.	  2012).	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3.2.2.3	  Co-­‐Immunoprecipitation	  of	  Coa3	  from	  wild	  type	  vs.	  Cox15FLAG	  
To	   clarify	   the	   contradictory	   results	   on	   the	   interaction	   of	   Cox15	   with	   COA	   complexes	  
obtained	   by	   different	   methods,	   we	   applied	   an	   additional	   method.	   Wild	   type	  
mitochondria	   were	   subjected	   to	   co-­‐immunoprecipitation	   with	   Coa3	   or	   control	  
antibodies	   in	   order	   to	   isolate	   COA	   complexes	   (Mick	   et	   al.	   2010).	   Coa3	   antibodies	  
efficiently	  precipitated	  COA	  complexes,	   indicated	  by	  the	  presence	  of	  Shy1,	  Cox1,	  Cox5,	  
Mss51,	   Coa1	   and	   Cox14.	   In	   addition,	   Cox15	   was	   also	   specifically	   enriched,	   providing	  




FIG	  3.16	  Influence	  of	  a	  C-­‐terminal	  tag	  on	  Cox15	  on	  interaction	  with	  COA	  complexes	  
Co-­‐immunoprecipitation	  of	  Coa3	  (and	  control)	  from	  digitonin-­‐solubilized	  mitochondria,	  isolated	  from	  wild	  type	  
(WT)	   and	   Cox15FLAG.	   Bound	  material	  was	   eluted	   and	   analysed	   by	   SDS-­‐PAGE	   and	  Western	   blotting	   (total	   8%,	  
eluate	  100%).	  
	  
Control	   proteins	   from	   different	   mitochondrial	   compartments	   were	   not	   isolated.	   We	  
speculated	  that	  a	  C-­‐terminal	  tag	  on	  Cox15	  interfered	  with	  COA	  association.	  In	  order	  to	  
address	  this	  theory,	  we	  performed	  co-­‐immunoprecipitation	  from	  solubilized	  Cox15FLAG	  
mitochondria,	   using	  Coa3	  antibodies	   (FIG	  3.16,	   lanes	  4-­‐6).	  To	  avoid	   the	   interaction	  of	  
protein	   A	   with	   antibodies,	   the	   tag	   was	   replaced	   by	   a	   FLAG	   tag.	   COA	   complex	  
constituents	  were	   precipitated	  with	   identical	   efficiency	   from	  wild	   type	   and	   Cox15FLAG	  
mitochondria	   by	   Coa3	   immuniprecipitation.	   Cox15,	   however	   was	   only	   isolated	   from	  
wild	   type	   and	   was	   lacking	   when	   the	   precipitation	   was	   performed	   in	   Cox15FLAG.	  
Therefore	   we	   concluded	   that	   a	   C-­‐terminal	   tag	   on	   Cox15	   affects	   the	   stability	   of	   the	  
association	   between	  Cox15	   and	  COA	   complexes	   but	   not	   between	  Cox15	   and	   Shy1	   (as	  
seen	   in	   FIG	   3.15).	   To	   circumvent	   interferences	   caused	   by	   protein	   tags,	   the	   following	  
isolations	   of	   assembly	   intermediates	   were	   performed	   via	   co-­‐immunoprecipitations	  
against	  the	  early	  assembly	  factor	  Coa3	  (in	  some	  cases	  also	  against	  Coa1).	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3.2.3	  COX	  assembly	  in	  strains	  with	  affected	  heme	  biogenesis	  
3.2.3.1	  Cox15	  enzymatic	  function	  is	  not	  required	  for	  association	  to	  COA	  complexes	  
The	   heme	   a	   synthase	   is	   a	   conserved	   protein	   across	   species.	   A	   study	   on	   the	   Bacillus	  
subtilis	   heme	   a	   synthase,	   CtaA,	   illustrated	   the	   importance	   of	   4	   highly	   conserved	  
histidines	  for	  catalytical	  activity	  by	  the	  presence	  of	  heme	  o	  /	  heme	  a	   in	  different	  point	  
mutants.	   If	   the	   residue	  H216,	   that	   corresponds	   to	  H368	   in	  yeast	  Cox15,	   is	  mutated	   to	  
methionine,	   heme	   a	   is	   barely	   detectable	   and	   heme	   o	   accumulates	   (Hederstedt	   et	   al.	  
2005).	  	  
In	  order	   to	   study	   if	   the	  association	  of	  Cox15	  with	  COA	  complexes	   is	  dependent	  on	   its	  
catalytical	  activity,	  we	   transferred	   this	   specific	  mutation	   into	  yeast	  Cox15.	  FIG	  3.17;	  A	  
shows	  the	  region	  in	  Cox15	  homologues	  from	  different	  species,	  including	  B.	  subtilis.	  The	  
COX15	  gene	  was	  cloned	  into	  pRS416	  under	  control	  of	  its	  endogenous	  promotor	  and	  site	  
directed	  mutagenesis	  was	  performed.	  The	  resulting	  vector,	  carrying	  a	  H368M	  exchange	  
in	  Cox15,	  was	  transformed	  into	  cox15Δ cells.	  For	  control	  purposes,	  an	  empty	  plasmid	  as	  
well	  as	  the	  non-­‐mutated	  parental	  plasmid,	  was	  transformed.	  Growth	  of	  the	  strains	  was	  
analysed	  on	  fermentable	  and	  non-­‐fermentable	  carbon	  source	  at	  different	  temperatures	  




FIG	  3.17	  Analysis	  of	  a	  Cox15	  variant,	  defective	  in	  heme	  a	  biogenesis	  
(A)	   Alignment	   of	   a	   region	   in	   Cox15	   homologues	   from	   different	   species	   (ClustalW2).	   Black	   boxes	   indicate	  
identical	  residues	  in	  all	  species	  shown.	  Arrowhead	  indicates	  a	  conserved	  histidine	  at	  position	  216	  in	  B.	  subtilis,	  
corresponding	   to	  H368	   in	  S.	   cerevisiae	   (B)	  Serial	  dilutions	  of	  cox15Δ	   cells,	   containing	  an	  empty	  plasmid	   (-­‐)	  or	  
expressing	  wild	   type	   Cox15	   (Cox15WT)	   or	   a	   catalytically	   inactive	   variant	   of	   Cox15	   (Cox15H368M)	  were	   spotted	  
onto	  fermentable	  (YPD)	  or	  non-­‐fermentable	  (YPG)	  solid	  medium	  and	  incubated	  at	   indicated	  temperatures.	  (C)	  
Whole	   cell	   extracts	   of	   strains,	   described	   in	   (B)	  were	   analysed	   by	   SDS-­‐PAGE	   and	  Western	   Blotting	   for	   Cox15	  
protein	  levels.	  Por1	  was	  used	  as	  loading	  control.	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Because	  the	  heme	  a	  cofactor	  is	  essential	  for	  cytochrome	  c	  oxidase	  and	  Cox15	  is	  required	  
for	   its	   synthesis,	   COX15	   deletion	   leads	   to	   a	   deficiency	   in	   respiratory	   growth.	  
Cytochrome	  c	  oxidase	  subunits	  are	  present	   in	  the	  cox15	  mutant	  but	  are	  not	  assembled	  
into	  a	  functional	  enzyme	  (Glerum	  et	  al.	  1997).	  In	  accordance	  with	  these	  findings,	  cox15Δ	  
cells	   with	   an	   empty	   plasmid	  were	   not	   able	   to	   grow	   under	   respiratory	   conditions.	   As	  
expected,	  wild	   type	  Cox15	  was	   able	   to	   rescue	   this	   growth	  phenotype	  under	   all	   tested	  
conditions	   but	   Cox15H368M	   was	   not.	   To	   exclude	   that	   the	   respiratory	   defect	   is	   due	   to	  
instability	  of	  the	  mutant	  form	  of	  Cox15,	  Cox15	  protein	  levels	  were	  compared	  in	  whole	  
cell	   extracts	   (FIG	   3.17;	   C).	   We	   found	   comparable	   amounts	   of	   wild	   type	   and	   mutant	  
Cox15	  protein,	  detected	  with	  Cox15	  antibody.	  No	  protein	  was	  detected	   in	  the	  deletion	  
strain.	   Equal	   loading	   was	   confirmed	   using	   antibodies	   against	   mitochondrial	   porin	  
(Por1).	  
To	   confirm	   the	   stability	   of	   Cox15H368M	   also	   in	  mitochondria,	   cox15Δ	   cells,	   carrying	   an	  
empty	  plasmid	  or	  expressing	  wild	  type	  or	  mutant	  Cox15	  were	  grown	  on	  SGal-­‐Ura	  and	  
mitochondria	  were	  purified.	  Different	  amounts	  of	  mitochondria	  were	  separated	  by	  SDS-­‐
PAGE,	   followed	  by	  Western	  blot	  analysis	  (FIG	  3.18;	  A).	  With	   identical	  amounts	  of	  wild	  
type	   and	   mutant	   Cox15	   protein,	   we	   confirmed	   that	   the	   stability	   of	   Cox15	   was	   not	  




FIG	  3.18	  Analysis	  of	  steady	  state	  protein	  levels	  of	  cells	  expressing	  Cox15H368M	  
(A)	   For	   analysis	   of	   steady	   state	   protein	   levels,	   mitochondria	   (Mito)	   isolated	   from	   the	   indicated	   strains	   were	  
separated	  by	  SDS-­‐PAGE	  or	  (B)	  4-­‐13%	  BN-­‐PAGE	  and	  analysed	  by	  Western-­‐blotting.	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Cytochrome	  c	  oxidase	  subunits	  Cox1	  and	  Cox2	  were	  reduced	  in	  the	  deletion	  and	  mutant	  
mitochondria.	   However,	   levels	   of	   Coa3	   and	   Shy1	   as	   well	   as	   of	   control	   proteins	   were	  
unaffected.	  Mitochondrial	  protein	  complexes	  were	  also	  analysed	  in	  these	  mitochondria	  
by	  BN-­‐PAGE	  (FIG	  3.18;	  B).	  As	  expected,	  in	  cox15Δ,	  no	  mature	  cytochrome	  c	  oxidase	  was	  
detectable	   (Glerum	   et	   al.	   1997).	   In	   accordance	   with	   the	   growth	   phenotype	   and	   the	  
reduced	   levels	   of	   Cox1	   and	   Cox2,	   no	   mature	   COX	   was	   detected	   in	   Cox15H368M	  
mitochondria.	  Instead,	  residual	  Cox1	  was	  found	  to	  accumulate	  in	  COA	  complexes.	  
In	   cox15Δ	   cells	   containing	   an	   empty	   plasmid	   or	   expressing	   Cox15H368M,	   other	  
mitochondrial	   protein	   complexes,	   such	   as	   the	   TOM	   complex	   (detected	   with	   Tom40	  
antibody)	  and	  the	  F1FO-­‐ATP-­‐synthase	  (detected	  with	  Atp5	  antibody)	  were	  not	  affected	  
in	   stability	   or	   quantity.	   Due	   to	   the	   lack	   of	   cytochrome	   c	   oxidase,	   the	   cytochrome	   bc1	  
complex	  (detected	  with	  Rip1	  antibody)	  was	  not	  able	  to	  form	  supercomplexes,	  and	  was	  
present	  only	  in	  its	  dimeric	  form.	  However,	  the	  total	  amount	  of	  cytochrome	  bc1	  complex	  
was	   similar	   to	   wild	   type.	   Next,	   we	   analysed	   cytochrome	   c	   oxidase	   assembly	  
intermediates	   that	   accumulated	   in	   Cox15H368M	   mitochondria.	   We	   addressed	   the	  
association	   of	   wild	   type	   Cox15	   and	   Cox15H368M	   with	   COA	   complexes	   by	   Coa3	  




FIG	  3.19	  Association	  of	  Cox15H368M	  with	  COA	  complexes	  
Co-­‐immunoprecipitation	   of	   Coa3	   (and	   control)	   from	  digitonin-­‐solubilized	  mitochondria,	   isolated	   from	   cox15Δ	  
cells,	   containing	   an	   empty	   plasmid	   (-­‐)	   or	   expressing	   Cox15WT	   or	   Cox15H368M.	   Bound	  material	  was	   eluted	   and	  
analysed	  by	  SDS-­‐PAGE	  and	  Western	  blotting	  (total	  8%,	  eluate	  100%).	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Western	  blot	  analysis	  revealed	  that	  Cox15WT	  and	  Cox15H368M	  were	  precipitated	  with	  the	  
same	   efficiency.	   The	   small	   residual	   amount	   of	   Cox1	   in	   the	   mutant	   was	   present	   in	  
Coa3-­‐containing	  complexes,	   together	  with	  other	  COA	  components	   (Coa1,	  Cox14,	  Cox5,	  
Mss51).	   These	   results	   indicated	   the	   accumulation	   of	   COA	   complexes	   in	  mitochondria	  
expressing	   a	   catalytically	   compromised	   Cox15,	   previously	   observed	   during	   BN-­‐PAGE	  
analysis	   (FIG	   3.18;	   B).	   We	   concluded	   that	   Cox15	   interaction	   with	   Cox1	   assembly	  
intermediates	   occurs	   independently	   of	   its	   enzymatic	   function	   and	   the	   final	   product,	  
heme	  a.	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3.2.3.2	  Heme	  o	   supply	  by	  Cox10	   is	  not	   required	   for	  Cox15	   interaction	  with	  COA	  
complexes	  
We	   stepped	   one	   step	   backwards	   in	   the	   heme	  biogenesis	   pathway	   and	   asked	   if	   Cox15	  
still	   interacts	  with	  COA	   complexes	   in	   the	   absence	  of	   its	   substrate	  heme	  o.	   To	   address	  
this	  question,	  we	  generated	  a	  cox10Δ	  strain.	  The	  COX10	  gene	  encodes	  the	  mitochondrial	  
heme	  o	  synthase	  that	  catalyzes	  the	  conversion	  of	  protoheme	  IX	  to	  heme	  o	  (Tzagoloff	  et	  
al.	  1993),	  which	  is	  further	  modified	  by	  Cox15	  to	  form	  heme	  a.	  Since	  the	  heme	  a	  cofactor	  
is	   essential	   to	   COX	   catalytical	   function,	   deletion	   or	   mutation	   of	   COX10	   leads	   to	   a	  
deficiency	  in	  respiratory	  growth.	  This	  is	  caused	  by	  the	  absence	  of	  functional	  cytochrome	  
c	  oxidase	  (Nobrega	  et	  al.	  1990;	  Tzagaoloff	  et	  al.	  1993;,	  Valnot	  et	  al.	  2000a).	  To	  confirm	  
this,	  we	  purified	  mitochondria	   from	  wild	   type,	  cox10Δ	   and	  cox15Δ	   and	  analysed	   them	  
for	   cytochrome	   c	   oxidase	   by	   BN-­‐PAGE	   and	  Western	   blotting,	   probing	   against	   various	  




FIG	   3.20	   Composition	   of	   COA	   complexes	   in	   absence	   of	   heme	   o	   synthase	   (Cox10)	   or	   heme	   a	   synthase	  
(Cox15)	  
(A)	  35	  µg	  digitonin-­‐solubilized	  wild	  type	  (WT),	  cox10Δ	  and	  cox15Δ	  mitochondria	  separated	  by	  4-­‐13%	  BN-­‐PAGE	  
and	   analysed	   by	  Western-­‐blotting	   for	   COX	   subunits	   Cox1,	   Cox4	   and	   Cox5	   and	   the	   early	   COX	   assembly	   factor	  
Cox14.	   Asteriks	   indicates	  monomeric	   COX	   (B)	   Co-­‐immunoprecipitation	   of	   Coa3	   (and	   control)	   from	   digitonin-­‐
solubilized	   wild	   type	   or	   cox10Δ	   mitochondria.	   Bound	   material	   was	   eluted	   and	   analysed	   by	   SDS-­‐PAGE	   and	  
Western	  blotting	  (total	  8%,	  eluate	  100%).	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As	   expected,	   in	  mitochondria	   isolated	   from	   cox15Δ	   and	   cox10Δ	   (that	   lack	   heme	   a	   or	  
heme	  a	  and	  o,	  respectively),	  no	  mature	  cytochrome	  c	  oxidase	  was	  detected.	  Instead,	  on	  
BN-­‐PAGE,	  an	  assembly	   intermediate	  of	  cytochrome	  c	  oxidase	  of	   identical	   size	   (around	  
220	  kDa)	  accumulated	  in	  both	  strains,	  represented	  by	  detection	  of	  the	  early	  cytochrome	  
c	  oxidase	  subunits	  Cox1	  and	  Cox5	  as	  well	  as	  the	  assembly	  factor	  Cox14.	  The	  late	  subunit	  
Cox4,	   however	   was	   not	   detected	   in	   this	   assembly	   intermediate	   (FIG	   3.20;	   A).	   An	  
intermediate	  of	  similar	  size	  was	  found	  also	  in	  the	  strain	  that	  lacked	  the	  assembly	  factor	  
Shy1.	  In	  a	  coa1Δ strain,	  the	  intermediate	  complex	  was	  also	  detected	  but	  shifted	  slightly	  
to	  a	  smaller	  size,	  potentially	  indicating	  that	  the	  intermediate,	  described	  above,	  contains	  
Coa1	  (FIG	  3.7).	  
We	  speculated	  that	  this	  220	  kDa	  complex	  reflects	  the	  assembly	  stage	  at	  which	  the	  heme	  
a	   is	   inserted	   into	  Cox1.	  The	   fact	   that	   the	  accumulated	  complex	   is	  not	  shifted	   in	  size	   in	  
cox15Δ,	  compared	  to	  cox10Δ,	  indicated	  that	  Cox15	  was	  no	  stoichiometric	  component	  of	  
the	   complex.	   This	   finding	   agreed	  with	   the	   small	   fraction	   of	   Cox15,	   compared	   to	   total	  
levels,	   that	   were	   found	   to	   co-­‐isolate	   with	   COA	   complexes	   (FIG	   3.16,	   lanes	   1-­‐3).	   To	  
determine	  if	  Cox15	  was	  associated	  with	  COA	  complexes	  in	  cox10Δ,	  we	  performed	  Coa3	  
immunoprecipitation	   from	   these	  mitochondria	   (FIG	   3.20;	   B).	   In	   cox10Δ,	   the	   assembly	  
factors	   (Coa1,	   Cox14,	   Shy1),	  Mss51,	   structural	   subunits	   (Cox1,	   Cox5)	   and	  Cox15	  were	  
efficiently	  and	  specifically	  precipitated	  by	  the	  Coa3	  antibody.	  The	  small	  residual	  amount	  
of	   Cox1	   in	   the	   mutant	   was	   present	   in	   Coa3	   containing	   complexes,	   indicating	   the	  
accumulation	  of	  COA	  complexes	  in	  cox10Δ	  mitochondria,	  previously	  observed	  with	  BN-­‐
PAGE	   analysis	   (FIG	   3.20;	   A).	   Accordingly,	   the	   Cox15	   interaction	   with	   Cox1	   assembly	  
intermediates	  occured	   independently	  of	   the	  heme	  o	   synthase	  Cox10	  and	  the	  substrate	  
of	  the	  heme	  a	  synthase	  Cox15,	  heme	  o.	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3.2.4	  Association	  of	  Cox15	  and	  Shy1	  with	  COA	  complexes	  
3.2.4.1	  Shy1	  is	  not	  required	  for	  Cox15	  association	  to	  COA	  complexes	  
Shy1	  and	  its	  homolog	  SURF1	  have	  been	  implicated	  to	  assist	  in	  the	  heme	  a	  insertion	  into	  
Cox1	  (Bundschuh	  et	  al.	  2009).	  As	  we	   found	   the	   terminal	  enzyme	  of	  heme	  a	  synthesis,	  
Cox15,	  to	  interact	  with	  Shy1	  and	  with	  COA	  complexes,	  we	  asked	  whether	  the	  interaction	  
with	   COA	   complexes	   might	   be	   promoted	   by	   Shy1.	   Therefore,	   we	   analysed	   the	  
interaction	   of	   Cox15	   with	   COA	   complexes	   in	   absence	   of	   Shy1.	   To	   address	   this,	   we	  
performed	  Coa3	  immunoprecipiation	  from	  shy1Δ mitochondria,	  compared	  to	  wild	  type	  
and	   analysed	   Cox15	   and	   selected	   proteins	   in	   the	   eluates	   by	   SDS-­‐PAGE	   and	   Western	  
blotting	   (FIG	   3.21;	   A).	   In	   shy1Δ,	   Cox15	   is	   precipitated	   with	   Coa3,	   together	   with	   the	  
assembly	   factor	   Cox14,	   translational	   regulator	  Mss51	   and	   early	   assembling	   structural	  
subunits	  of	  cytochrome	  c	  oxidase	  (Cox1,	  Cox5,	  Cox6).	  Despite	  the	  reduced	  levels	  of	  Cox1	  
in	   shy1Δ,	   similar	   amounts	   were	   found	   in	   COA	   complexes	   in	   wild	   type	   and	   mutant	  





FIG	  3.21	  Association	  of	  Shy1	  and	  Cox15	  with	  COA	  complexes	  
(A)	  Co-­‐immunoprecipitation	  of	  Coa3	  (and	  control)	  from	  digitonin-­‐solubilized	  wild	  type	  or	  shy1Δ	  mitochondria.	  
Bound	  material	  was	  eluted	  and	  analysed	  by	  SDS-­‐PAGE	  and	  Western	  blotting	   (total	  8%,	  eluate	  100%).	   (B)	  Co-­‐
immunoprecipitation	  of	  Coa3	  from	  wild	  type	  or	  cox15Δ	  mitochondria	  as	  in	  (A).	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3.2.4.2	  Cox15	  is	  not	  required	  for	  Shy1	  association	  to	  COA	  complexes	  
As	  the	  interaction	  of	  Cox15	  with	  COA	  complexes	  was	  not	  dependent	  on	  Shy1,	  we	  asked	  
in	  parallel	  if	  the	  recruitment	  of	  Shy1	  was	  dependent	  on	  Cox15.	  Therefore	  we	  performed	  
Coa3	   immunoprecipitation	   from	  wild	   type	   and	   cox15Δ	  mitochondria	   (FIG	   3.21;	   B).	   In	  
mitochondria	  lacking	  Cox15,	  COA	  complexes	  (indicated	  by	  the	  presence	  of	  Cox14,	  Coa1,	  
Mss51,	   Cox1	   and	   Cox5)	  were	   precipitated	  with	   identical	   efficiency,	   compared	   to	  wild	  
type.	  In	  analogy	  to	  shy1Δ	  cells,	  Cox1	  levels	  were	  also	  severely	  reduced	  in	  cox15Δ	  cell	  but	  
the	   residual	   amount	   accumulated	   in	   COA	   complexes	   and	  was	   efficiently	   precipitated.	  
Most	  interestingly,	  Shy1	  was	  also	  co-­‐precipitated	  from	  cox15Δ	  mitochondria.	  	  
We	   concluded	   that	   Cox15	   was	   not	   necessary	   for	   the	   association	   of	   Shy1	   with	  
cytochrome	  c	  oxidase	  assembly	  intermediates.	  Moreover,	  Shy1	  and	  Cox15	  were	  able	  to	  
associate	  with	  cytochrome	  c	  oxidase	  assembly	  intermediates	  independent	  of	  each	  other.	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3.2.4.3	  Cox15	  associates	  with	  COA	  complexes	  in	  absence	  of	  Cox1	  
Evidence	   from	   the	   bovine	   cytochrome	   c	   oxidase	   structure	   (Tsukihara	   et	   al.	   1995;	  
Tsukihara	  et	  al.	  1996)	  suggested	  that	  insertion	  of	  heme	  a,	  that	  is	  unique	  to	  cytochrome	  c	  
oxidase,	  into	  Cox1	  has	  to	  occur	  before	  the	  addition	  of	  Cox2.	  We	  therefore	  asked	  if	  Cox15	  
interacts	  with	   COX	   assembly	   factors	   in	   the	   absence	   of	   Cox1	   or	   Cox2.	   To	   address	   this	  
question,	   we	   isolated	   mitochondria	   from	   cox1-­‐	   (Netter	   et	   al.	   1982)	   and	   cox2-­‐	  
(Kruszewska	   et	   al.	   1980)	   cells	   grown	   on	   YPGal.	   Immunoprecipitation	  with	   antibodies	  
directed	   against	   Coa3	   and	   Coa1	   were	   performed	   from	   digitonin	   solubilized	  
mitochondria,	   followed	   by	   Western	   blot	   analysis	   for	   the	   presence	   of	   Cox15	   and	  
cytochrome	   c	   oxidase	   assembly	   factors	   (FIG	   3.22).	   In	   the	   absence	   of	   Cox1,	   Coa3	  
precipitated	  Cox14,	  but	   in	  comparison	  to	  wild	  type	  or	  cox2-­‐,	   failed	  to	  precipitate	  Cox1,	  
Shy1	  or	  Mss51.	  Cox15	  however	  was	  efficiently	  isolated	  in	  the	  absence	  of	  Cox1	  and	  Cox2	  
(FIG	   3.22;	   A).	   Similar	   results	   were	   obtained	   by	   immunoprecipitation	   of	   Coa1	  
(FIG	  3.22;	  A).	  
Accordingly,	  Cox15	  was	  able	   to	   interact	  with	  Coa3,	  Coa1	  and	  Cox14	   in	   the	  absence	  of	  
Cox1	   in	   a	   way	   comparable	   to	   wild	   type.	   In	   contrast,	   the	   interaction	   of	   Shy1	   with	  




FIG	  3.22	  Association	  of	  Shy1	  and	  Cox15	  with	  COA	  complexes	  in	  absence	  of	  Cox1	  or	  Cox2	  
(A)	   Co-­‐immunoprecipitation	   of	   Coa3	   (and	   control)	   from	   digitonin-­‐solubilized	   wild	   type,	   cox1-­‐	   or	   cox2-­‐	  
mitochondria.	   Bound	  material	  was	   eluted	   and	   analysed	   by	   SDS-­‐PAGE	   and	  Western	   blotting	   (total	   8%,	   eluate	  
100%).	  (B)	  Co-­‐immunoprecipitation	  of	  Coa1	  as	  in	  (A).	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3.2.4.4	  Cox15	  and	  Shy1	  form	  complexes	  in	  absence	  of	  mitochondrial	  DNA	  
Next,	   we	   analysed	   the	   differential	   behavior	   of	   Shy1	   and	   Cox15	   in	   respect	   to	   their	  
interaction	   with	   assembly	   factors	   in	   a	   native	   way.	   As	   elution	   after	   co-­‐
immunoprecipitation	   was	   only	   possible	   in	   a	   denaturing	   way	   and	   due	   to	   the	   lack	   of	  
genomic	  markers,	  chromosomal	  tagging	  of	  Shy1	  or	  Cox15	  was	  not	  possible	  in	  the	  cox1-­‐	  
and	   cox2-­‐	   background.	  We	   therefore	   had	   to	   pursue	   a	   different	   experimental	   strategy.	  
The	   mutagen	   ethidium	   bromide	   has	   been	   used	   to	   reduce	   the	   mitochondrial	   copy	  
number	   (Diaz	   et	   al.	   2002).	   By	   growth	   of	   Shy1ProtA	   cells	   on	  media	   containing	   EtBr,	  we	  
generated	   a	   strain	   lacking	  mitochondrial	   DNA	   (rho0)	   and	   as	   a	   consequence	   also	   Cox1	  
and	   all	   proteins	   encoded	   by	   the	  mitochondrial	   genome.	   Cox2	   however,	   as	   previously	  
shown,	   had	   no	   significant	   effect	   on	   the	   association	   of	   Shy1	   and	   Cox15	   with	   COA	  
complexes	  (FIG	  3.22).	  We	  isolated	  mitochondria	  from	  wild	  type,	  Shy1ProtA	  and	  Shy1ProtA,	  
lacking	  mitochondrial	  DNA,	  grown	  on	  YPGal.	  Solubilized	  mitochondria	  were	  subjected	  
to	   IgG-­‐chromatography	  and	  proteins,	  eluted	  with	  acidic	  buffer,	  were	  analysed	  by	  SDS-­‐




FIG	  3.23	  Interaction	  of	  Shy1	  and	  Cox15	  in	  the	  absence	  of	  mitochondrial	  DNA	  (rho0)	  
(A)	   Purification	   of	   Shy1ProtA	   containing	   complexes	   by	   IgG-­‐chromatography	   from	   wild	   type	   mitochondria,	  
compared	  to	  mitochondria	  lacking	  mitochondrial	  DNA	  (rho0).	  Total	  samples	  and	  acidic	  elution	  were	  analysed	  by	  
SDS-­‐PAGE,	   followed	  by	  Western	  blotting.	  Amounts	  of	  protein	   loaded	  in	  the	  total	  samples	  correspond	  to	  3%	  of	  
the	  elution.	  Asterisk	  indicates	  a	  cross-­‐reactive	  signal	  (B)	  Purification	  of	  Shy1ProtA	  containing	  complexes	  by	  IgG-­‐
chromatography	  from	  strains	  as	  in	  (A).	  TEV	  cleaved	  native	  eluates	  were	  separated	  by	  4-­‐13%	  BN-­‐PAGE,	  followed	  
by	  Western	  blotting.	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For	   analysis	   of	   native	   protein	   complexes,	   proteins	  were	   cleaved	   off	   the	   resin	   by	   TEV	  
protease	  and	  subsequently	  analysed	  by	  BN-­‐PAGE	  and	  Western	  blotting	  (FIG	  3.23;	  B).	  In	  
the	  absence	  of	  mitochondrial	  DNA	  and	  mitochondria-­‐encoded	  proteins,	  Cox15	  was	  still	  
detectable	  after	  Shy1ProtA	  isolation.	  As	  expected,	  in	  contrast	  to	  wild	  type,	  no	  components	  
of	   COA	   complexes	   were	   copurified	   from	   rho0	   cells.	   When	   the	   native	   eluate	   of	   IgG-­‐
chromatography	  was	   analysed	   by	   BN-­‐PAGE,	   we	   observed	   Shy1	   in	   distinct	   complexes	  
and	   Cox15	   in	   complex	   with	   Shy1,	   predominantly	   at	   smaller	   size	   but	   also	   in	   higher	  
molecular	  weight	  COA	  complexes,	  as	  previously	  seen	  (FIG	  3.	  13).	  In	  contrast	  in	  Shy1ProtA,	  
lacking	   mitochondrial	   DNA,	   only	   the	   two	   smaller	   complexes	   were	   isolated	   and	  
contained	  Cox15.	  
Taken	  together,	  the	  association	  of	  Shy1	  and	  Cox15	  occurred	  independently	  of	  Cox1	  (or	  
mitochondrial	  DNA).	  In	  addition,	  Cox15	  was	  able	  to	  bind	  Coa3	  and	  Coa1	  in	  the	  absence	  








In	   this	   study,	   different	   stages	   in	   the	   early	   cytochrome	   c	   oxidase	   assembly	   steps	  were	  
analysed.	  We	  started	  with	   the	  membrane	   insertion	  of	   the	  central	   subunit	  Cox1	  by	   the	  
Oxa1	  insertase.	  Next,	   isolations	  of	   interaction	  partners	  of	  Mss51	  were	  used	  to	  address	  
the	   feedback	   regulation	   mechanism	   of	   COX1	   translation.	   Furthermore,	   the	   dual	  
functionality	   of	   Shy1	  was	  dissected	  with	   the	  help	  of	   a	   Leigh	   syndrome	  patient	   SURF1	  
mutation,	   transferred	   to	   yeast	   Shy1.	   Finally	   assembly	   intermediates	   containing	   the	  
assembly	   factor	   Shy1	   were	   characterized	   in	   an	   unbiased	   manner.	   This	   revealed	   the	  
unexpected	  interaction	  of	  the	  heme	  a	  synthase	  Cox15	  with	  early	  COX	  intermediates	  that	  
allowed	   speculations	   on	   the	   heme	   transfer	   mechanism	   and	   timing	   during	   Cox1	  
maturation.	  
4.1	   Oxa1-­‐Ribosome	   complexes	   coordinate	   the	   assembly	   of	  
cytochrome	  c	  oxidase	  
Oxa1	  plays	  an	  early	  role	  in	  cytochrome	  c	  oxidase	  biogenesis:	  The	  three	  core	  subunits	  of	  
cytochrome	   c	   oxidase	   (Cox1,	   Cox2	   and	   Cox3)	   are	   synthesized	   on	   mitochondrial	  
ribosomes	   and	   inserted	   into	   the	   inner	   membrane	   in	   a	   co-­‐translational	   reaction	  
facilitated	   by	   the	   Oxa1	   insertase	   (He	  &	   Fox	   1997;	   Hell	   et	   al.	   2001).	   In	   this	   study,	  we	  
characterize	   Oxa1	   variants	   with	   flexible	   linker	   regions	   of	   100	   or	   200	   amino	   acids,	  
inserted	   between	   the	   N-­‐terminal	   insertase	   domain	   and	   the	   C-­‐terminal	   ribosome-­‐
binding	   region.	   These	  mutants,	   in	   the	   combination	  with	   the	   absence	   of	   the	   ribosome	  
receptor	  Mba1,	  show	  reduced	  cytochrome	  c	  oxidase	  activity,	  caused	  by	  the	  reduction	  of	  
Cox1	  steady-­‐state	   levels	  and	  cytochrome	  c	  oxidase-­‐containing	  supercomplexes	  (Keil	  et	  
al.	   2012).	   As	   membrane	   insertion	   of	   mitochondrial	   translation	   products	   remained	  
unaffected	  we	  concluded	  that	  the	  defects	  observed	  in	  the	  linker	  mutants	  are	  not	  caused	  
by	  a	  block	  in	  membrane	  insertion	  but	  rather	  occur	  further	  downstream	  in	  the	  assembly	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Interestingly,	  several	   factors	   involved	   in	  cytochrome	  c	  oxidase	  assembly	  or	  biogenesis	  
have	  previously	  been	  shown	  to	  bind	  to	  mitochondrial	  ribosomes:	  
Cox11,	   the	  protein	  required	   for	  copper	  delivery	  to	  newly	  synthesized	  Cox1,	  associates	  
with	  the	  mitochondrial	  translation	  machinery	  (Khalimonchuk	  et	  al.	  2005).	  
Mdm38,	   an	   inner	   membrane	   protein,	   cooperates	   with	   Mba1	   in	   ribosome	   binding.	  
Moreover,	   Mdm38	   is	   a	   critical	   regulatory	   factor	   of	   the	   synthesis	   and	   assembly	   of	  
mitochondrial	   translation	   products	   (Frazier	   et	   al.	   2006;	   Bauerschmitt	   et	   al.	   2010).	  
Therefore,	   simultaneous	   loss	   of	   Mba1	   and	   Mdm38	   leads	   to	   severe	   defects	   in	   the	  
biogenesis	   of	   respiratory	   chain	   complexes	   III	   and	   IV,	   not	   caused	   by	   disturbed	  
membrane	   binding	   of	   the	   mitochondrial	   ribosome	   but	   rather	   by	   misregulation	   of	  
synthesis	  of	  cytochrome	  b	  (Cob)	  or	  Cox1,	  respectively	  (Bauerschmitt	  et	  al.	  2010).	  
Mss51,	   a	   protein	   loosely	   associated	   with	   the	   matrix	   side	   of	   the	   inner	   membrane,	  
interacts	  with	  mitochondrial	  ribosomes	  and	  initiates	  COX1	  translation	  (Perez-­‐Martinez	  
et	  al.	  2003;	  Barrientos	  et	  al.	  2004).	  Additionally,	  Mss51	  serves	  as	  a	  chaperone	  binding	  
directly	  to	  newly	  synthesized	  Cox1	  and	  to	  the	  assembly	  factors	  Cox14,	  Coa1,	  Coa3,	  and	  
Shy1	  (Pierrel	  et	  al.	  2007;	  Mick	  et	  al.	  2010;	  Fontanesi	  et	  al.	  2011).	  This	  dual	  functionality	  
of	  Mss51	  directly	  couples	  synthesis	  of	  Cox1	  to	  assembly	  of	  cytochrome	  c	  oxidase	  (Perez-­‐
Martinez	  et	  al.	  2009).	  These	  examples	  illustrate	  that	  the	  mitochondrial	  ribosome	  is	  able	  
to	   serve	   as	   a	   binding	   platform	   for	   COX	   assembly	   factors.	   In	   yeast,	   several	   feedback	  
mechanism	   regulating	   translation	   of	   mitochondria-­‐encoded	   subunits	   of	   respiratory	  
chain	   complexes	   have	   been	   described	   (Fontanesi	   2013).	   In	   the	   case	   of	   cytochrome	   c	  
oxidase,	  translation	  of	  the	  central	  subunit	  Cox1	  is	  regulated	  by	  Mss51	  in	  dependence	  of	  
the	  assembly	  state	  of	  newly	  synthesized	  Cox1	  (Perez-­‐Martinez	  et	  al.	  2003;	  Barrientos	  et	  
al.	   2004;	   Perez-­‐Martinez	   et	   al.	   2009).	   In	   this	   context,	   it	   is	   reasonable	   to	   tether	   the	  
ribosome	   close	   to	   the	   site	  of	   cytochrome	  c	   oxidase	   assembly,	   the	  mitochondrial	   inner	  
membrane.	  
In	  mba1Δ cells	   expressing	  Oxa1100	   or	  Oxa1200,	   the	   tight	   contact	   of	   ribosomes	  with	   the	  
membrane	   is	   lost.	   This	   may	   impair	   the	   function	   of	   different	   assembly	   factors	   and	  
therefore	   efficiency	   of	   cytochrome	   c	   oxidase	   assembly	   is	   decreased.	   Thus,	   the	   close	  
proximity	  of	  Oxa1	  to	  the	  ribosome	  is	  not	  only	  important	  for	  the	  membrane	  insertion	  but	  
also	   for	   cytochrome	   c	   oxidase	   biogenesis.	   We	   speculate	   that	   the	   spatial	   proximity	   of	  
mitochondrial	   ribosomes	   to	   the	   insertion	   site	   in	   the	   inner	   membrane,	   mediated	   by	  
Oxa1,	   allows	   the	   binding	   of	   assembly	   factors	   required	   for	   biogenesis	   of	   cytochrome	   c	  
oxidase	  (FIG	  4.1).	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FIG	  4.1	  Mitochondrial	  ribosomes	  serving	  as	  a	  binding	  platform	  for	  COX	  assembly	  factors	  
Spatial	  proximity	  of	  mitochondrial	  ribosome	  with	  the	  inner	  membrane	  enables	  assembly	  factors	  to	  bind	  to	  the	  
sites	  at	  which	  newly	  synthesized	  proteins	  are	  inserted	  into	  the	  membrane	  by	  Oxa1	  (upper	  panel).	  In	  the	  lower	  
panel,	   the	   membrane-­‐embedded	   insertase	   region	   and	   the	   ribosome-­‐binding	   region	   of	   Oxa1	   are	   spatially	  
separated	   by	   a	   flexible	   linker.	   The	   proposed	   coordination	   of	   assembly	   factors	   is	   interfered	   and	   therefore	  
assembly	  of	  cytochrome	  c	  oxidase	  is	  disturbed.	  Figure	  adapted	  from	  (Keil	  et	  al.	  2012).	  
	  
	  
In	   contrast	   to	   Oxa1,	   YidC,	   the	   bacterial	   member	   of	   the	   conserved	   YidC/Alb3/Oxa1	  
protein	   family,	   lacks	  a	  ribosome-­‐binding	  domain	  (Wang	  &	  Dalbey	  2011).	  According	   to	  
our	   results,	   one	   might	   speculate	   that	   this	   region	   has	   been	   added	   to	   Oxa1	   during	  
evolution	   for	   two	   distinct	   reasons.	   First,	   the	   additional	   ribosome-­‐binding	   domain	  
evolved	   to	   improve	   co-­‐translational	   insertion	   of	   membrane	   proteins.	   Second,	   the	  
positioning	  of	   the	  mitochondrial	   ribosome	   to	   the	   site	   of	   protein	   insertion	   enables	   the	  
ribosome	   to	   serve	   as	   binding	   platform	   for	   assembly	   factors.	   As	   mitochondrial	  
ribosomes,	  compared	  to	  their	  bacterial	  counterparts,	  only	  have	  a	  very	   limited	  number	  
of	  proteins	  to	  synthesize	  (8	  in	  S.	  cerevisiae,	  13	  in	  human),	  they	  were	  potentially	  able	  to	  
adopt	  this	  additional	  function.	  
Taken	   together,	   we	   report	   Oxa1-­‐Ribosome	   complexes	   to	   coordinate	   the	   assembly	   of	  
cytochrome	   c	   oxidase	   (Keil	   et	   al.	   2012).	   Further	   characterization	  of	   the	   structure	   and	  
function	  of	  these	  mitochondrial	  ribosome	  assembly	  complexes,	  e.g.	  by	   identification	  of	  
exact	  interaction	  surfaces	  using	  crosslinking	  techniques,	  will	  be	  exciting.	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4.2	  Interaction	  partners	  of	  Mss51	  in	  coa1Δ 	  
Mss51	  is	  a	  protein	  that	  fulfills	  dual	  functions.	  On	  the	  one	  hand	  it	  acts	  as	  a	  translational	  
activator	  (Perez-­‐Martinez	  et	  al.	  2003;	  Zambrano	  et	  al.	  2007).	  On	  the	  other	  hand,	  Mss51	  
is	  involved	  in	  cytochrome	  c	  oxidase	  assembly,	  together	  with	  other	  assembly	  factors.	  By	  
these	   dual	   activities,	   Mss51	   is	   able	   to	   regulate	   COX1	   translation	   in	   response	   to	   the	  
assembly	   state	   of	   Cox1	   via	   a	   feedback	   regulatory	  mechanism	   (Barrientos	   et	   al.	   2004;	  
Perez-­‐Martinez	   et	   al.	   2009).	   Furthermore,	   the	   protein	   associates	   with	   newly	  
synthesized	   Cox1	   and	   early	   assembly	   factors,	   such	   as	   Coa3,	   Cox14,	   Coa1	   and	   Shy1	  
(Barrientos	  et	  al.	  2004;	  Mick	  et	  al.	  2007;	  Pierrel	  et	  al.	  2007;	  Perez-­‐Martinez	  et	  al.	  2009;	  
Mick	   et	   al.	   2010;	   Reinhold	   et	   al.	   2011;	   Fontanesi	   et	   al.	   2011).	   The	   latter	   interaction	  
transfers	   Mss51	   into	   an	   sequestered	   inactive	   state.	   In	   coa1Δ mitochondria,	   Mss51	  
accumulates	   in	   one	   prominent	   assembly	   intermediate	   complex	   with	   Cox1	   (around	  
220	  kDa,	   compare	   FIG	   3.6;	   B)	   in	   its	   sequestered,	   but	   active	   form.	   As	   a	   consequence,	  
Mss51	   is	  not	  able	   to	  shut	  down	  COX1	   translation	  despite	  a	  defect	   in	   the	  cytochrome	  c	  
oxidase	   assembly	   process	   (Khalimonchuk	   et	   al.	   2010;	   Mick	   et	   al.	   2010).	   In	   order	   to	  
identify	   interaction	  partners	  of	  Mss51	   in	   the	  described	  complex,	  Mss51SF	  was	  purified	  
from	  coa1Δ	  mitochondria	  under	  native	  conditions.	  Yeast	  cells	  were	  grown	  under	  SILAC	  
conditions	   (see	   section	   2.9)	   in	   order	   to	   obtain	   quantitative	   data.	   Mass	   spectrometry	  
analysis	   reveals	   Cox1,	   Ssc1,	   Shy1,	   Cox5a,	   Cox6	   and	   Oms1	   to	   interact	   with	   the	   bait	  
protein.	   An	   interaction	   of	   the	   small	   COX	   assembly	   factors	   Coa3	   and	   Cox14	   was	   not	  
revealed	  with	  the	  SILAC	  analysis.	  However,	  Coa3	  and	  Cox14	  were	  confirmed	  to	  interact	  
with	  Mss51	  by	  Western	  blot	  analysis.	  
Cox1	   is	   found	   to	   interact	   with	   Mss51	   which	   is	   in	   line	   with	   the	   current	   model	   of	  
cytochrome	  c	  oxidase	  assembly,	  where	  Cox1	  forms	  the	  core	  of	  assembly	  intermediates	  
(e.g.	  reviewed	  in	  Mick	  et	  al.	  2011).	  Also	  in	  accordance	  with	  this	  model,	  Mss51	  is	  known	  
to	   be	   associated	  with	   Cox1	   during	   early	   assembly	   steps	   in	   order	   to	   sequester	  Mss51	  
(especially	   before	   Coa1	   is	   associated	   to	   the	   assembly	   intermediate).	   In	  
coa1Δ mitochondria,	   Mss51	   can	   not	   be	   released	   from	   the	   220	   kDa	   complex	   and	  
assembly	  intermediates	  accumulate	  (Khalimonchuk	  et	  al.	  2010;	  Mick	  et	  al.	  2010).	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It	   is	   very	  much	  under	  debate	  whether	   Shy1	  and	  Mss51	   can	  be	   found	   in	  one	   complex.	  
Several	  publication	  disclaimed	  this	  fact	  by	  density	  gradient	  experiments	  (Barrientos	  et	  
al.	  2002;	  Fontanesi	  et	  al.	  2010;	  Khalimonchuk	  et	  al.	  2010).	  However,	  other	  publications	  
applying	  other	  methods	  could	  show	  a	  clear	  copurification	  of	  Mss51	  and	  Shy1	  (Mick	  et	  
al.	   2007;	   Mick	   et	   al.	   2010).	  With	   this	   SILAC	   analysis,	   we	   present	   further	   evidence	   to	  
support	  the	  fact	  that	  Shy1	  and	  Mss51	  indeed	  are	  found	  in	  one	  complex.	  Nevertheless,	  it	  
is	   very	   surprising	   to	   find	   Shy1	   in	   a	   complex	   with	   Mss51,	   isolated	   from	   coa1Δ	  
mitochondria:	   Coa1	   was	   believed	   to	   promote	   the	   recruitment	   of	   Shy1	   to	   Cox1,	  
contributing	   to	   the	   release	   of	   Mss51	   from	   the	   COA	   complex	   (Pierrel	   et	   al.	   2007;	  
Khalimonchuk	   et	   al.	   2010).	   In	   contrast	   to	   this	  model,	   our	   results	   suggest	   that	   Shy1	   is	  
able	   to	   associate	   with	   early	   assembly	   intermediates	   independent	   of	   the	   presence	   of	  
Coa1.	  
Ssc1	   was	   described	   before	   to	   interact	   with	   Mss51	   (Krogan	   et	   al.	   2006)	   and	   Mss51-­‐
containing	   complexes	   (Fontanesi	   et	   al.	   2010)	   which	   is	   confirmed	   by	   the	   presented	  
results.	   However,	   Fontanesi	   and	   coworkers	   (2010)	   found	   Ssc1	   to	   be	   in	   one	   complex	  
with	  Mss51	  alone	   and	   in	   a	   further	   complex	  with	  Mss51,	  Cox14	  and	  Cox1.	   In	   contrast,	  
our	   data	   suggest	   that	   Ssc1	   is	   present	   in	   an	   additional	   complex	   with	   Cox1	   and	   early	  
assembly	  factors	  (Coa3	  and	  Cox14,	  as	  confirmed	  by	  Western	  blotting)	  that	  also	  contains	  
Shy1,	  Cox5a	  and	  Cox6.	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4.3	  New	  order	  in	  the	  assembly	  process	  of	  COX:	  Cox5a	  and	  Cox6	  	  
To	   our	   surprise	  we	   find	   Cox5a	   and	   Cox6	   as	   part	   of	   the	   220	   kDa	   complex	   isolated	   by	  
Mss51	  from	  coa1Δ	  mitochondria.	  Although	  it	  is	  known	  that	  Cox5a	  and	  Cox6	  are	  the	  first	  
nuclear-­‐encoded	  subunits	  that	  are	  added	  to	  the	  maturing	  cytochrome	  c	  oxidase,	  it	  was	  
believed	   that	   this	   event	   takes	   place	   at	   a	   downstream	   stage	   of	   the	   assembly	   process.	  
Cox5a	   and	   Cox6	   form	   a	   complex	  which	   is	   necessary	   for	   the	   stabilization	   of	   Cox5a.	   In	  
cox6Δ,	   only	   minor	   amounts	   of	   Cox5a	   remain	   detectable	   (Glerum	   &	   Tzagoloff	   1997;	  
Church	  et	  al.	  2005).	  According	  to	  our	  findings,	  the	  Cox5a/Cox6	  module	  is	  added	  to	  the	  
cytochrome	   c	   oxidase	   assembly	   complex	   even	   before	   Coa1	   and	   the	   release	   of	  Mss51.	  
Analysis	   of	   import	   and	   assembly	   of	   radiolabeled	   Cox5a	   into	   coa1Δ	   mitochondria	  
confirms	  that	  Cox5a	  is	  a	  component	  of	  the	  accumulating	  COA	  complex	  of	  about	  220	  kDa	  
(FIG	  3.6).	  
Therefore,	   we	   propose	   a	   novel	   order	   in	   the	   COX	   assembly	   process:	   after	   newly	  
synthesized	   Cox1	   is	   bound	   by	   Coa3,	   Cox14	   and	   Mss51,	   Shy1	   and	   the	   Cox5a/Cox6	  
module	  is	  recruited	  to	  the	  complex,	  independent	  of	  the	  action	  of	  Coa1.	  Moreover,	  Coa1	  
is	  not	  sufficient	  but	  rather	  requires	  the	  presence	  of	  the	  Cox5a/Cox6	  module	  in	  order	  to	  
recruit	  Shy1	  to	  COX	  assembly	  intermediates.	  The	  finding	  that	  the	  addition	  of	  Cox6	  is	  a	  
key	  step	  in	  the	  release	  of	  Mss51	  from	  assembling	  complexes	  is	  further	  supported	  by	  a	  
comparison	  of	  Cox1	  synthesis	   rates	   in	  a	   set	  of	   cytochrome	  c	  oxidase	  mutants.	  Shingu-­‐
Vazquez	  and	  co-­‐workers	  (2010)	  showed	  that	  deletion	  of	  the	  nuclear	  COX6	  gene	  causes	  
the	   greatest	   reduction	   of	   mitochondrial	   translation	   of	   Cox1,	   compared	   to	   other	  
assembly	  factors,	  such	  as	  Coa1	  (Shingú-­‐Vázquez	  et	  al.	  2010).	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4.4	  Oms1:	  a	  new	  player	  in	  COX	  assembly?	  
Oms1	   is	   an	   integral	   inner	   mitochondrial	   membrane	   protein	   with	   a	   conserved	  
methyltransferase	  motif,	  exposed	  to	  the	  IMS.	  Oms1	  has	  been	   implicated	   in	  respiratory	  
chain	   function	  as	   it	  was	   found	  to	  act	  as	  a	  multicopy	  suppressor	  of	  respiratory	  defects,	  
caused	  by	  OXA1	  mutations	  (Lemaire	  et	  al.	  2004).	  However,	  we	  identified	  an	  interaction	  
of	   Oms1	  with	   the	   translational	   activator	  Mss51.	   The	   interaction	   of	   Oms1	  with	  Mss51	  
could	   be	   confirmed	   by	   Oms1FLAG	   isolation	   (data	   not	   shown).	   In	   initial	   growth	   tests,	  
oms1Δ	  cells	  show	  no	  respiratory	  defect	  on	  non-­‐fermentable	  full	  media,	  but	  if	  challenged	  
by	   growth	   on	   minimal	   media,	   growth	   defects	   of	   oms1Δ	   become	   visible	   at	   24	  °C	   and	  
37	  °C.	   If	   mitochondria	   prepared	   from	   oms1Δ	   cells	   (grown	   on	   YPGal	   at	   30	  °C)	   are	  
analysed	  on	  a	  molecular	  level,	  reorganization	  of	  the	  respiratory	  chain	  supercomplexes,	  
containing	   COX	   can	   be	   observed	   (data	   not	   shown).	   For	   a	   long	   time,	   Mss51	   was	  
speculated	  to	  undergo	  some	  still	  undefined	  modification	  for	  regulation	  of	  its	  activity.	  It	  
is	   therefore	   tempting	   to	  speculate	   that	  Oms1	  might	  be	   involved	   in	   the	  modification	  of	  
Mss51.	  However,	   several	   facts	   argue	   against	   this	   theory.	   First	   of	   all,	   the	  nature	  of	   the	  
modification	   has	   to	   be	   elucidated.	   As	   Oms1	   contains	   a	   conserved	   methyltransferase	  
domain,	  methylation	  of	  Mss51	  is	  most	  likely.	  However,	  Mss51	  is	  so	  far	  not	  shown	  to	  be	  
modified,	  neither	  by	  methylation	  nor	  by	  another	  type	  of	  modification.	  Furthermore,	  the	  
methyltransferase	   domain	   of	   Oms1	   is	   localized	   to	   the	   IMS	   (Lemaire	   et	   al.	   2004),	   but	  
Mss51	   is	   found	   in	   the	   mitochondrial	   matrix	   (Barrientos	   et	   al.	   2004).	   However,	   the	  
topology	   of	   Oms1	   awaits	   confirmation.	   If	   Oms1	   would	   be	   responsible	   for	   the	  
modification	  of	  the	  translational	  activator	  Mss51,	  a	  change	  in	  mitochondrial	  translation,	  
particularly	   in	   Cox1,	  would	   be	   expected.	   However,	  mitochondrial	   translation	   remains	  
unaltered	   upon	   deletion	   of	   OMS1	   (at	   30	  °C,	   data	   not	   shown).	   In	   conclusion,	   most	  
evidence	  speaks	  against	  Oms1	  being	  the	  factor	  responsible	  for	  the	  regulation	  of	  Mss51	  
activity	  by	  methylation.	  Nevertheless,	   taken	  the	  genetic	   interaction	  with	  OXA1	  and	  the	  
physical	   interaction	   with	   Mss51,	   a	   role	   of	   Oms1	   in	   the	   biogenesis	   of	   cytochrome	   c	  
oxidase	  in	  the	  widest	  sense	  is	  highly	  likely.	  More	  evidence	  is	  required	  to	  understand	  the	  
exact	  molecular	   function	  of	  Oms1.	   In	  order	   to	   clarify	   this,	  mitochondria	   isolated	   from	  
oms1Δ	  cells	  grown	  on	  minimal	  media	  at	  non-­‐permissive	  temperature	  are	  interesting	  to	  
analyse.	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In	   addition,	   an	   antibody	   against	   Oms1	   has	   to	   be	   generated	   to	   be	   able	   to	   detect	   the	  
endogenous	  protein	  by	  Western	  blot	   analysis	   and	   to	  perform	   immunoprecipitation	  or	  
antibody-­‐shift	   assays.	   In	   parallel,	   import	   of	   radiolabeled	   Oms1	   into	   isolated	  
mitochondria	  and	  assembly	   into	  potential	  assembly	   intermediates	  or	  even	   the	  mature	  
oxidase	  can	  be	  analysed.	  Furthermore,	  epitope	  tagged	  Oms1	  can	  be	   isolated	  in	  a	  more	  
preparative	   way	   in	   order	   to	   identify	   interacting	   proteins	   by	   a	   combination	   of	   mass	  
spectrometry	   and	  Western	   blotting,	   as	   it	   was	   done	   for	   Shy1-­‐containing	   complexes	   in	  
this	  study.	  
4.5	  Accumulation	  of	  COA	  complexes	  in	  a	  SHY1	  mutant	  
Leigh	   syndrome,	   a	   fatal	   encephalomyopathy,	   is	   often	   associated	   with	   cytochrome	   c	  
oxidase	   deficiency.	   Multiple	   mutations	   in	   SURF1,	   an	   assembly	   factor	   of	   COX,	   are	  
described	   to	   cause	   Leigh	   syndrome	   (Péquignot	   et	   al.	   2001;	   Shoubridge	   2001).	   In	   this	  
study,	   we	   use	   the	   yeast	   homolog	   of	   SURF1,	   Shy1,	   to	   study	   defects	   in	   COX	   assembly	  
observed	   in	   Leigh	   syndrome	   patients.	   Therefore,	   a	  missense	  mutation	   of	   a	   conserved	  
amino	  acid	  that	  is	  reported	  from	  Leigh	  syndrome	  patients	  was	  transferred	  to	  the	  yeast	  
homolog	   Shy1	   (SURF1Y274D/Shy1Y344D).	   SURF1Y274D	   is	   known	   to	   affect	   cytochrome	   c	  
oxidase	   biogenesis	   (Teraoka	   et	   al.	   1999).	   Yeast	   strains	   expressing	   the	   corresponding	  
mutant	  Shy1YD	  display	  a	  cold	  sensitive	  growth	  phenotype	  on	  non-­‐fermentable	  media.	  As	  
a	   consequence	  of	   defective	  COX	  assembly,	   levels	   of	  mature	  COX	  and	   of	  mitochondria-­‐
encoded	   subunits	   Cox1	   and	   Cox2	   are	   severely	   reduced.	   Synthesis	   of	   Cox1	   occurs	   at	  
same	  rates	  in	  wild	  type	  and	  mutant	  strains,	  however	  newly	  synthesized	  Cox1	  undergoes	  
rapid	   degradation	   in	   the	   strain,	   expressing	   Shy1YD	   (Reinhold	   et	   al.	   2011).	   The	  
degradation	   of	   misfolded	   or	   in	   this	   case,	   unassembled	   proteins	   is	   mediated	   by	  
mitochondrial	  inner	  membrane	  m-­‐AAA	  proteases	  (Guzélin	  et	  al.	  1996;	  Arlt	  et	  al.	  1998).	  
Therefore,	   we	   conclude	   that	   in	   yeast	   cells,	   expressing	   Shy1YD,	   COX1	   translational	  
regulation	   is	   uncoupled	   from	   cytochrome	   c	   oxidase	   assembly.	   Similarly,	   the	   Y274D	  
exchange	  in	  SURF1	  alters	  the	  assembly	  process	  of	  cytochrome	  c	  oxidase,	  leading	  to	  the	  
accumulation	   of	   an	   COX	   assembly	   intermediate	   of	   200	   kDa	   (Reinhold	   et	   al.	   2011).	   In	  
order	   to	   elucidate	   the	   reason	   behind	   this	   uncoupling	   phenomenon	   in	   yeast,	   COA	  
complexes	   were	   isolated	   by	   Coa3-­‐immunoprecipitation.	   By	   analysis	   of	   co-­‐purified	  
proteins	  by	  SDS-­‐PAGE,	  no	  accumulation	  of	  components	  of	  COA	  complexes	  was	  observed	  
(Reinhold	  et	  al.	  2011).	  However,	  in	  this	  study,	  COA	  complexes	  are	  isolated	  and	  analysed	  
in	  their	  native	  state	  by	  BN-­‐PAGE.	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In	   contrast	   to	   previous	   analysis,	   accumulation	   of	   a	   complex,	   containing	   Shy1YD,	   Cox1	  
and	  Mss51	  was	  observed.	  Similar	  assembly	   intermediates	   containing	  Mss51	  and	  Cox1	  
accumulate	  in	  shy1Δ	  mitochondria	  (Pierrel	  et	  al.	  2007).	  Shy1	  fulfills	  a	  dual	  role	  in	  COX	  
assembly	   by	   releasing	   the	   COX1	   translational	   block	   and	   as	   an	   assembly	   factor,	  
potentially	   in	   heme	   insertion	   into	   newly	   synthesized	   Cox1	   (Mashkevick	   et	   al.	   1997;	  
Mick	   et	   al.	   2007;	   Bundschuh	   et	   al.	   2009).	   The	   cooperation	   of	   Shy1	   and	   Mss51	   is	   of	  
importance	   for	   the	   negative	   feedback	   regulation	   mechanism	   of	   COX1	   translation	  
(Perez—Martinez	  et	  al.	  2009).	  Under	   regular	   circumstances,	   this	  mechanism	  prevents	  
the	  accumulation	  of	  unassembled	  Cox1	  species	  that	  can	  potentially	  act	  as	  pro-­‐oxidants,	  
generating	  reactive	  oxygen	  species	  (Khalimonchuk	  et	  al.	  2007).	  Taken	  together,	  Shy1YD	  
is	  obviously	  still	  able	  to	  conduct	  one	  of	  its	  functions	  as	  mitochondrial	  translation	  rates	  
are	  comparable	  to	  wild	  type	  mitochondria.	  On	  the	  other	  hand,	  Shy1YD	  is	  no	  longer	  able	  
to	   promote	   Cox1	  maturation.	  We	   speculate	   that	  Mss51	   indeed	   is	   sequestered	   in	   COA	  
complexes,	  containing	  Shy1YD.	  Despite	  the	  successful	  sequestration,	  the	  mutant	  form	  of	  
Shy1	   is	  not	  able	   to	   transform	  Mss51	   into	   its	   inactive	   form.	  Thus,	  Mss51	   is	  still	  able	   to	  
initiate	   further	   rounds	   of	   Cox1	   synthesis	   although	   COX	   assembly	   can	   not	   progress.	  
These	  results	  also	  explain	  the	  molecular	  mechanism	  behind	  the	  defects	  leading	  to	  Leigh	  
syndrome	  in	  patients	  carrying	  the	  analysed	  Y274D	  mutant	  version	  of	  SURF1.	  SURF1YD	  is	  
efficiently	   imported	   into	   mitochondria	   and,	   in	   contrast	   to	   other	   described	   missense	  
mutations,	  remains	  stable.	  Despite	  these	  facts,	  cells	  expressing	  SURF1YD	  exhibit	  severe	  
defects	   in	   COX	   assembly	   that	   lead	   to	   the	   subsequent	   accumulation	   of	   SURF1YD	   in	  
assembly	  intermediates	  (Reinhold	  et	  al.	  2011).	  However,	  even	  in	  the	  absence	  of	  SURF1,	  
up	   to	   20%	   residual	   cytochrome	   c	   oxidase	   activity	   is	   observed	   in	   Leigh	   syndrome	  
patients	   (Tiranti	   et	   al.	   1998),	   indicating	   that	   assembly	   of	   the	   cytochrome	   c	   oxidase	   is	  
still	  possible	  to	  some	  extent.	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4.6	   The	   heme	   a	   synthase	   Cox15	   associates	   with	   cytochrome	   c	   oxidase	  
assembly	  intermediates	  during	  Cox1	  maturation	  
During	   assembly	   of	   cytochrome	   c	   oxidase,	   prosthetic	   groups	   have	   to	   be	   inserted	   into	  
Cox1	   and	   Cox2	   (Tsukihara	   et	   al.	   1995;	   Soto	   et	   al.	   2012).	   Although	   these	   non-­‐protein	  
cofactors	  are	  essential	   for	   the	  catalytic	  activity	  of	   the	  enzyme,	   little	   is	  known	  about	  at	  
which	  step	  of	   the	  assembly	  process	  the	   insertion	  occurs.	  Cox1,	   the	  core	  subunit	  of	   the	  
cytochrome	   c	   oxidase,	   receives	   two	   heme	   a	   cofactors	   during	   its	   maturation.	   After	  
combined	  mass	   spectrometry	   and	  Western	   blot	   analysis	   of	   Shy1-­‐containing	   assembly	  
intermediates,	  we	  unexpectedly	   found	   the	  heme	  a	   synthase	  Cox15	   to	   form	  complexes	  
with	   Shy1	   and	   to	   associate	   with	   cytochrome	   c	   oxidase	   assembly	   intermediates	  
(Bareth	  et	  al.	   2013).	   The	   heme	   a	   synthase	   Cox15	   catalyzes	   the	   last	   step	   of	   heme	   a	  
synthesis	   from	   heme	   o	   (Tzagoloff	   et	   al.	   1993).	   Shy1/SURF1	   is	   involved	   in	   Cox1	  
maturation,	   serving	   as	   an	   assembly	   factor	   of	   cytochrome	   c	   oxidase	   (Nijtmans	   et	   al.	  
2001;	  Mick	   et	   al.	   2007).	  A	   recent	   in	   vitro	   study	  with	   Surf1	   (a	  homolog	  of	   yeast	   Shy1)	  
from	   the	   bacterium	   P.	   denitrificans	   indicates	   its	   ability	   to	   bind	   heme	   a.	   This	   finding	  
linked	  Surf1	  function	  to	  the	  heme	  incorporation	  into	  Cox1	  during	  cytochrome	  c	  oxidase	  
biogenesis	   (Bundschuh	   et	   al.	   2009).	   Therefore,	   Surf1	   is	   proposed	   to	   act	   as	   a	   mobile	  
heme	  carrier	  between	   the	  heme	  a	   synthase	  and	  Cox1.	   In	  contrast,	  our	  results	   in	  yeast	  
indicate	  that	  Cox15	  is	  able	  to	  associate	  with	  Cox1-­‐containing	  complexes	  independent	  of	  
Shy1.	  We	  conclude	  that	  Shy1	  does	  not	  act	  as	  a	  mobile	  heme	  carrier,	  as	  proposed	  earlier,	  
but	   rather	   teams	  up	  with	  Cox15	   in	  order	   to	   transfer	  and	   insert	  heme	  a	   into	  maturing	  




FIG	  4.2	  The	  heme	  a	  synthase	  Cox15	  forms	  complexes	  with	  Shy1	  and	  associates	  with	  COA	  complexes	  
Cox15	  catalyzes	  the	  last	  step	  of	  the	  biogenesis	  of	  heme	  a,	  an	  essential	  cofactor	  of	  COX.	  Cox15	  is	  found	  in	  native	  
complexes	  with	  Shy1	  alone	  but	  also	   in	  COA	  complexes,	   together	  with	  assembly	   factors	  Coa3,	  Cox14,	  Coa1	  and	  
Shy1.	  This	  complex	  reflects	  the	  potential	  stage	  of	  heme	  insertion	  into	  maturing	  Cox1.	  Association	  of	  Mss51	  with	  
Cox15-­‐containing	  COA	  complexes	  was	  not	  specifically	  addressed.	  Inner	  mitochondrial	  membrane	  (IM).	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In	  addition,	  the	  presence	  of	  Shy1	  and	  Cox15	  in	  COA	  complexes	  allows	  to	  conclude	  that	  
the	   last	  step	  of	  heme	  a	  synthesis	  occurs	   in	  close	  proximity	  to	  the	  site	  of	   insertion	  into	  
the	  target	  protein,	  Cox1.	  This	  coupling	  would	  minimize	  the	  risk	  of	  damages	  to	  the	  cell	  
caused	  by	  the	  release	  of	  a	  highly	  reactive	  free	  heme	  moiety.	  In	  this	  context,	  not	  only	  a	  
spatial	  but	  even	  a	  timed	  coordination	  of	  both	  processes	  is	  imaginable.	  
4.7	  Association	  of	  Shy1	  and	  Cox15	  with	  COA	  complexes	  
Surprisingly,	   the	  association	  of	  Cox15	  with	  COA	  complexes	   is	   independent	  of	   Shy1.	   In	  
shy1Δ,	  Cox15	   is	   in	  complex	   together	  with	  Coa3,	  Cox14,	  Coa1	  and	  with	  Cox1,	   the	  heme	  
receiving	   protein.	   This	   finding	   is	   especially	   interesting	   as	   it	   explains	   residual	   COX	  
activity	  found	  not	  only	  in	  shy1Δ	  yeast	  mitochondria	  but	  also	  in	  Leigh	  syndrome	  patients	  
with	   SURF1	   mutations	   (Tiranti	   et	   al.	   1998;	   Zhu	   et	   al.	   1998;	   Barrientos	   et	   al.	   2002;	  
Mick	  et	   al.	   2007;	   Bestwick,	   Jeong,	   et	   al.	   2010a;).	   In	   order	   to	   display	   COX	   activity,	   the	  
essential	  heme	  groups	  have	  to	  be	  inserted	  into	  Cox1.	  Our	  results	  allow	  us	  to	  speculate	  
that	  Cox15,	  in	  the	  absence	  of	  Shy1/SURF1	  is	  able	  to	  perform	  this	  insertion,	  however	  at	  
drastically	  reduced	  efficiency.	  In	  contrast,	  disruption	  of	  COX15	  or	  mutations	  leading	  to	  a	  
catalytic	   inactive	   Cox15	   result	   in	   a	   complete	   loss	   of	   mature	   cytochrome	   c	   oxidase	  
(FIG	  3.18	   and	   Glerum	   et	   al.	   1997;	   Antonicka	   et	   al.	   2003).	   This	   is	   due	   to	   a	   lack	   of	   the	  
essential	   cofactor	  heme	  a	   (FIG	  4.3).	   The	  presented	   results	   indicate	   that	   enzymatically	  
compromised	   Cox15	   still	   forms	   complexes	   with	   Shy1	   and	   is	   associated	   with	   COA	  
complexes,	  indistinguishable	  from	  wild	  type	  Cox15.	  Therefore	  complex	  formation	  is	  not	  
linked	  to	  the	  heme	  a	  synthase	  activity	  of	  Cox15.	  The	  same	  is	  true	  in	  the	  absence	  of	  heme	  
o,	  the	  substrate	  of	  the	  heme	  a	  synthase.	  If	  the	  heme	  o	  synthase	  Cox10	  is	  deleted,	  Cox15	  
is	  not	  able	  to	  synthesize	  heme	  a	  but	  is	  still	  found	  in	  COA	  complexes.	  Taken	  together,	  our	  
results	  indicate	  that	  complex	  formation	  of	  Cox15	  with	  COA	  complexes	  and	  therefore	  the	  
role	   of	   Cox15	   in	   COX	   assembly	   is	   not	   linked	   to	   its	   catalytic	   activity.	   Therefore	   we	  
propose	  an	  additional	  chaperone-­‐like	  function	  of	  Cox15	  which	  is	  independent	  of	  its	  role	  
in	  the	  synthesis	  of	  heme	  a.	  We	  speculate	  that	  Cox15	  might	  not	  act	  as	  heme	  a	  synthase	  
but	  in	  addition	  as	  heme	  a	  insertase.	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FIG	  4.3	  Interaction	  of	  Cox15	  and	  Shy1	  with	  COA	  complexes	  	  
In	   wild	   type,	   Cox15	   interacts	   with	   Shy1	   and	   COA	   complexes,	   formed	   after	   membrane	   insertion	   of	   newly	  
synthesized	  Cox1.	  In	  the	  absence	  of	  Shy1	  (b),	  Cox15	  is	  still	  found	  in	  COA	  complexes,	  potentially	  inserting	  heme	  a	  
into	  Cox1	  without	  the	  cooperation	  with	  Shy1,	  accounting	  for	  residual	  amounts	  of	  active	  COX.	  In	  the	  absence	  of	  
Cox15	  (c),	  mature	  COX	  is	  absent	  due	  to	  a	  lack	  of	  essential	  cofactor	  heme	  a.	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4.8	  Conclusion	  	  
The	   results	   presented	   in	   this	   study	   add	   novel	   aspects	   that	   help	   for	   a	   more	   precise	  
understanding	  of	  early	  steps	  of	  cytochrome	  c	  oxidase	  assembly.	  	  
	  
i)	   Oxa1	   is	   involved	   not	   only	   in	   the	   membrane	   insertion	   of	   Cox1	   but	   acts	   also	   in	  
downstream	   processes	   of	   cytochrome	   c	   oxidase	   assembly.	   Oxa1	   ensures	   the	   spatial	  
proximity	   of	  mitochondrial	   ribosomes	   to	   the	   site	   of	  membrane	   insertion	   at	   the	   inner	  
membrane,	   important	   for	   membrane	   insertion	   of	   newly	   synthesized	   proteins.	  
Moreover,	  this	  Oxa1-­‐ribosome	  complex	  coordinates	  cytochrome	  c	  oxidase	  assembly	  by	  
providing	  a	  platform	  for	  binding	  of	  assembly	  factors	  (Keil	  et	  al.	  2012).	  
	  
ii)	  After	  membrane	  insertion	  of	  Cox1	  by	  the	  Oxa1	  insertase,	  early	  assembly	  factors	  such	  
as	  Coa3	  and	  Cox14	  as	  well	  as	   the	   translational	   regulator	  Mss51	  associate	   to	  Cox1	  and	  
form	   COA	   complexes.	   Subsequent	   binding	   of	   Coa1	   is	   believed	   to	   recruit	   Shy1	   to	   the	  
assembly	  intermediate	  and	  Mss51	  is	  sequestered	  and	  inactivated	  in	  this	  complex	  (Mick	  
et	  al.	  2007;	  Pierrel	  et	  al.	  2007).	  However	  our	  results	  propose	  a	  novel	  order	  in	  the	  COX	  
assembly	   process:	   after	   binding	   of	   Cox1	   by	   Coa3,	   Cox14	   and	   Mss51,	   Shy1	   and	   the	  
Cox5a/Cox6	  module	   are	   recruited	   to	   the	   complex,	   independent	   of	   the	   action	   of	   Coa1.	  
Moreover,	  Coa1	  is	  not	  sufficient	  for	  the	  recruitment	  of	  Shy1	  to	  assembly	  intermediates	  
but	  rather	  requires	  the	  presence	  of	  Cox5a/Cox6.	  
	  
iii)	   Oms1,	   a	   novel	   interaction	   partner	   of	   Mss51	   is	   identified.	   Oms1	   was	   originally	  
described	  as	  a	  multicopy	  suppressor	  of	  respiratory	  defects,	  caused	  by	  a	  OXA1	  mutation	  
(Lemaire	  at	  al.	  2004).	  Taken	   this	  genetic	   interaction	  and	   the	  physical	   interaction	  with	  
Mss51,	   Oms1	   is	   an	   interesting	   potential	   new	   candidate	   involved	   in	   cytochrome	   c	  
oxidase	   assembly.	   Initial	   results	   suggest	   respiratory	   defects	   and	   specific	   alteration	   of	  
cytochrome	   c	   oxidase	   containing	   supercomplexes	   upon	   deletion	   of	   OMS1,	   providing	  
direction	  for	  future	  studies.	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iv)	   Shy1	   couples	   Cox1	   translational	   regulation	   to	   COX	   assembly	   by	   a	   regulatory	  
feedback	  mechanism	   in	   yeast	  mitochondria	   (Barrientos	   et	   al.	   2002;	  Mick	   et	   al.	   2007).	  
Defects	   in	   cytochrome	   c	   oxidase	   assembly	   observed	   in	   Leigh	   syndrome	   patients	   are	  
studied	   using	   use	   the	   yeast	   homolog	   of	   SURF1,	   Shy1.	   In	   yeast	   cells	   expressing	   the	  
corresponding	   patient	   mutation	   form	   (Shy1YD),	   cytochrome	   c	   oxidase	   assembly	   is	  
disturbed	  but	  Cox1	  translation	  rates	  are	  comparable	  to	  wild	  type,	  indicates	  uncoupling	  
of	  translational	  regulation	  from	  cytochrome	  c	  oxidase	  assembly	  (Reinhold	  et	  al.	  2011).	  
This	   uncoupling	   phenomenon	   can	   be	   explained	   by	   the	   accumulation	   of	   an	   assembly	  
intermediate,	  containing	  Cox1,	  Mss51	  and	  Shy1YD.	  Based	  on	  this	  finding	  we	  propose	  that	  
Shy1YD	  is	  indeed	  able	  to	  sequester	  but	  not	  to	  transform	  Mss51	  into	  its	  inactive	  state.	  	  
	  
v)	   Biogenesis	   of	   mature,	   catalytic	   active	   cytochrome	   c	   oxidase	   requires	   the	  
incorporation	  of	  prosthetic	  groups	  into	  the	  core	  subunits	  Cox1	  and	  Cox2.	  Upon	  isolation	  
of	  Shy1-­‐containing	  complexes,	  we	  find	  the	  heme	  a	  synthase	  Cox15	  associated	  with	  Shy1	  
and	  with	   cytochrome	   c	   oxidase	   assembly	   intermediates,	   containing	   Cox1.	   This	   notion	  
allows	  the	  speculation	  that	  the	  transfer	  and	  insertion	  of	  heme	  a	   into	  maturing	  Cox1	  is	  
facilitated	  by	   the	   cooperated	   function	  of	   Shy1	  and	  Cox15.	   In	  addition,	   the	  presence	  of	  
Shy1	  and	  Cox15	  in	  COA	  complexes	  suggests	  that	  the	  last	  step	  of	  heme	  a	  synthesis	  occurs	  
in	   close	   proximity	   to	   the	   site	   of	   insertion	   into	   the	   target	   protein,	   Cox1	   (Bareth	   et	   al.	  
2013).	  
	  
vi)	   The	   reported	   interaction	   of	   Cox15	  with	   COA	   complexes	   persists	   upon	   deletion	   of	  
SHY1.	   In	   shy1Δ	   yeast	  mitochondria	  as	  well	   as	   in	  Leigh	   syndrome	  patients	  with	  SURF1	  
mutations	   residual	   COX	   activity	   is	   reported	   (Tiranti	   et	   al.	   1998;	   Zhu	   et	   al.	   1998;	  
Barrientos	   et	   al.	   2002;	  Mick	   et	   al.	   2007;	  Bestwick,	   Jeong,	   et	   al.	   2010a;).	   Therefore	  we	  
conclude	  from	  our	  results	  that	  Cox15,	  in	  the	  absence	  of	  Shy1/SURF1	  is	  able	  to	  perform	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  all	  my	  life.	  I	  would	  also	  like	  to	  thank	  my	  friends	  in	  Göttingen,	  Balingen	  
or	  wherever	  they	  are	  for	  their	  friendship	  throughout	  years	  and	  decades.	  And	  of	  course,	  I	  
thank	  Hartmut	  for	  his	  love,	  his	  constant	  support	  and	  for	  making	  me	  smile!	  
